MouseID Strain Sex Group Drug Date.of.Birth Date.Dose Date.Dead BW1 BW2 BW3 BW4 BW5 BW6 BW7 BW8 BW9 BW10 WBC1 RBC1 HGB1 HCT1 MCV1 MCH1 MCHC1 PLT1 NEUT1 LYMPH1 MONO1 EOS1 BASO1 Comment1 WBC2 RBC2 HGB2 HCT2 MCV2 MCH2 MCHC2 PLT2 NEUT2 LYMPH2 MONO2 EOS2 BASO2 Comment2 JAXW202-2129 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 21.9 21.5 21.3 20.6 20.6 20.7 19.8 20 NA NA 4.34 9.61 15.4 47.4 49.3 16 32.5 761 598.1 3310.6 417.9 10.4 3.5 2.76 9.41 12.3 44.6 47.4 13.1 27.6 379 244.81 2319.23 170.57 18.22 6.9 JAXW202-2130 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 15.3 14.5 14.2 13.8 14.2 14 13.7 14 NA NA 4.84 10.28 14.9 48.1 46.8 14.5 31 624 1001.9 3576.8 252.2 4.8 4.8 2.2 8.89 12 40.6 45.7 13.5 29.6 582 318.34 1774.52 97.02 8.36 1.76 JAXW202-2131 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 23.4 23 22.4 21.4 21 19.9 18.4 17.1 NA NA 10.54 10.69 16.6 54.3 50.8 15.5 30.6 585 1773.9 8022 708.3 27.4 9.5 4.22 11.13 16.6 57.8 51.9 14.9 28.7 205 652.41 3228.72 322.41 12.66 3.8 JAXW202-2132 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 23 22.3 21.4 20.8 20.8 20.3 19.6 20.6 NA NA 6.28 9.91 14.6 47 47.4 14.7 31.1 542 1073.9 5012.7 185.9 0.6 6.9 2.02 8.87 11.9 42.1 47.5 13.4 28.3 348 285.83 1645.49 62.22 21.01 5.05 JAXW202-2133 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 31.8 31.2 29.1 27.8 27.1 26.4 25.1 24 NA NA 4.72 10.15 14.8 49 48.3 14.6 30.2 671 1093.2 3345.5 270.5 10.9 0 2.18 8.06 11.4 37.6 46.7 14.1 30.3 NA 221.05 1853.44 83.06 13.73 8.94 JAXW202-2134 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 22 21.3 20.6 20.8 21.8 22.3 21.6 22.3 NA NA 3.12 10.6 15.1 65 61.3 14.2 23.2 682 313.9 2583 219.3 3.7 0 1.28 9.15 12.9 54 59 14.1 23.9 328 132.1 1081.22 61.44 5.25 0 JAXW202-2135 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 20.1 19.5 18.8 18.3 18.4 19.4 18.7 19.4 NA NA 4.8 9.81 13.9 45 45.9 14.2 30.9 678 988.8 3496.8 298.6 11.5 3.4 1.4 8 10.7 36.3 45.4 13.4 29.5 500 146.58 1171.24 73.36 5.32 3.5 JAXW202-2136 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 19.3 18.7 17.6 17.1 17.4 16.7 15.4 14.4 NA NA 6.68 10.62 16.1 52 49 15.2 31 643 1005.3 5357.4 313.3 3.3 0 2.52 10.28 15.3 49.9 48.5 14.9 30.7 349 272.16 2111 124.49 7.06 5.29 JAXW202-2137 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 19 18.4 18.1 18.2 18.3 18.4 18.1 17.9 NA NA 6.12 10.57 15.8 53 50.1 14.9 29.8 665 599.8 5251.6 254 14.1 0 1.64 9.24 13.2 44.9 48.6 14.3 29.4 382 289.95 1305.77 27.88 7.87 8.36 JAXW202-2138 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 19.9 19.4 19.1 18.8 19.1 19.7 19.3 19.6 NA NA 3.7 10.93 15.5 54 49.4 14.2 28.7 879 530.2 2944.5 222.4 3.3 0 2.06 9.11 13.1 43.5 47.7 14.4 30.1 595 257.29 1676.63 118.45 7.42 0 JAXW202-2139 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 21.4 20.9 20.8 19.3 19.5 19.9 18.8 20 NA NA 6.76 10.48 15.1 48.8 46.6 14.4 30.9 571 702.4 5593.2 465.1 0 0 2.92 9.92 13.5 44.4 44.8 13.6 30.4 481 121.18 2644.35 135.2 11.97 3.8 JAXW202-2140 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 17.7 17.5 17.4 17.8 17.9 18 17.8 18.1 NA NA 6.44 11.13 16.1 54.9 49.3 14.5 29.3 602 750.9 5304 371.6 10.9 1.9 4.22 9.53 13.4 45.4 47.6 14.1 29.5 581 276.83 3791.25 146.43 3.8 1.69 JAXW202-2141 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 26.3 25.5 25.7 23.6 24.1 23.5 21.8 21 NA NA 8.62 10.34 15.4 66.3 64.1 14.9 23.2 663 1604.2 6524.5 483.6 6 1.7 2.72 9.79 14 61.7 63 14.3 22.7 425 294.03 2289.7 130.83 5.44 0 JAXW202-2142 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 16.3 17.3 17.2 16.3 16.8 16.6 16.5 17.5 NA NA 5.2 10.27 15.5 48.9 47.6 15.1 31.7 602 1793 3057.1 319.3 29.1 1.6 2 7.62 10.9 36 47.2 14.3 30.3 615 289.6 1583 106 17.2 4 JAXW202-2143 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 20.3 20.7 20.2 19.4 19.4 19.1 19.8 19.3 NA NA 6.58 9.76 14.5 47 48.2 14.9 30.9 706 NA 4406.6 543.5 31.6 3.3 2.6 7.55 11.1 36.2 47.9 14.7 30.7 540 136.24 2399.54 48.1 1.82 14.3 JAXW202-2144 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 22.4 22.3 21.8 22.3 22.4 22.5 21.7 22 NA NA 6.66 11.22 15.8 67.3 60 14.1 23.5 708 1429.9 4800.5 413.6 8 8 2.34 8.92 12.4 52.1 58.4 13.9 23.8 516 219.73 2076.98 41.65 1.64 0 JAXW202-2145 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 16.9 16 15.1 15 15.4 15.8 15.7 15.5 NA NA 6.12 11.73 16.1 46.7 39.8 13.7 34.5 673 1021.4 4845.2 251.5 1.8 0 2.42 9.14 12.2 35.6 38.9 13.3 34.3 477 155.85 2195.91 64.61 1.69 1.69 JAXW202-2146 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 20.9 20.4 19 18.2 18.3 18.3 17.4 16.6 NA NA 8.26 11.94 16.8 56.4 47.2 14.1 29.8 822 1371.2 6335.4 545.2 5.8 3.3 2.38 9.9 13.8 44.8 45.3 13.9 30.8 376 324.39 1975.16 55.93 18.8 5.71 JAXW202-2147 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 27.9 26 24.6 23.8 23.1 23.2 22 21.2 NA NA 6.32 10.31 15.2 64.8 62.9 14.7 23.5 938 1261.5 4829.1 211.1 16.4 2.5 0.82 10.11 15 60.3 59.6 14.8 24.9 266 38.7 717.66 45.35 18.29 0 JAXW202-2148 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 17.5 16.7 16.2 16.8 17.4 17.7 17.3 17.1 NA NA 9.66 10.91 16.2 52.9 48.5 14.8 30.6 534 1527.2 7632.4 492.7 7.7 1.9 3 8.69 12 40.4 46.5 13.8 29.7 462 350.4 2494.2 155.4 0 0 JAXW202-2149 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 28.6 28.7 27.4 26.3 26 24.6 23.2 21.9 NA NA 5 10.36 15.2 50.1 48.4 14.7 30.3 661 895 3724 349 26.5 5.5 1.64 9.25 13.7 42.7 46.2 14.8 32.1 385 139.4 1394.82 90.53 15.09 0 JAXW202-2150 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 18.5 18.3 20.4 20 18.5 18.4 18.2 18.1 NA NA 4.3 10.36 15.3 51.3 49.5 14.8 29.8 773 865.2 3189.3 218.9 19.8 7.3 1.02 9.19 13 43.3 47.1 14.1 30 464 151.37 828.24 36.21 2.35 1.84 JAXW202-2151 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 23.4 22.3 22.4 22 21.9 21.6 21.1 21.5 NA NA 6.36 10.63 14.7 46.2 43.5 13.8 31.8 755 1485.7 4721 147.6 6.4 0 1.06 9.37 12.8 38.7 41.3 13.7 33.1 436 140.98 894 6.89 16.32 1.91 JAXW202-2152 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 21.4 21.7 21.6 18 19.7 19.1 17.6 16.8 NA NA 4.16 10.87 14.9 54.3 50 13.7 27.4 626 666.4 3286.8 199.3 7.1 0 3.38 8.99 12.9 43.9 48.8 14.3 29.4 359 186.24 3096.76 80.78 14.2 1.69 JAXW202-2153 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 16.2 15.6 17.7 15.1 15.4 15.3 14.8 15.3 NA NA 2.4 10 15.7 46.1 46.1 15.7 34.1 741 654.5 1559.8 171.6 14.4 0 1.04 9.84 13.4 44.1 44.8 13.6 30.4 474 127.61 871.83 36.82 1.87 1.87 JAXW202-2154 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 17.8 17.6 16.8 15.8 17 17.9 17.5 17.6 NA NA 3.92 11.14 11.6 61.6 55.3 NA 18.8 771 723.6 2904.3 283 9 0 1.56 8.86 12 48 54.2 13.5 25 499 181.43 1342.85 35.1 0.78 0 JAXW202-2155 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 19 18.5 17.5 17.3 17.9 18.5 18.4 18.6 NA NA 3.12 10.2 14.4 47.7 46.8 14.1 30.2 654 561.6 2408.6 138.8 7.2 3.7 1.74 8.1 11.4 36 44.4 14.1 31.7 489 148.6 1547.38 20.53 19.84 3.65 JAXW202-2156 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 23.8 22.2 21.7 20.3 19.5 18.7 17.8 17.3 NA NA 7.78 9.64 14.5 47.4 49.2 15 30.6 620 1160 6210.8 378.1 23.3 7 3.12 10.01 14.5 47.1 47.1 14.5 30.8 386 117.62 2810.5 130.73 57.72 3.43 JAXW202-2157 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 24 22.2 20.8 20 19.8 20 18.6 17.7 NA NA 5.24 10.6 15.8 53.8 50.8 14.9 29.4 627 843.6 4173.1 211.7 11.5 0 2.2 10.62 15.4 52.9 49.8 14.5 29.1 527 645.04 1443.42 86.02 25.52 0 JAXW202-2158 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 19.2 19.4 19.3 19.3 19.8 20.1 20.3 19.8 NA NA 11.38 10.22 15.1 51.7 50.6 14.8 29.2 613 1590.9 9370.3 406.3 12.5 0 4.26 9.15 12.7 44.2 48.3 13.9 28.7 359 176.79 3902.59 173.81 4.69 1.7 JAXW202-2159 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 20.5 19 18.5 17.4 17.6 17.7 17.3 17.4 NA NA 5.38 9.82 14.4 45.3 46.1 14.7 31.8 564 555.2 4525.1 288.9 6.5 3.8 2.2 8.43 12.4 37.4 44.4 14.7 33.2 543 426.8 1571.46 187 12.98 1.54 JAXW202-2160 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 22 21.4 20.4 20.4 20.2 19.9 19.6 21.6 NA NA 4.7 8.38 15.4 40 47.7 18.4 38.5 607 NA NA 50.9 30.1 3.3 3.06 10.48 14.5 48.6 46.4 13.8 29.8 489 521.73 2309.08 190.64 32.44 5.81 JAXW202-2161 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 23.6 23.6 24.3 23.1 23.6 23.9 23.4 23.6 NA NA 4 10.23 14.9 50.9 49.8 14.6 29.3 633 446.8 3334.4 208 3.6 7.2 2.6 9.13 12.6 44 48.2 13.8 28.6 487 147.94 2345.98 95.16 10.92 0 JAXW202-2162 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 32.9 31.4 30.1 28.7 28.3 27.8 26.2 25.3 NA NA 6.48 10.85 15.2 64.2 59.2 14 23.7 632 863.1 5148.4 460.1 9.1 0 1.42 11.41 15.3 65.5 57.4 13.4 23.4 344 386.1 944.3 82.79 2.7 3.98 JAXW202-2163 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 16.9 16.9 16.2 15.7 15.6 15.7 15.9 15.4 NA NA 5.14 10.21 15.5 52.5 51.4 15.2 29.5 685 408.1 4482.1 237.5 8.7 3.6 1.56 9.3 13.4 46.6 50.1 14.4 28.8 299 168.32 1306.5 78.16 7.18 0 JAXW202-2164 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 23.9 23.4 22.3 21.6 21.8 22.3 22.1 21.8 NA NA 10.8 10.45 15.6 65.6 62.8 14.9 23.8 748 1338.1 9101.2 334.8 23.8 3.2 4.16 9.69 13.5 57.1 58.9 13.9 23.6 446 192.19 3832.61 131.46 2.5 1.25 JAXW202-2165 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 18.3 17.5 16.1 15.5 15.9 15.9 15.4 15.8 NA NA 9.6 10.19 14.9 65.6 64.4 14.6 22.7 559 518.4 8707.2 365.8 8.6 0 2.84 9.64 13.7 59.4 61.6 14.2 23.1 257 89.46 2623.31 115.3 8.52 3.69 JAXW202-2166 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 19.5 19.5 18.3 17.8 18 17.9 16.6 15.9 NA NA 7.64 10.31 15.4 66.2 64.2 14.9 23.3 771 802.2 6519.2 309.4 5.3 3.8 1.94 10.13 14.8 63 62.2 14.6 23.5 510 161.41 1649 122.61 3.49 3.49 JAXW202-2167 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 25.3 25.1 24.7 23.3 23.3 23.3 22.9 22.9 NA NA 6.26 10.73 16.1 NA NA 15 NA 855 1100.5 4738.2 407.5 14.4 0.6 2.66 9.32 13.6 58 62.2 14.6 23.4 583 228.49 2253.82 148.16 26.33 3.46 JAXW202-2168 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 19.5 19.1 18.6 18.2 18.1 18 17 16.4 NA NA 5.24 10.39 15.5 63.1 60.7 14.9 24.6 634 517.7 4455 247.9 19.4 0 1.32 9.16 12.7 54.1 59.1 13.9 23.5 406 55.57 1200.14 62.96 1.32 0 JAXW202-2169 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 21.1 20.7 19.5 18.8 19.3 19.7 19 19 NA NA 9.78 9.41 14.7 45.2 48 15.6 32.5 593 785.3 8598.6 373.6 20.5 2 2.7 8.73 13 40 45.8 14.9 32.5 337 111.24 2470.77 109.08 7.02 1.89 JAXW202-2170 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 17.6 18 17.3 16.7 16.8 16.9 16.3 16.3 NA NA 9.56 10.73 14.9 50.1 46.7 13.9 29.7 634 2704.5 6574.4 248.6 28.7 3.8 3.74 9.32 12.7 42.1 45.2 13.6 30.2 493 592.79 3008.83 112.95 21.69 3.74 JAXW202-2171 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 17.8 17.3 16.5 16.3 16.8 17.7 17.3 17.3 NA NA 8.56 10.82 15.4 51.7 47.8 14.2 29.8 553 1241.2 6967 337.3 11.1 3.4 3.24 9.99 13.9 47.4 47.4 13.9 29.3 412 276.7 2875.5 82.94 3.89 1.62 JAXW202-2172 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 23 22.3 21.8 21.4 21.5 21.1 19.7 19.2 NA NA 6.76 10.82 15.8 54.2 50.1 14.6 29.2 641 1059.3 5406 281.9 12.8 0 1.78 10.46 14.9 50.8 48.6 14.2 29.3 446 155.39 1565.69 53.22 2.31 3.56 JAXW202-2173 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 20.9 20.2 19 18.4 18.9 19 18.4 18.3 NA NA 7.58 10.6 16.2 66.8 63 15.3 24.3 548 1324.2 5977.6 260 17.4 1.5 2.02 10.89 15.1 66.8 61.3 13.9 22.6 370 96.15 1843.05 76.15 4.85 0 JAXW202-2174 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 20.2 18.7 17.6 16.5 16.1 15.6 15 15.7 NA NA 4 10.8 15.5 63.2 58.5 14.4 24.5 551 1056.8 2787.6 130 26 0 2.04 10.06 13.7 57.8 57.5 13.6 23.7 353 161.98 1783.98 76.5 8.98 8.57 JAXW202-2175 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 18.9 18.4 17.4 16.5 17.1 16.7 15.3 16.1 NA NA 12.56 10 15.6 50.4 50.4 15.6 31 467 1679.3 10600.6 271.3 7.5 1.3 2.2 9.28 13.8 45.6 49.1 14.9 30.3 581 358.6 1730.52 103.84 7.04 0 JAXW202-2176 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 18.3 18.3 17.9 17.4 17.6 18.2 17.6 18.2 NA NA 6.98 10.96 15.2 66.1 60.3 13.9 23 459 2152.6 4236.9 393.7 180.1 17.5 2.54 9.47 13.7 55.4 58.5 14.5 24.7 336 477.27 2032 13.46 12.7 4.32 JAXW202-2177 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 20.6 19.8 18.9 18.6 19 20 18.9 19.8 NA NA 6.78 10.94 16 66.6 60.9 14.6 24 787 871.9 5688.4 200.7 14.9 3.4 3.62 9.79 13.2 57.3 58.5 13.5 23 488 497.39 2982.88 118.37 10.86 10.5 JAXW202-2178 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 23.4 22.5 21.1 20.2 20 19.1 17.9 17 NA NA 3.72 11.32 15.9 68.3 60.3 14 23.3 632 649.9 3001.7 57.3 11.2 0 2.3 10.78 15.7 62.3 57.8 14.6 25.2 418 104.65 2140.15 51.98 3.22 0 JAXW202-2179 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 19.7 20 19.7 18.8 18.8 19.2 18.9 19.1 NA NA 4.56 10.28 14.9 51.5 50.1 14.5 28.9 518 1136.8 3232.6 184.7 5.9 0 1.7 8.87 13.3 43.4 48.9 15 30.6 347 381.65 1170.79 142.12 5.27 0 JAXW202-2180 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 20.2 19.8 18.9 18.6 17 18.4 18 17.8 NA NA 6.84 10.05 14.7 46.2 46 14.6 31.8 634 789.3 5597.9 420.7 30.1 2.1 3.36 8.7 12.8 39.2 45.1 14.7 32.7 556 821.86 2386.61 135.41 10.75 5.71 JAXW202-2181 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 17.5 17.1 16.6 16.3 16.6 15.8 14.7 15.2 NA NA 2.62 10.09 15.4 49.5 49.1 15.3 31.1 569 516.9 1955.8 145.1 0 1.8 1.4 9.59 13.5 46.8 48.8 14.1 28.8 296 141.54 1171.24 84.7 2.24 0 JAXW202-2182 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 25.6 24.8 24.1 23 22.9 23.4 22.8 22.2 NA NA 3.16 9.76 16.2 49.5 50.7 16.6 32.7 516 754 2207.9 193.1 5.1 0 0.88 10.38 15 52.7 50.8 14.5 28.5 337 117.66 704.53 47.17 4.93 5.63 JAXW202-2183 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 17.1 16.8 16.3 16.6 16.6 16.8 16.3 16.6 NA NA 4.18 10.26 15.9 67.2 65.5 15.5 23.7 555 505.4 3362.8 288.4 20.5 2.5 1.5 8.84 13.2 57 64.5 14.9 23.2 334 55.2 1394.4 38.55 8.1 3.6 JAXW202-2184 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 20.2 20.9 19.7 19 20 20.9 20.6 20.7 NA NA 2.8 10.51 15 67.6 64.3 14.3 22.2 699 331.2 2277.2 182.3 7.3 1.7 1.58 9.84 13.4 61.6 62.6 13.6 21.8 399 359.13 1108.84 106.65 3.63 1.74 JAXW202-2185 Diversity Outbred Female Group 22 Doxorubicin Female Doxorubicin 2010-04-13 2010-06-03 NA 17 17.8 17.1 17.3 16.9 17 16.7 16.6 NA NA 5.54 9.19 14.6 51.4 55.9 15.9 28.4 598 825.5 4510.1 197.2 4.4 3.3 2.86 7.92 11.5 43.4 54.8 14.5 26.5 348 301.16 2446.44 110.68 1.72 0 JAXW202-2186 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.1 25.2 23.7 24.6 24.2 24.8 24.8 25.3 NA NA 4.1 12.14 15.7 56.9 46.9 12.9 27.6 898 731.9 3170.5 197.6 0 0 1.58 10.18 14.4 45.5 44.7 14.1 31.6 523 274 1295.4 4 3.2 3.5 JAXW202-2187 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 32.3 NA NA NA NA NA NA NA NA NA 8.14 10.74 15.4 68.4 63.7 14.3 22.5 942 1852.7 5733 536.4 15.5 1.6 NA NA NA NA NA NA NA NA NA NA NA NA NA JAXW202-2188 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 22.1 21.5 20.1 20.2 20 20 18.6 18.3 NA NA 10.04 10.16 15.1 48.5 47.7 14.9 31.1 646 1532.1 8045.1 416.7 39.2 6 1.28 9.27 13.6 40.9 44.1 14.7 33.3 288 111.6 1113.1 46.1 7.4 1.8 JAXW202-2189 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 29.3 27.6 26.4 26.2 27.1 26.9 25.7 24.3 NA NA 7.92 10.76 16.3 67 62.3 15.1 24.3 618 1291.8 6128.5 494.2 0 5.5 1.9 10.2 14.5 59.3 58.1 14.2 24.5 314 92.9 1733.4 72.2 1.3 0 JAXW202-2190 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 28.3 27.2 25.8 24.6 24.5 24.5 23 21.8 NA NA 8.26 11.17 16.1 64.6 57.8 14.4 24.9 776 1488.5 6514.7 249.5 5 1.7 0.98 10.92 15.5 60.1 55 14.2 25.8 467 63.7 860.6 47.5 4.6 3.5 JAXW202-2191 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 28 28.4 26.2 26.2 26.3 24.7 23.2 22.3 NA NA 7.26 9.94 15 49 49.3 15.1 30.6 606 1560.9 5569.9 119.1 10.9 0 0.9 9.12 13.2 42.8 46.9 14.5 30.8 338 93.2 785.6 11.8 7.6 1.8 JAXW202-2192 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 22.7 22.9 22.4 22.5 22.8 22.6 21.9 22.7 NA NA 7.1 10.18 15.1 65.2 64 14.8 23.2 922 678.8 6202.6 218.7 0 0 3.06 9.16 13.1 55 60 14.3 23.8 664 456.9 2520.8 61.5 20.8 0 JAXW202-2193 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 22.5 21.1 19.1 18.7 18 NA NA NA NA NA 7.06 9.99 14.7 50.1 50.2 14.7 29.3 605 1428.9 5465.9 153.9 7.1 3.5 1.18 10.99 16.3 55.3 50.3 14.8 29.5 829 381.97 685.34 101.6 11.09 0 JAXW202-2194 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 31.1 30.4 28.6 29.6 28.7 28.1 26.8 27.2 NA NA 8.56 9.92 15.9 53.7 54.1 16 29.6 847 1410.7 6806.9 332.1 6.8 3.4 1.4 9.64 14.8 49.2 51 15.4 30.1 371 130.8 1223.5 19.6 22.7 3.6 JAXW202-2195 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.3 25 23.6 24.1 24.5 24 22.1 21.5 NA NA 3.72 10.27 15.5 45 43.8 15.1 34.4 804 416.3 2952.2 349.7 0 1.9 0.7 10.3 14.9 43.4 42.1 14.5 34.3 467 137.1 513.2 41.4 8.3 0 JAXW202-2196 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 29.9 28.6 27.3 25.8 25.1 24 22.6 20.6 NA NA 4.46 10.57 15.5 61.6 58.3 14.7 25.2 888 775.6 3553.3 126.2 4.9 0 0.72 10.68 15.2 59.6 55.8 14.2 25.5 304 617 NA 19.9 NA 1.7 JAXW202-2197 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 27.7 26.8 25 24.3 24.1 23.4 22.4 22.7 NA NA 6.92 10.7 15.9 69.7 65.1 14.9 22.8 821 1166 5468.2 278.2 7.6 0 2 10.14 14.7 62.3 61.4 14.5 23.6 532 364.2 1520.6 103.8 7 4.6 JAXW202-2198 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 24.7 22.7 21 21 20.3 19.2 17.5 16.8 NA NA 4.14 10.4 16.2 49 47.1 15.6 33.1 794 465.3 3433.7 237.2 1.2 1.7 1.14 10.6 16.3 47.3 44.6 15.4 34.5 456 293.7 757 87.7 1.8 0 JAXW202-2199 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 34.3 34.7 31.7 30.7 29.4 29.2 27.7 27.2 NA NA 7.5 9.71 13.3 56.7 58.4 13.7 23.5 731 1139.3 6217.5 141.8 2.3 0 1.6 9.38 12.3 52 55.4 13.1 23.7 211 33.1 1521.1 35.4 5.1 5.4 JAXW202-2200 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 23.5 23.5 22.2 22.1 21.5 21.4 21.3 21.8 NA NA 11.1 10.6 16.3 50.6 47.7 15.4 32.2 655 2077.9 8673.5 333 13.3 2.2 2.22 9.34 14.1 42.3 45.3 15.1 33.3 389 263.1 1922.3 28 4.9 1.8 JAXW202-2201 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 29.7 28.6 27.5 26.7 27.2 27.5 26.3 26.4 NA NA 3.52 9.4 12.6 44.8 47.7 13.4 28.1 710 316.4 3040.2 151.7 6.3 5.3 1.54 8.66 12.5 39.7 45.8 14.4 31.5 497 229.5 1203.2 86.2 13.7 7.5 JAXW202-2202 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 30.1 28.1 26.2 25.5 24.1 24 22.2 21.3 NA NA 5.52 9.67 15.5 49.8 51.5 16 31.1 829 1041.1 4151.6 309.7 11 7.2 1.06 9.29 13.4 46.3 49.8 14.4 28.9 432 111.2 911 32.5 4.6 0.8 JAXW202-2203 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 24.9 22.3 21.5 20.4 20.5 19.7 18.5 17.1 NA NA 6.74 8.56 14.2 40.3 47.1 16.6 35.2 997 1073 5265.3 392.3 6.1 3.4 1.72 9.79 14.7 45.1 46.1 15 32.6 619 382.4 1284.3 31.8 19.8 1.9 JAXW202-2204 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.3 25.4 24.2 24.3 24.1 23.5 22 19.9 NA NA 7.02 10.58 15.7 64.5 61 14.8 24.3 840 1684.1 5145 172 9.8 9.1 0.98 9.24 12.9 54.1 58.5 14 23.8 398 43.9 917.6 16.8 1.8 0 JAXW202-2205 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.6 26 24.1 24 24.6 25.3 24.9 25 NA NA 8.1 11.91 15.7 67.1 56.3 13.2 23.4 656 1428.8 6194.1 460.1 16.2 0 2.38 9.65 13.1 50.7 52.5 13.6 25.8 344 431.5 1817.8 98.1 29.5 3.3 JAXW202-2206 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 24.9 23.5 22.1 21.6 22.7 23.4 22.8 23.7 NA NA 7.4 9.93 14 56.2 56.6 14.1 24.9 784 773.3 6327 262 30.3 7.4 1.88 10.73 13.9 59.8 55.7 13 23.2 468 690.5 1073.7 97.8 13.5 4.5 JAXW202-2207 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 27 25.8 25.1 25.2 25.3 25.6 24.6 25.8 NA NA 10 10.25 14.7 64.3 62.7 14.3 22.9 928 1377 8391 229 0 2 2.08 10 13.5 58.7 58.7 13.5 23 676 371.9 1633.8 72.6 0 1.7 JAXW202-2208 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 28.5 28.3 27.2 27.7 27.2 28.3 27.2 27.5 NA NA 8.76 9.46 14.6 51.7 54.7 15.4 28.2 954 1483.9 7108.7 160.3 3.5 3.5 2.14 8.11 13.4 42.5 52.4 16.5 31.5 528 411.5 1612.1 67.4 36 13.1 JAXW202-2209 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 28.1 27.4 26.5 27.3 27.2 26.4 25 25.1 NA NA 5.68 10.26 15.1 50.8 49.5 14.7 29.7 771 818.5 4392.3 455.5 8 5.1 2.52 9.71 14.1 45.2 46.5 14.5 31.2 695 508 1916.2 91 4.8 0 JAXW202-2210 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 21.7 21 19.8 19.5 20 21.1 20.8 20.5 NA NA 10.16 9.68 15.4 52.8 54.5 15.9 29.2 642 1294.4 8488.7 369.8 3 4.1 1.68 8.54 14 43.4 50.8 16.4 32.3 480 128.4 1488 59.5 4.2 0 JAXW202-2211 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 29.6 28.1 26.7 26.9 27.2 26.5 23.7 21.9 NA NA 7.98 10.52 15.1 64.3 61.1 14.4 23.5 780 1786.7 5731.2 460.4 1.6 0 1.42 9.82 13.9 56.3 57.3 14.2 24.7 528 464.3 939.9 14.2 1.7 0 JAXW202-2212 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 25.8 25.2 24.1 24 24 24 23 23 NA NA 6.56 7.45 14.3 49.4 66.3 19.2 28.9 618 1395.3 5007.9 148.3 7.2 2 2.08 8.75 13.6 54.3 62.1 15.5 25 506 152.9 1856.4 67.2 3.3 0 JAXW202-2213 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 32.1 31.2 29.7 28.9 28.9 29.5 29.5 29.9 NA NA 5.22 9.9 15.1 52.1 52.6 15.3 29 750 1115 3867.5 234.9 2.1 0 1.94 10.49 15.3 53.6 51.1 14.6 28.5 456 672.2 1145.2 85.9 27 9.7 JAXW202-2214 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 30.7 29.2 27.4 26.7 26.2 25 22.9 21 NA NA 6.36 10.24 14.5 63.1 61.6 14.2 23 747 1146.7 5009.1 195.9 8.9 0 1.24 9.46 13 56.3 59.5 13.7 23.1 462 314.3 901.1 18.6 5.8 0 JAXW202-2215 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 27.2 25.9 24.9 24.9 24.7 23.9 23.7 23.7 NA NA 8.06 10.43 14.6 44.5 42.7 14 32.8 804 1145.3 6549.6 344.2 17.7 3.2 1.02 9.97 13.7 40.5 40.6 13.7 33.8 391 141.8 822.8 37.7 14.8 2.8 JAXW202-2216 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.1 NA NA NA NA NA NA NA NA NA 9.7 10.53 15.5 68.4 65 14.7 22.7 747 3474.5 5708.5 517 0 0 NA NA NA NA NA NA NA NA NA NA NA NA NA JAXW202-2217 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.9 NA NA NA NA NA NA NA NA NA 9.82 9.48 14.7 51.8 54.6 15.5 28.4 910 1373.8 8074 368.3 0 3.9 NA NA NA NA NA NA NA NA NA NA NA NA NA JAXW202-2218 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 25.8 25 24.1 23.6 23.5 22.9 21.9 21 NA NA 5.14 9.49 13.8 47.7 50.3 14.5 28.9 872 929.8 4001.5 206.6 2.1 0 1.34 8.83 12.9 43.4 49.2 14.6 29.7 500 123.3 1128.3 67.9 20.5 0 JAXW202-2219 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 23.7 22.9 21.3 21.2 21.2 20.8 19 18 NA NA 10.52 10.57 16 52.3 49.5 15.1 30.6 934 1745.3 8386.5 385 3.2 0 3.22 10.89 15.9 52.7 48.4 14.6 30.2 566 618.6 2457.8 106.3 30.3 7.1 JAXW202-2220 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 28.6 27.6 26.3 25 24.8 25.5 24.3 23.9 NA NA 5.8 9.8 15.1 53.1 54.2 15.4 28.4 713 1104.3 4568.1 122.4 3.5 1.7 0.84 9.29 13.8 48.5 52.2 14.9 28.5 264 111.6 671.2 42.8 12.4 1.8 JAXW202-2221 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 27.8 25.9 25.3 26 26.7 26.1 25.8 25.9 NA NA 5.84 10.32 15.5 51.7 50.1 15 30 941 1037.8 4444.2 344.6 13.4 0 1.2 9.38 13.5 45.5 48.5 14.4 29.7 458 166.1 941.9 66 20.3 5.6 JAXW202-2222 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 27.6 27.2 25.4 24.7 25.1 24.7 23.8 23.2 NA NA 9.02 9.67 14.9 44.6 46.1 15.4 33.4 649 1858.1 6834.5 325.6 1.8 0 1.2 9.36 13.9 41.6 44.4 14.9 33.4 240 83.9 1069.6 41.2 5.4 0 JAXW202-2223 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 23.3 22.3 21 19.8 20.9 20.2 18.3 17.4 NA NA 9.08 9.6 14.6 46.2 48.1 15.2 31.6 679 1787.9 6896.3 386.8 4.5 5.4 2.42 9.65 13.5 45.5 47.2 14 29.7 470 771 1593.1 46.9 9 0 JAXW202-2224 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 28.9 28.2 26.6 26.9 26.4 26.4 25.7 25.3 NA NA 11.08 10.52 15.9 51.2 48.7 15.1 31.1 727 2024.3 8525 501.9 16.6 14.4 2.26 10.75 15.2 50.7 47.2 14.1 30 362 745.8 1387.9 103.1 23.1 0 JAXW202-2225 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.7 25.2 24 24.1 24.2 24.2 23.2 23.2 NA NA 10.32 10.51 15 62.6 59.6 14.3 24 739 1376.7 8341.7 565.5 33 2.1 1.9 10.95 15 63.8 58.3 13.7 23.5 397 335.9 1485.2 73.9 4.9 0 JAXW202-2226 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 28.7 27.4 25.9 25.6 25.4 24.8 23.3 22 NA NA 8.28 8.79 17.4 56.6 64.4 19.8 30.7 735 999.4 6835.1 402.4 39.7 3.3 1.24 9.97 14.9 63 63.2 14.9 23.7 536 254.2 930.5 29.6 22.3 3.3 JAXW202-2227 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 22.7 22.1 21.2 21.6 21 21.3 20.4 19.7 NA NA 3.94 7.47 14.9 48.6 65.1 19.9 30.7 633 397.9 3358.9 178.9 0.8 3.5 1.62 9.4 12.6 60.9 64.8 13.4 20.7 444 38.2 1537.9 40.3 3.6 0 JAXW202-2228 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.8 25.7 24.8 23.9 23.8 23.8 23.2 22.8 NA NA 8.96 10.36 14.8 47 45.4 14.3 31.5 819 1140.6 7452 355.7 9.9 1.8 1.92 10.07 15 44.4 44.1 14.9 33.8 432 484.8 1350.1 57.6 25.9 1.7 JAXW202-2229 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.8 26.1 24.9 25 24.5 24 22.7 22.1 NA NA 7.54 10.27 15.4 63.5 61.8 15 24.3 738 1171 6175.3 192.3 0 1.5 1.34 10.24 15 62.3 60.8 14.6 24.1 456 134.5 1182.3 15.5 5.9 1.5 JAXW202-2230 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.3 24.6 23.4 23.8 23.7 23.4 22.7 22.5 NA NA 6.34 9.21 14.3 45.3 49.2 15.5 31.6 921 1087.9 4830.4 412.7 5.7 3.8 1.12 9.47 14.6 45.2 47.7 15.4 32.3 328 141.8 943.4 24 11 0 JAXW202-2231 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 21.7 21.3 19.4 19.5 20.2 19.4 17.5 15.5 NA NA 2.96 10.71 16.2 63.7 59.5 15.1 25.4 591 663.9 2123.2 172.9 0 0 1.92 11.33 16.1 65.7 58 14.2 24.5 475 529 1251.3 97.5 39.7 2.5 JAXW202-2232 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 35.2 34.6 32.5 31.3 29.7 28.6 26 24.6 NA NA 8.96 10.68 15.9 66.9 62.6 14.9 23.8 924 1305.5 7351.7 293.9 1.8 7.2 1.32 10.96 15.2 65.9 60.1 13.9 23.1 523 88.2 1177.4 48.2 4.4 1.8 JAXW202-2233 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 24.1 24 23.2 22.7 22.7 21.1 19.4 18.3 NA NA 8.2 7.82 15.2 50.8 65 19.4 29.9 876 1357.1 6355.8 472.3 10.7 4.1 1.66 10.8 16.1 68.4 63.3 14.9 23.5 559 315.4 1187.2 156.5 1 0 JAXW202-2234 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 24.3 22.6 21.5 21.1 21 20.6 19.5 19.8 NA NA 7.34 10.33 15 64.3 62.2 14.5 23.3 693 1199.4 5882.3 243.7 12.5 1.5 1.54 10.48 15.1 62.6 59.7 14.4 24.1 658 441.8 1028.7 65.9 2.3 1.1 JAXW202-2235 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 23.4 22.6 21.7 21.5 21.8 21.1 20.1 20.4 NA NA 8.04 10.82 15.4 51.1 47.2 14.2 30.1 758 850.6 6595.2 584.5 8 1.6 0.78 9.69 13.5 44.2 45.6 13.9 30.5 596 162 579.5 33.6 3 1.7 JAXW202-2236 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 25.1 23.7 22.5 22.2 22.7 23 22.6 22.3 NA NA 9.74 8.54 15.3 42 49.2 17.9 36.4 644 1291.5 8239.1 203.6 4.9 0 1.7 9.25 12.8 42.8 46.3 13.8 29.9 204 81.1 1556.5 41.8 20.4 0 JAXW202-2237 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 27.8 27.7 26.1 26.6 26.7 26.4 25.3 24.6 NA NA 11.18 11.14 16.3 55.1 49.5 14.6 29.6 937 1410.9 9401.3 364.5 3.4 0 3.12 10.29 14.5 48.2 46.8 14.1 30.1 510 137.9 2926.6 40.2 13.4 1.9 JAXW202-2238 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.8 26.2 24.7 24 24.3 24.4 23.9 23.6 NA NA 7.06 10.06 15.2 48.4 48.1 15.1 31.4 789 1403.5 5372 244.3 36.7 3.5 1.14 9.75 13.4 43.4 44.5 13.7 30.9 394 116.5 995.8 24.5 3.2 0 JAXW202-2239 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.7 24.6 22.6 21.5 20.8 NA NA NA NA NA 8.62 10.66 15.7 68.7 64.4 14.7 22.9 848 1298.2 7067.5 250 0 3.4 1.02 11.19 17.4 67 59.9 15.5 26 832 393.9 586 30.6 7.7 1.8 JAXW202-2240 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 29.3 27.4 25 25 25.2 25.3 24.4 24.1 NA NA 10.86 9.5 14.2 63.2 66.5 14.9 22.5 896 1708.3 8688 434.4 27.2 2.2 2.64 9.46 13.9 58.7 62.1 14.7 23.7 694 157.6 2457.8 20.6 2.1 1.8 JAXW202-2241 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 22 21.1 20.2 19.9 20.5 20.4 19 17.9 NA NA 9.06 10.28 14.8 52.5 51.1 14.4 28.2 762 1199.5 7383.9 474.7 0 1.8 1.84 9.57 14 46.4 48.5 14.6 30.2 518 212.9 1571.7 46.4 3.7 5.3 JAXW202-2242 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.6 25.8 24.3 23.6 23.6 23.6 21.1 20.98 NA NA 7.88 10.05 15 48.2 48 14.9 31.1 834 1069.3 6633.4 167.1 7.9 1.6 0.94 10.27 14.5 46.6 45.4 14.1 31.1 365 205.8 677.2 53.4 3.7 0 JAXW202-2243 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 32.7 31.3 30 29.1 28.5 27.6 26 25.4 NA NA 6.86 10.49 15.8 67 63.9 15.1 23.6 847 1063.3 5352.2 321 94.7 28.8 1.8 11.03 15.5 66.7 60.5 14.1 23.2 564 214.6 1479.6 72 27.5 6.3 JAXW202-2244 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 23.1 22.1 20.8 21.3 21.7 22.5 20.4 21.2 NA NA 10.74 9.94 15.1 49.7 50 15.2 30.4 796 1942.9 8362.2 408.1 25.8 2.1 1.54 9.08 13.1 43.3 47.7 14.4 30.3 467 240.1 1242.6 51.3 4.2 1.8 JAXW202-2245 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 26.8 26.5 25.3 24.6 23.9 23.1 22.3 21.7 NA NA 5.1 10.01 14.7 68.4 68.3 14.7 21.5 744 1421.9 3471.6 198.4 5.6 1.5 1 9.09 13.1 57.7 63.5 14.4 22.7 209 73.2 908.4 13.1 5.3 0 JAXW202-2246 Diversity Outbred Male Group 22 Doxorubicin Male Doxorubicin 2010-04-13 2010-06-04 NA 24.6 24.7 23.8 23.4 23.4 23.3 22.5 22.3 NA NA 6.44 9.73 15.7 52.6 54.1 16.1 29.8 795 854.6 5456.6 118.5 10.3 0 0.72 9.64 14.6 50.3 52.2 15.1 29 273 70.8 608 37.7 3.5 0 JAXW202-2248 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 25.6 24.4 25 24 23.4 23.6 22.9 22.4 NA NA 3.96 9.93 14.2 48.2 48.5 14.3 29.5 723 870.41 3031.38 45.14 9.9 2.77 1.18 8.59 13.2 40.8 47.5 15.4 32.4 664 262.79 851.13 51.8 14.28 0 JAXW202-2249 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 20.8 20.4 20.6 19.9 20.9 20 19.7 19.9 NA NA 4.06 10.43 14.7 53 50.8 14.1 27.7 667 715.78 3215.93 123.02 5.28 0 0.94 8.5 12.3 42.2 49.6 14.5 29.1 718 118.82 803.14 12.03 4.14 1.88 JAXW202-2250 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 22.9 22.4 23 21 21.9 21.8 21.6 21.6 NA NA 3.2 11.21 14.9 53 47.3 13.3 28.1 688 794.88 2313.6 81.92 7.68 1.92 0.92 8.84 11.8 40.8 46.2 13.3 28.9 563 220.34 648.23 44.16 5.52 1.84 JAXW202-2251 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 23.4 22.8 23.2 22.7 22.7 22.4 22.7 23 NA NA 3.5 10.56 13.9 49.9 47.3 13.2 27.9 611 622.3 2746.1 122.15 7.7 1.75 1.32 7.84 10.8 37.1 47.3 13.8 29.1 790 195.23 1057.06 66 0 1.72 JAXW202-2252 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 22.3 22.6 22.9 22.7 22.6 22.6 22.3 22.6 NA NA 3.34 10.95 14.6 53.3 48.7 13.3 27.4 697 579.16 2700.72 60.45 0 0 0.92 8.05 11.4 38.5 47.8 14.2 29.6 770 134.04 750.35 33.76 1.75 0 JAXW202-2253 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 21.3 20.7 21.5 20.5 20.3 20.3 19.4 19.7 NA NA 6.9 10.62 14.4 47.9 45.1 13.6 30.1 692 1377.93 5355.09 159.39 3.45 3.45 0.72 7.31 11.4 46.8 64 15.6 24.4 503 82.37 550.73 77.54 9.29 0 JAXW202-2254 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 31.9 31.4 31.5 30.4 30.3 30 30 29.6 NA NA 4.18 9.92 14.6 50.7 51.1 14.7 28.8 631 843.11 3117.03 210.67 7.11 1.67 0.64 7.82 11.3 40.3 51.5 14.5 28 677 178.11 360.64 97.6 3.58 0 JAXW202-2255 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 24.4 24 23.4 23.1 23 22.7 22.6 22.5 NA NA 5.72 10.22 13.9 50.2 49.1 13.6 27.7 728 1444.87 3825.54 438.72 10.87 0 3.08 8.41 11.2 41.5 49.3 13.3 27 1130 844.84 2014.01 217.76 3.39 0 JAXW202-2256 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 21.2 21.3 20.4 20 19.6 19.2 18.6 19 NA NA 5.38 10.24 14.8 66.7 65.1 14.5 22.2 631 568.67 4707.5 93.07 8.61 1.61 1.44 7.89 11.8 36.5 46.3 15 32.3 871 219.6 1139.33 63.22 15.98 1.87 JAXW202-2257 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 23.9 23.3 22.8 21.1 21.2 20.7 20.3 20.4 NA NA 4.56 8.97 14.2 47.5 53 15.8 29.9 823 996.82 3456.48 101.23 3.65 1.82 1.02 8.64 13.8 44.5 51.5 16 31 705 96.39 797.74 124.03 0 1.73 JAXW202-2258 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 25.4 24.5 25.2 24 24 24.5 23.6 23 NA NA 6.92 10.29 15.2 56.2 54.6 14.8 27 869 704.46 5989.26 213.14 9 3.46 1.2 7.81 11.6 42.6 54.5 14.9 27.2 740 163.2 961.68 69.84 3.36 1.8 JAXW202-2259 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 34.1 33.1 33.9 33.9 33.2 32.6 31.7 32 NA NA 4.04 9.55 14.5 53 55.5 15.2 27.4 943 857.69 2910.82 231.09 31.11 9.29 1.8 7.63 11.5 41.7 54.7 15.1 27.6 916 770.94 884.52 126.36 9 9 JAXW202-2260 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 22.7 21.5 21.6 20.3 20.1 20.3 20.2 19.9 NA NA 6.18 9.59 14.2 50.3 52.5 14.8 28.2 692 807.73 5216.54 145.23 9.27 1.85 1 8.06 12.1 43.3 53.7 15 27.9 508 183.1 742.2 67.5 5.4 1.8 JAXW202-2261 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 20.9 20.4 20.9 20.5 21.2 21 21 21.1 NA NA 3.5 10.34 13.6 61.3 59.3 13.2 22.2 748 947.1 2398.2 149.1 3.5 1.75 0.82 7.8 10.2 45.1 57.8 13.1 22.6 604 228.12 425.91 152.36 11.97 1.64 JAXW202-2262 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 26.2 25.9 24.9 25.2 24.7 24.4 24.3 24.7 NA NA 8.8 9.64 13.2 48.2 50 13.7 27.4 625 917.84 7504.64 368.72 7.04 1.76 1.04 7.38 10.4 36.3 49.2 14.1 28.7 514 71.97 889.41 65.21 7.8 5.51 JAXW202-2263 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 24.6 NA NA NA NA NA NA NA NA NA 5.98 8.98 13.7 59.4 66.1 15.3 23.1 1033 702.05 5049.51 209.3 9.57 8.97 NA NA NA NA NA NA NA NA NA NA NA NA NA JAXW202-2264 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 21.3 22 21.4 21.4 20.9 20.5 20.6 20.6 NA NA 5.14 7.65 13.7 37.3 48.8 17.9 36.7 726 588.02 4319.66 220.51 7.71 3.6 0.74 7.36 10.3 34.9 47.4 14 29.5 822 72.52 624.12 39.81 3.55 0 JAXW202-2265 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 28.8 27.9 27.3 27.1 26.6 26.6 25.9 25.2 NA NA 4.46 10.96 15.2 66.7 60.9 13.9 22.8 874 605.22 3769.59 76.71 4.46 3.57 0.96 8.52 11.9 50.6 59.4 14 23.5 541 49.92 869.28 33.6 5.76 1.54 JAXW202-2266 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 27.4 26.8 26.7 26.5 25.9 25.5 24.9 24.8 NA NA 10.3 NA NA NA NA NA NA 1530 1232.91 8655.09 394.49 15.45 3.09 1.64 NA 9.5 32.4 73.1 NA 29.3 1191 140.06 1371.86 122.84 3.44 1.8 JAXW202-2267 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 31 28.9 29.6 28.2 27.9 27.3 27.4 27.3 NA NA 5.58 10.48 14.4 49 46.8 13.7 29.4 817 1205.84 4200.07 167.96 5.02 1.67 1.1 8.33 11.8 38.6 46.3 14.2 30.6 562 277.42 759.33 54.01 9.35 0 JAXW202-2268 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 27.8 26 26.8 24.4 24 24 23 23.2 NA NA 9.92 9.63 14.4 49.9 51.8 15 28.9 736 1623.9 7987.58 283.71 16.86 5.95 1.16 8.58 12 44 51.3 14 27.3 435 463.42 659 34.34 3.25 0 JAXW202-2269 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 21.5 22.6 22.9 20.2 20 20.3 20.1 20.3 NA NA 3.1 10.78 13.9 46.8 43.4 12.9 29.7 629 399.28 2527.43 167.09 6.2 0 1.04 7.49 10.7 31.5 42.1 14.3 34 612 64.58 919.57 46.49 9.36 0 JAXW202-2270 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 23.7 21.5 23 23 23.2 22.8 22.7 22.6 NA NA 4.48 8.08 14.4 47.6 58.9 17.8 30.3 564 605.7 3638.21 230.27 5.82 0 0.58 8.46 11.3 49.3 58.3 13.4 22.9 624 65.08 477.17 32.31 4.06 1.45 JAXW202-2271 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 25.7 25.8 24.6 24 23.4 23.4 23.4 23.5 NA NA 5.42 10.31 14.3 48 46.6 13.9 29.8 651 546.34 4724.07 139.29 9.76 1.08 0.78 7.44 10.2 33.8 45.4 13.7 30.2 445 53.43 613.86 110.99 1.72 0 JAXW202-2272 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 25.9 26.8 26.4 26.4 25.9 26.4 26.2 26.2 NA NA 2.92 11.1 14.5 63.8 57.5 13.1 22.7 837 398.87 2422.43 94.9 1.75 1.75 0.52 7.57 9.9 42.1 55.6 13.1 23.5 611 80.13 401.49 34.68 3.64 0 JAXW202-2273 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 18.3 17.4 17.7 17.6 17.2 18 17.2 17.5 NA NA 6.2 10.21 13.9 50.5 49.5 13.6 27.5 739 1640.52 4309 246.76 3.72 0 NA NA NA NA NA NA NA NA NA NA NA NA NA JAXW202-2274 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 22.7 21.4 22.4 22.2 21.8 21.9 22 22.1 NA NA 7.6 9.68 14.8 49.5 51.1 15.3 29.9 750 741.76 6579.32 236.36 42.56 0 2.02 8.65 12.9 43.1 49.8 14.9 29.9 907 53.33 1882.03 76.96 7.68 0 JAXW202-2275 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 21.9 20.8 21.4 21.8 21.7 21.3 21.1 21.9 NA NA 4.22 11.62 14.9 51.1 44 12.8 29.2 780 737.66 3312.28 160.78 5.49 3.8 0.82 8.12 11.6 40.8 50.2 14.3 28.4 604 116.11 604.91 91.92 5.25 1.8 JAXW202-2276 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 22.8 22.2 23 22.8 22.2 22.2 22 22.3 NA NA 6.98 9.57 13.1 43.1 45 13.7 30.4 815 723.83 5979.77 274.31 2.09 0 1.06 7.69 11 33.9 44.1 14.3 32.4 906 80.56 908 64.13 3.5 3.71 JAXW202-2277 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 28.5 NA NA NA NA NA NA NA NA NA 6.86 9.77 13.8 52.5 53.7 14.1 26.3 881 976.18 5610.11 249.7 19.89 3.43 0.88 8.19 11.2 34.6 42.2 13.7 32.4 572 18.3 838.11 16.19 3.7 3.61 JAXW202-2278 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 32.5 30.5 30 29.3 28.1 28.3 28.1 27.4 NA NA 5.98 10.17 15.2 68.4 67.3 14.9 22.2 833 956.8 4763.07 239.2 17.34 3.59 0.7 8.51 12.8 55.8 65.6 15 22.9 750 43.82 608.79 42.91 4.48 0 JAXW202-2279 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 27.1 26.2 26.8 27.2 27 26.6 26.7 26.7 NA NA 8.88 10.42 14.4 53 50.9 13.8 27.2 850 1199.69 7432.56 224.66 20.42 2.66 1.66 8.08 10.9 39.5 48.9 13.5 27.6 445 244.02 1354.73 44.65 16.6 0 JAXW202-2280 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 27 26.3 26.6 26.5 26.4 26.4 26 27.8 NA NA 3.92 10.49 15.2 51.9 49.5 14.5 29.3 817 371.62 3340.23 204.23 3.92 0 0.5 8.95 12 42.2 47.2 13.4 28.4 446 64.1 394.35 39.75 0 1.85 JAXW202-2281 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 30.2 NA NA NA NA NA NA NA NA NA 3.32 9.63 13.8 52.4 54.4 14.3 26.3 735 403.38 2805.4 96.94 13.94 0 NA NA NA NA NA NA NA NA NA NA NA NA NA JAXW202-2282 Diversity Outbred Female Group 19 - Cyclophosphamide Females Cyclophosphamide 2010-04-13 2010-07-08 NA 23.4 21.7 23 23.2 23.1 22.6 22.4 22.9 NA NA 4.76 9.42 13.6 49.5 52.5 14.4 27.5 706 852.99 3741.36 159.94 5.71 0 0.76 7.84 10.7 39.5 50.4 13.6 27.1 583 18.47 672.22 63.76 3.72 1.9 JAXW202-2283 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 28.9 29.3 28.7 28.3 27.6 26.7 27.1 26.9 NA NA 4.5 10.11 12 47.7 47.2 11.9 25.2 758 904.05 3377.25 176.85 32.4 9.45 8.6 8.32 11.1 41.5 49.9 13.3 26.7 382 1774.18 6105.14 460.1 222.74 36.98 JAXW202-2284 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 24.5 23.8 23.2 23.1 23.8 22.6 23.1 22.8 NA NA 4.18 10.64 14.2 60.2 56.6 13.3 23.6 725 782.08 3147.12 226.97 23.83 0 1.32 8.44 11.2 47.5 56.3 13.3 23.6 335 217.93 1047.29 46.99 6.2 1.72 JAXW202-2285 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 24.4 23.5 23.1 22.7 23.8 22.8 23.4 23.2 NA NA 7.66 9.14 14.1 60.8 66.5 15.4 23.2 1063 1577.96 5922.71 150.9 6.89 1.53 1.62 7.67 11 49.4 64.4 14.3 22.3 635 296.46 1279.64 40.82 2.92 0 JAXW202-2286 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 32 31.8 30.6 29.2 28.5 27.6 27.4 27.6 NA NA 6.38 10.05 15.6 66.5 66.2 15.5 23.5 770 1311.73 4749.27 309.43 4.47 5.1 2.56 9.33 14.3 61.1 65.5 15.3 23.4 459 691.71 1740.8 90.88 28.42 8.19 JAXW202-2287 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 34.2 32.5 32.1 31.7 31.8 30.8 29.3 30 NA NA 7.02 9.65 13.8 42.4 43.9 14.3 32.5 689 1062.83 5630.04 304.67 19.66 2.11 0.94 8.93 11.9 39.1 43.8 13.3 30.4 782 221.28 629.05 82.16 7.52 0 JAXW202-2288 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 33.9 32.2 32 31.3 31.5 31.4 30.7 29.7 NA NA 5.48 9.65 14.6 47.1 48.8 15.1 31 967 1080.11 4144.52 248.24 4.93 1.64 0.62 7.9 11.6 38.6 48.9 14.7 30.1 801 173.1 420.73 24.37 1.8 0 JAXW202-2289 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 32.9 32.2 30.9 29.8 29.7 30.2 30.2 30.2 NA NA 8.5 10.36 14.4 47.7 46 13.9 30.2 867 1173.85 7037.15 284.75 5.1 0 0.5 7.88 10.7 36.7 46.6 13.6 29.2 813 54.75 417.95 27.35 0 0 JAXW202-2290 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 32.2 31.7 29.5 29.4 29.1 28.8 28.1 29.1 NA NA 7.08 9.86 15 66.6 67.5 15.2 22.5 944 1638.31 4919.18 515.42 0 7.08 1.08 8.43 13.1 57.9 68.7 15.5 22.6 850 255.2 725.22 92.23 5.62 1.62 JAXW202-2291 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 30.6 29.1 28.5 27.5 28.5 27.9 27.8 28.3 NA NA 5.26 9.81 14.6 47.9 48.8 14.9 30.5 807 1260.82 3828.23 157.8 6.31 7.36 0.76 7.97 11 39.3 49.3 13.8 28 717 96.06 587.4 71.21 3.57 1.75 JAXW202-2292 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 32.5 31.3 29.9 29.7 29.8 28.5 28.7 28.2 NA NA 8.46 9.2 14.1 48 52.2 15.3 29.4 944 1331.6 6791.69 317.25 19.46 0 0.82 7.2 10.6 37.7 52.4 14.7 28.1 849 184.66 503.23 123.08 9.02 0 JAXW202-2293 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 36.5 35.7 34.8 33.7 34.1 32.9 32.6 33.1 NA NA 3.04 10.82 16 68.6 63.4 14.8 23.3 920 722.91 2214.64 80.26 20.67 1.82 0.76 7.92 11.3 49.8 62.9 14.3 22.7 704 328.62 327.56 59.74 38.84 5.24 JAXW202-2294 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 29.8 27.7 27.1 26.9 25.8 25.9 26.1 25.5 NA NA 9.18 9.88 14.3 49 49.6 14.5 29.2 787 2132.51 6827.17 209.3 10.1 0 2.42 8.41 12.3 42 49.9 14.6 29.3 460 676.39 1612.69 112.05 18.88 0 JAXW202-2295 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 33.5 31.8 31.2 30.5 30 29.3 27.8 29.8 NA NA 5.5 10.32 14.7 52.8 51.2 14.2 27.8 737 1020.25 4186.05 273.35 13.2 7.7 1.28 9.18 13.2 47.5 51.7 14.4 27.8 536 354.56 746.5 137.34 31.62 9.98 JAXW202-2296 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 28.4 25.9 26.3 25.1 25.3 23.7 23.8 24 NA NA 4.88 9.37 13.3 57.2 61 14.2 23.3 885 476.78 4259.75 135.18 5.37 3.42 0.7 7.53 10.1 45.2 60 13.4 22.3 545 38.85 591.36 66.15 0 3.64 JAXW202-2297 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 39 37.3 37.3 35.9 36 34.3 34.8 34.8 NA NA 8.12 10.13 15.4 53.4 52.7 15.2 28.8 1140 2106.33 5596.3 406 8.12 3.25 0.98 8.53 12.3 43.3 50.8 14.4 28.4 921 159.35 780.28 35.57 4.8 0 JAXW202-2298 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 31.6 29.9 28.4 26.9 27.1 28.2 28.3 30.5 NA NA 7.32 9.66 13.9 58.2 60.2 14.4 23.9 1063 2208.44 4894.15 208.62 7.32 2.2 0.86 8.71 11.7 50.6 58.1 13.4 23.1 586 253.27 524.08 71.81 8.86 1.89 JAXW202-2299 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 24.1 23.5 23.1 23.5 23.7 22.4 23.2 22.9 NA NA 4.44 7.97 14.1 47.1 59.1 17.7 29.9 754 523.48 3756.68 153.18 2.22 4.88 0.82 7.16 9.6 41.3 57.7 13.4 23.2 883 82.16 621.4 106.85 9.51 0 JAXW202-2300 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 38.4 NA NA NA NA NA NA NA NA NA 4.98 10.79 14 59.8 55.4 13 23.4 911 1061.74 3640.88 238.54 32.87 5.48 NA NA NA NA NA NA NA NA NA NA NA NA NA JAXW202-2301 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 38.5 37.4 36.7 36.4 36.8 35.4 35.9 35.5 NA NA 5.68 9.61 15.7 63.7 66.3 16.3 24.6 842 1253.58 4207.74 202.78 10.22 5.11 0.44 7.55 11.2 49.2 65.2 14.8 22.8 647 38.06 352.44 48.88 0.62 0 JAXW202-2302 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 31.1 29.1 29.4 28.9 28.9 28.1 28.8 28.8 NA NA 4.78 9.96 14.6 61.6 61.8 14.7 23.7 904 738.51 3874.67 163 1.91 1.91 1.36 8.48 11.8 52 61.3 13.9 22.7 826 354.42 944.66 52.5 6.53 1.77 JAXW202-2303 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 30.4 28.9 29.5 29.3 29.5 28.4 28.7 29.3 NA NA 6.82 9.42 13.4 60.3 64 14.2 22.2 907 868.19 5423.95 507.41 15.69 5.46 2.22 9.26 12.7 59.5 64.3 13.7 21.3 747 233.99 1763.35 219.34 3.55 0 JAXW202-2304 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 32.1 29.7 29.3 29.3 29.6 27.9 28.2 28.6 NA NA 5.32 9.71 13.7 59.6 61.4 14.1 23 765 604.88 4494.87 202.16 16.49 1.6 1.1 8.35 11 49.7 59.5 13.2 22.1 444 185.35 845.9 52.36 14.52 1.76 JAXW202-2305 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 32.2 31 30 29.3 30 29.2 29.2 29.2 NA NA 4.84 8.93 13.3 42.4 47.5 14.9 31.4 700 666.47 3972.19 187.31 11.62 1.94 0.76 7.41 10.9 35.6 48 14.7 30.6 644 36.4 705.43 18.16 0 0 JAXW202-2306 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 25 NA NA NA NA NA NA NA NA NA 5.56 9.24 13.5 46.2 50 14.6 29.2 796 636.06 4644.82 267.44 8.34 3.34 NA NA NA NA NA NA NA NA NA NA NA NA NA JAXW202-2307 Diversity Outbred Male Group 19 - Cyclophosphamide Males Cyclophosphamide 2010-04-13 2010-07-09 NA 32.6 31.7 30.5 29.5 29.5 29.6 28.8 28.3 NA NA 4.62 10.48 14.4 62.1 59.3 13.7 23.2 912 606.61 3804.57 200.97 7.39 0 1.16 9.82 13.2 58.7 59.8 13.4 22.5 911 170.87 896.33 76.56 16.12 0 JAXW202-2308 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 28.1 26.6 25 24.3 24.1 22.3 20.5 19.6 NA NA 4.92 11.2 17.2 51.9 46.34 15.36 33.14 628 534.31 4099.84 283.39 1.97 0 1.54 9.64 15.9 46.5 48.24 16.49 34.19 334 73 1403.56 57.75 5.7 0 JAXW202-2309 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 24.3 24.4 24.4 23.5 23.5 22 20.9 20.5 NA NA 6.26 10.75 16.8 49.2 45.77 15.63 34.15 572 920.85 4728.18 591.57 16.9 3.76 1.38 9.63 15.2 45.3 47.04 15.78 33.55 542 317.68 1028.65 23.46 6.76 3.45 JAXW202-2310 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 29.3 28.6 27 26.4 26.1 25.2 24.1 24 NA NA 6 9.97 14.3 44.3 44.43 14.34 32.28 751 993.6 4784.4 220.2 1.8 0 1.04 8.48 13.3 37.1 43.75 15.68 35.85 414 101.61 914.37 16.43 7.59 0 JAXW202-2311 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 23.9 23.2 22.1 21.5 20.7 20.2 19.1 17.9 NA NA 9.22 8.75 14.9 55.7 63.66 17.03 26.75 795 1565.56 7395.36 230.5 23.97 4.61 1.14 7.66 13.1 48.1 62.79 17.1 27.23 515 91.77 1035.8 6.84 1.82 3.65 JAXW202-2312 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 20.6 20.3 19.4 19.5 19.7 19.9 19.7 20.3 NA NA 8.02 9.61 14.9 40.4 42.04 15.5 36.88 554 1106.76 6670.23 241.4 1.6 0 1.14 8.03 12 33.1 41.22 14.94 36.25 497 72.62 1015.85 51.41 0 0 JAXW202-2313 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 24.8 24.1 23.1 22.8 22.5 22.1 21.7 22.5 NA NA 5.72 9.47 15.6 43.1 45.51 16.47 36.19 857 1334.48 4173.88 207.06 3.43 1.72 0.66 8.74 14.6 39 44.62 16.7 37.44 558 45.61 581.53 17.82 15.05 0 JAXW202-2314 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 26 24.4 22.3 22.6 23.1 23 21.8 23.1 NA NA 6.6 10.16 15.4 43.9 43.21 15.16 35.08 960 566.28 5742.66 280.5 6.6 3.3 1.32 8.78 14.1 37.3 42.48 16.06 37.8 523 115.24 1136.65 60.72 3.83 3.7 JAXW202-2315 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 25.6 23.1 26.3 20.6 20.1 20.1 20.1 19.3 NA NA 14.78 10.42 15.7 57.3 54.99 15.07 27.4 953 1105.54 13256.18 407.93 10.35 0 1.44 9.15 13.5 49.5 54.1 14.75 27.27 743 172.08 1257.41 10.51 0 0 JAXW202-2316 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 29.5 28.7 25.9 26.6 26.7 26.7 25.8 25.2 NA NA 6.96 10.79 16.6 47.4 43.93 15.38 35.02 733 805.27 6051.02 97.44 6.26 0 1.42 9.11 13.8 39.9 43.8 15.15 34.59 309 99.54 1278.85 34.22 7.38 0 JAXW202-2317 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 23.7 23.8 21.6 22.6 21.9 20.9 19.8 18.2 NA NA 6 11.01 16.2 62.6 56.86 14.71 25.88 532 1147.8 4573.2 277.2 1.8 0 1.28 9.47 14.9 52.8 55.76 15.73 28.22 395 89.22 1154.69 12.8 21.63 1.79 JAXW202-2318 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 23.9 22.1 25 20.5 19.5 18.7 17.6 17.2 NA NA 6.3 10.75 15.9 44.5 41.4 14.79 35.73 690 1130.22 4964.4 200.97 2.52 1.89 0.94 9.97 15.8 40.8 40.92 15.8 38.7 473 105.28 785.28 31.96 16.17 1.32 JAXW202-2319 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 26.9 26.7 26.5 24.6 24.9 25.2 24.7 25.5 NA NA 7.06 10.33 15.2 43.3 41.92 14.71 35.1 747 1221.38 5600.7 234.39 4.24 0 0.88 9.06 14.2 37.1 40.95 15.67 38.27 490 135.08 727.76 14.08 2.99 0 JAXW202-2320 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 24.8 23.7 22.7 23 23.3 22.7 21.8 22.3 NA NA 7.62 10.6 15.7 56.6 53.4 14.81 27.74 792 924.31 6554.72 134.11 6.86 0 1.44 9.48 14.2 49.1 51.79 14.98 28.92 504 182.88 1236.53 18 2.59 0 JAXW202-2321 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 30.5 29.5 28.3 27.9 27.7 27.6 26.2 26.2 NA NA 4.8 9.96 15.8 45.8 45.98 15.86 34.5 866 686.88 3755.04 327.36 23.04 7.2 1.2 8.34 12.9 37.8 45.32 15.47 34.13 726 257.76 890.16 45.12 5.04 1.92 JAXW202-2322 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 27.5 26.6 24.9 25.3 25.3 23.4 21.3 20.5 NA NA 2.76 9.36 14.7 43.2 46.15 15.71 34.03 788 667.64 2034.67 53.54 3.86 0 0.6 8.36 13.1 37.2 44.5 15.67 35.22 565 38.82 526.74 24.78 8.28 1.38 JAXW202-2323 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 24.4 23.8 23.1 22.9 23.2 22.5 21.9 22.1 NA NA 7.4 9.28 15.1 40.9 44.07 16.27 36.92 562 1247.64 5710.58 441.78 0 0 1.44 8.7 12.9 37.8 43.45 14.83 34.13 415 241.2 1185.7 9.5 1.73 1.73 JAXW202-2324 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 24.5 24.1 23.4 21.9 22.9 22.6 22.7 23.1 NA NA 10.22 10.49 16.3 48.8 46.52 15.54 33.4 679 1864.13 7956.27 391.43 7.15 2.04 4.26 8.58 14.5 38.7 45.1 16.9 37.47 577 659.02 3514.5 84.77 0 1.7 JAXW202-2325 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 25.5 24.5 23.4 23.4 23.6 23.4 23.4 23.7 NA NA 2.94 9.79 14.8 43.4 44.33 15.12 34.1 859 502.45 2271.74 162.29 1.76 1.76 1.7 7.33 12.7 32.9 44.88 17.33 38.6 669 370.09 1258.51 65.96 5.44 0 JAXW202-2326 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 33.2 31.8 31.1 30.1 30 28.9 28.4 28.2 NA NA 4.54 9.96 16 58.7 58.94 16.06 27.26 917 1014.69 3411.36 112.14 0 1.82 0.64 8.73 14.3 38.1 43.64 16.38 37.53 655 59.97 556.29 21.95 1.86 0 JAXW202-2327 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 25.8 23.9 23.3 22.5 22.5 21.9 21.6 21.2 NA NA 4.44 8.24 15.8 47.3 57.4 19.17 33.4 909 843.16 3420.13 174.49 1.78 0 0.88 7.87 13 44.9 57.05 16.52 28.95 699 369.07 500.63 10.3 0 0 JAXW202-2328 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 33.8 34.7 32.4 31.1 30.4 28.9 27.1 27.1 NA NA 7.24 10.26 15.9 45.9 44.74 15.5 34.64 816 1978.69 5044.1 214.3 1.45 0 1.36 9.1 13.7 38.8 42.64 15.05 35.31 535 379.44 875.7 91.39 11.56 1.9 JAXW202-2330 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 22.4 22.9 21.2 20.4 20 18.3 17.1 15.8 NA NA 6.66 9.61 16.2 44.5 46.31 16.86 36.4 811 849.15 5533.79 274.39 2.66 0 1.76 8.86 14.5 39.3 44.36 16.37 36.9 514 394.77 1302.75 34.14 26.75 1.58 JAXW202-2331 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 33 32 30.8 30.2 29.8 28.9 28.1 29.1 NA NA 6.02 9.79 15.3 46.7 47.7 15.63 32.76 790 1214.84 4401.22 398.52 3.61 1.81 1.86 8.5 13.9 40 47.06 16.35 34.75 395 592.04 1171.61 87.42 1.67 7.07 JAXW202-2332 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 29.5 28 26.8 26.1 26.1 26 24.9 23.9 NA NA 9.48 9.47 15.8 45.9 48.47 16.68 34.42 699 1923.49 7297.7 255.01 3.79 0 1.5 8.68 14.6 41.7 48.04 16.82 35.01 422 51.3 1379.85 38.55 24.75 5.55 JAXW202-2333 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 24 23.8 22.5 22.1 22.4 21.9 20.8 21.6 NA NA 6.58 9.8 15.4 46.4 47.35 15.71 33.19 747 1110.05 5351.51 107.91 8.55 1.97 1.82 8.28 14.1 37.7 45.53 17.03 37.4 450 140.69 1581.58 80.08 10.56 7.1 JAXW202-2334 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 23.8 22.4 21.9 21.2 21.6 21.6 21.3 21.1 NA NA 8.46 9.25 14.5 53.8 58.16 15.68 26.95 867 727.56 7548.86 179.35 3.38 0 1.54 8.3 13.4 47.8 57.59 16.14 28.03 569 135.37 1398.47 3.08 3.08 0 JAXW202-2335 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 30.7 29 28.5 28 28.9 29 28.4 28.8 NA NA 5.9 9.22 14.5 41.2 44.69 15.73 35.19 752 1048.43 4499.93 333.94 16.52 1.77 3.6 7.37 11.8 33.1 44.91 16.01 35.65 576 549.36 2989.44 59.76 1.44 0 JAXW202-2336 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 24.3 24.1 23.1 22.4 23.6 22.4 20.6 19.5 NA NA 6.3 10.23 17.6 64.7 63.25 17.2 27.2 784 721.98 5382.09 194.04 0 1.89 3.8 7.5 12 33.1 44.13 16 36.25 576 594.7 3118.28 79.42 7.6 0 JAXW202-2337 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 24.3 23.5 22.9 22.1 22 21.6 20 19.5 NA NA 5.04 10.42 16.6 55.5 53.26 15.93 29.91 743 317.52 4603.03 116.93 2.52 0 1.24 8.79 12.8 46.1 52.45 14.56 27.77 410 384.4 767.44 71.8 14.63 1.74 JAXW202-2338 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 32.8 32.6 30.2 28.9 29.3 28.6 27.6 27.7 NA NA 4.52 10.59 17 59.4 56.09 16.05 28.62 970 1145.37 3270.67 99.89 0.45 3.62 1.22 9.12 14.5 50.4 55.26 15.9 28.77 580 238.27 963.56 11.47 5 1.71 JAXW202-2339 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 25.7 25.3 23.5 22.8 23.1 22.4 22.5 21.2 NA NA 6.56 10.11 15.9 42.5 42.04 15.73 37.41 709 1233.94 5034.14 278.14 11.81 1.97 1 9.91 15 40 40.36 15.14 37.5 681 293.1 666.3 35.7 3.1 1.8 JAXW202-2340 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 31.7 31.1 29.8 29.1 29.4 27.1 27 26.1 NA NA 4.88 10.7 16.4 45.2 42.24 15.33 36.28 862 878.4 3782 210.82 6.83 1.95 1.06 9.48 14.7 39.9 42.09 15.51 36.84 689 321.92 689.85 30.85 17.38 0 JAXW202-2341 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 30.4 28.1 28.4 28.1 29 29.1 28 31.6 NA NA 10.58 9.62 16.9 51.1 53.12 17.57 33.07 753 1564.78 8560.28 325.86 97.34 30.68 1.18 8.8 14.6 36.3 41.25 16.59 40.22 486 369.93 789.66 10.38 8.14 1.89 JAXW202-2343 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 21.5 22.8 23.5 22.7 23.1 22.3 22.7 23 NA NA 7.88 9.97 15.6 59 59.18 15.65 26.44 604 789.58 6822.5 263.98 3.94 0 1.98 8.41 12.6 49.9 59.33 14.98 25.25 449 256.61 1704.19 13.86 1.58 3.76 JAXW202-2344 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 23.4 21.2 19.8 19.7 20.5 20 19.7 19.4 NA NA 3.2 10.11 16.4 60.9 60.24 16.22 26.93 864 572.16 2402.56 223.68 1.92 0 0.56 10.27 14.2 59.8 58.23 13.83 23.75 511 56.95 463.29 31.64 4.48 3.7 JAXW202-2346 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 25.9 24.5 23.8 23 25.1 23.9 22.9 23.2 NA NA 9.36 10.41 15.8 46.7 44.86 15.18 33.83 971 1202.76 7840.87 314.5 1.87 0 1.28 10.08 14.9 46.1 45.73 14.78 32.32 667 123.01 1093.76 54.14 7.42 1.79 JAXW202-2347 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 22.7 22.2 21.3 21 20.8 20.6 20 20.5 NA NA 6.08 10.07 15.3 43.6 43.3 15.19 35.09 794 769.12 5090.18 219.49 1.82 0 2.32 8.33 13.3 34.7 41.66 15.97 38.33 666 517.59 1708.22 64.03 27.84 2.32 JAXW202-2348 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 27.2 26.3 26 25.6 25.8 23 20.5 19.4 NA NA 5.24 10.28 14.7 56.4 54.86 14.3 26.06 815 591.6 4192 448.02 8.38 0 1.06 9.41 14.5 50 53.13 15.41 29 658 441.38 612.04 1.17 3.6 1.8 JAXW202-2349 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 23.4 22.4 22.1 22.1 22.3 22.1 20.8 21.9 NA NA 4.14 10.63 16.1 45.2 42.52 15.15 35.62 475 411.52 3488.36 240.12 0 0 1.06 8.85 14.1 37.6 42.49 15.93 37.5 256 181.15 863.37 15.48 0 0 JAXW202-2350 Diversity Outbred Male Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 29.1 27 27 25.9 25.8 25.3 24.7 24.6 NA NA 9.4 10.16 16.4 62.3 61.32 16.14 26.32 700 1332.92 7800.12 255.68 11.28 0 1.44 9.77 15.1 58.5 59.88 15.46 25.81 505 453.17 963.22 21.17 2.3 0 JAXW202-2351 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 23.3 23.1 22.9 23.6 23.2 22.8 23.45 23.15 NA NA 10.92 11.46 15.5 62.7 54.7 13.5 24.7 848 1157.52 9501.49 259.9 2.18 0 1.96 7.54 9.6 40.4 53.6 12.7 23.8 487 78.99 1824.17 44.3 12.74 0 JAXW202-2352 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 27.1 25.8 25.3 25.9 25.5 24.8 24.65 24 NA NA 4.16 8.45 14.6 46 54.4 17.3 31.7 796 865.28 3063.84 225.47 4.99 0 1.2 7.82 10.4 42.9 54.9 13.3 24.2 772 372.6 734.4 70.44 12.84 9.72 JAXW202-2353 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 30.9 27.2 28.4 29.5 29.8 29.5 29.23 29.52 NA NA 6.28 10.28 14.7 56.3 54.8 14.3 26.1 666 1288.66 4774.68 197.19 18.21 1.88 0.48 7.5 10.2 40.3 53.7 13.6 25.3 527 53.57 327.74 88.13 10.61 0 JAXW202-2354 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 26.9 24.4 25 25.4 25.5 24.6 24.48 24.41 NA NA 6.88 10.86 16.8 66.2 61 15.5 25.4 1027 976.96 5756.5 110.77 32.34 3.44 0.4 8.37 12.4 50.6 60.5 14.8 24.5 448 91.2 269.12 32.8 6.88 0 JAXW202-2355 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 26.7 26.2 26.1 25.2 25.7 25.6 25.51 25.08 NA NA 6.66 9.95 15.1 47.8 48 15.2 31.6 710 1579.09 4866.46 205.13 7.33 1.33 0.84 7.37 10.7 34 46.1 14.5 31.5 568 118.69 634.96 82.4 3.86 0 JAXW202-2356 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 22.7 21.9 21.3 21.8 21.9 20.6 21.83 21.16 NA NA 6.02 10.34 15.7 65.2 63.1 15.2 24.1 699 1294.9 4560.75 152.31 12.04 0 0.84 7.81 10.7 36.9 47.2 13.7 29 623 114.91 687.54 28.22 9.32 0 JAXW202-2357 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 25.9 25 25.7 26.6 27 25.9 26.12 27.16 NA NA 4.78 10.15 15.5 58.2 57.3 15.3 26.6 599 1009.06 3623.24 141.49 4.78 1.91 1.22 8.61 12.8 53.2 61.8 14.9 24.1 538 125.78 1041.15 47.46 3.9 1.71 JAXW202-2358 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 22.8 20.5 21.3 22 22.5 21.7 21.56 21.82 NA NA 7.8 8.44 13.5 39.2 46.4 16 34.4 848 908.7 6555.12 322.92 14.04 0 1.56 6.82 10 30.8 45.2 14.7 32.5 638 378.14 995.9 172.69 11.54 1.72 JAXW202-2359 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 31.2 29.5 29.3 29.3 29.2 28.4 28.5 29.34 NA NA 7.2 10.13 15.9 58.9 58.1 15.7 27 1013 956.16 5958.72 274.32 10.8 0 2.08 7.75 11.5 45.2 58.3 14.8 25.4 602 779.38 1182.9 78.83 38.9 0 JAXW202-2360 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 26.7 26.4 25.7 25.4 25 24.5 24.05 24.4 NA NA 6.28 8.55 13.8 40.4 47.3 16.1 34.2 1288 1105.91 4928.54 219.8 20.72 5.02 1.4 7.27 10.6 34.2 47 14.6 31 748 398.58 939.68 50.4 11.2 0 JAXW202-2361 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 29.3 28.3 28.6 29.2 29.3 27.8 28.44 28.78 NA NA 9.04 10.28 15.9 45.7 44.5 15.5 34.8 971 1294.53 7414.61 327.25 3.62 0 1.44 9.11 12.5 40.7 44.7 13.7 30.7 862 206.06 1118.74 113.47 1.87 0 JAXW202-2362 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 21.8 21.5 21.4 22.1 22.2 21.4 21.34 21.84 NA NA 5.94 10.99 15.4 46.4 42.2 14 33.2 831 1049.6 4838.13 39.8 8.91 3.56 0.66 7.67 10.3 31.8 41.5 13.4 32.4 729 285.98 347.29 18.41 8.32 0 JAXW202-2363 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 22.5 19.7 21.3 22.1 22.8 22 22.43 23.04 NA NA 6.88 9.91 14.9 43.6 44 15 34.2 830 1511.54 5102.9 238.05 22.7 5.5 0.6 8.28 11 36.2 43.7 13.3 30.4 619 142.14 432.12 18.24 5.58 1.86 JAXW202-2364 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 29.7 29.1 28.6 28.7 28.3 27.5 28.2 28.54 NA NA 9.02 10.84 15.8 46.3 42.7 14.6 34.1 1273 1481.99 7298.98 218.28 18.94 1.8 1.42 8.56 11.7 36.1 42.2 13.7 32.4 797 200.79 1184.99 32.38 1.85 0 JAXW202-2365 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 26.3 26.8 25.9 25.8 25.7 24.6 24.95 24.81 NA NA 5.74 10.7 15 43.8 40.9 14 34.2 606 1722.57 3838.34 170.48 4.59 3.44 0.5 7.9 10.4 31.3 39.6 13.2 33.2 514 164.75 275.15 51.45 6.75 1.95 JAXW202-2366 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 31.6 29.4 29.4 30.2 29.7 28.9 29.73 29.69 NA NA 3.8 10.34 15.7 45.6 44.1 15.2 34.4 721 619.02 2950.7 213.56 7.6 9.12 1.12 7.56 11.5 32 42.3 15.2 35.9 577 179.42 939.34 1.12 0 0 JAXW202-2367 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 30.3 28.7 28.5 28.7 28.6 27.7 27.88 28.07 NA NA 11.8 9.92 14.8 44.3 44.7 14.9 33.4 545 1853.78 9677.18 236 33.04 0 1.72 7.63 10.4 32.9 43.1 13.6 31.6 450 264.02 1417.62 34.23 4.13 0 JAXW202-2368 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 23.3 21 21.7 23.1 23.2 22.1 22.89 23.36 NA NA 7.68 10.33 15.1 59.5 57.6 14.6 25.4 937 1447.68 6063.36 160.51 4.61 3.84 1.04 8.74 11.7 49.2 56.3 13.4 23.8 788 209.25 799.14 13 14.87 3.74 JAXW202-2369 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 30.5 28 28.4 29.3 26.9 25.1 24.73 24.8 NA NA 7.02 10.14 14.4 53 52.3 14.2 27.2 881 1154.79 5674.27 174.1 16.85 0 1.84 10.18 13.3 51.6 50.7 13.1 25.8 658 814.38 940.42 56.67 26.86 1.84 JAXW202-2371 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 26.2 24.3 24.6 24.6 25 24.6 25.42 25.5 NA NA 4.7 10.63 15.5 45.1 42.4 14.6 34.4 796 1088.52 3348.75 261.32 1.88 0 0.74 8.3 11.5 33.9 40.8 13.9 33.9 452 138.6 533.24 52.17 10.36 5.62 JAXW202-2372 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 25.5 26.1 26.3 26.6 27.6 27.3 27.23 27.4 NA NA 5.6 9.88 15.1 47.2 47.8 15.3 32 694 758.24 4721.36 110.32 8.4 1.68 1.36 8.35 11.8 39 46.7 14.1 30.3 662 187.68 1161.03 9.52 1.77 0 JAXW202-2373 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 25.7 23.2 23.4 23 23.3 22.7 23.17 22.91 NA NA 7.34 9.47 14.1 43.2 45.6 14.9 32.6 680 1481.21 5625.38 222.4 8.81 1.47 1.04 7.91 11 34.9 44.1 13.9 31.5 565 316.58 717.6 4.06 1.77 0 JAXW202-2374 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 24.2 21.9 23 23.1 22.9 22 22.14 22.18 NA NA 7.96 10.44 15.6 47.3 45.3 14.9 33 808 1485.34 6199.25 274.62 1.59 0 1.56 8.78 12.1 38.4 43.7 13.8 31.5 617 391.72 1113.68 52.73 1.72 0 JAXW202-2375 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 29.3 29.3 28.5 27.8 28.1 27.5 28.27 28.13 NA NA 11.92 10.28 15.8 46.2 44.9 15.4 34.2 836 1942.96 9787.51 163.3 23.84 1.19 0.4 8.86 12 38.5 43.5 13.5 31.2 655 84.44 313.28 2.28 0 0 JAXW202-2376 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 27.1 25.5 25.7 25.2 25.8 25.3 25.68 26.1 NA NA 5.7 9.51 15.7 49.5 52.1 16.5 31.7 714 886.35 4668.3 126.54 17.67 1.71 1.36 7.18 11.6 37 51.5 16.2 31.4 317 546.18 716.31 72.08 23.53 1.77 JAXW202-2377 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 25.9 23.4 23.4 23.5 23.8 23.5 24.15 23.96 NA NA 7.7 10.16 15.2 46.2 45.5 15 32.9 996 640.64 6763.68 287.21 7.7 0 1.36 8.39 12.2 37.5 44.7 14.5 32.5 823 157.35 1113.57 82.42 4.76 1.77 JAXW202-2378 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 24.6 24.4 24.7 24.6 24.8 22.8 22.57 22.89 NA NA 7.7 10.34 15.8 59.5 57.5 15.3 26.6 717 872.41 6614.3 172.48 38.5 1.54 0.82 9.56 12.4 52.9 55.3 13 23.4 563 97.42 692.65 27.22 2.62 0 JAXW202-2379 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 26.1 22.9 21.7 22.1 23 22.5 23.4 23.56 NA NA 7.74 10.59 14.9 60.9 57.5 14.1 24.5 812 1367.66 6205.16 161.77 1.55 3.87 1.14 8.32 11.6 46 55.3 13.9 25.2 698 79.12 1033.98 21.32 5.59 0 JAXW202-2380 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 28.6 26 26.5 26.1 26.4 25.8 26.87 26 NA NA 6.98 10.81 16 62.4 57.7 14.8 25.6 613 1232.67 5574.23 161.24 12.56 0 0.96 8.8 11.8 49.5 56.3 13.4 23.8 585 259.87 654.05 44.26 1.82 0 JAXW202-2381 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 32.1 29.9 28.9 27.9 27.7 26.3 27.12 26.65 NA NA 8.18 9.81 14.7 57.9 59 15 25.4 921 876.9 7153.41 148.06 1.64 0 1.46 9.59 13.2 55 57.4 13.8 24 940 309.96 1078.65 48.47 17.67 5.26 JAXW202-2382 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 24.4 22 22.6 23.3 23.1 22.1 23.35 23.19 NA NA 6.72 10 14.5 44 44 14.5 33 783 1192.8 5341.06 177.41 8.74 0 1.48 9.35 12.6 40 42.8 13.5 31.5 832 156.14 1243.5 80.51 0 0 JAXW202-2383 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 31.3 29.2 28.7 29.7 29.5 29.4 29.53 29.44 NA NA 4.04 10.46 15.5 45 43 14.8 34.4 722 675.49 3243.72 94.94 20.6 5.25 0.9 8.7 12.4 36.1 41.5 14.3 34.3 663 169.83 681.03 28.71 18.36 1.89 JAXW202-2384 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 23.5 33.1 34.1 34.1 35 33.7 34.41 34.17 NA NA 6.92 10.18 14.2 55.4 54.4 13.9 25.6 628 839.4 5912.45 168.85 0 0 2.86 8.45 11.4 45 53.3 13.5 25.3 747 560.56 2118.4 157.01 24.31 0 JAXW202-2385 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 27.7 27.4 27.4 27 26.9 25.4 26.38 26.32 NA NA 6.02 9.3 15.2 43 46.2 16.3 35.3 657 992.7 4805.77 204.68 17.46 0 1.98 9.27 13.1 42.3 45.6 14.1 31 487 268.49 1635.28 62.37 10.49 3.56 JAXW202-2386 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 25.7 23.4 22.3 21.8 22.8 22.1 23.02 23.33 NA NA 6.08 11.5 14.8 45.1 39.2 12.9 32.8 661 1360.1 4595.87 117.95 5.47 0 1.96 9.84 14.5 47.2 48 14.7 30.7 675 957.85 927.47 53.12 18.23 3.33 JAXW202-2387 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 28.9 25.8 26.2 27.4 26.7 26.2 27.13 26.74 NA NA 9.02 9.63 15.2 46.6 48.4 15.8 32.6 815 1149.15 7519.97 340.96 7.22 1.8 2.1 7.74 12 38.1 49.2 15.5 31.5 740 316.05 1648.29 120.75 14.91 0 JAXW202-2388 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 25.9 24.3 25.7 25.4 25.7 25.5 25.52 25.06 NA NA 8.22 9.07 14.8 45.3 49.9 16.3 32.7 686 1598.79 6266.93 343.6 11.51 0 2.14 7.93 12 38.9 49.1 15.1 30.8 750 287.19 1680.97 160.29 11.77 0 JAXW202-2389 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - B Cyclophosphamide 2010-07-20 2010-09-16 NA 28.8 27.2 28.6 29 29.3 27.9 28.91 28.91 NA NA 4.8 10.78 15.4 61.7 57.2 14.3 25 958 737.28 3815.52 212.64 28.32 6.72 0.92 7.5 10.4 41.1 54.8 13.9 25.3 560 97.89 784.76 35.33 1.93 0 JAXW202-2390 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 26.2 23.2 23.2 23.9 24.13 24.3 23.5 25.67 NA NA 7.16 9.78 15.1 54.9 56.13 15.44 27.5 968 1113.38 5894.11 146.06 5.01 1.43 0.86 8.81 11.1 46.5 52.8 12.6 23.9 630 221.7 566.7 57.9 11.7 1.9 JAXW202-2391 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 32.6 31 30.5 30.2 30.58 30.39 29.5 30.99 NA NA 8.12 9.5 14.2 43 45.26 14.95 33.02 1379 963.84 6892.26 250.1 13.8 0 1.26 8.14 10.8 37.3 45.8 13.3 29 659 199.1 1000.7 46.7 13.5 0 JAXW202-2392 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 24.3 24 23.8 23.3 23.13 23.45 23.2 24.66 NA NA 5.22 11.02 15.2 47.3 42.92 13.79 32.14 838 1377.04 3530.81 281.36 24.53 6.79 1.78 8.55 11.1 36.6 42.8 13 30.3 521 379.5 1335.5 61.2 2 1.8 JAXW202-2393 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 28.8 27.7 27.5 27.2 27.31 26.78 26.2 26.37 NA NA 4.32 9.98 15.1 45.1 45.19 15.13 33.48 1193 698.11 3511.73 96.34 12.1 1.73 1.18 9.19 13 42 45.7 14.1 31 831 209.2 871 84.6 13.2 1.9 JAXW202-2394 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 27.2 25.5 25.4 26.3 26.2 26.17 26.4 26.81 NA NA 5.84 10.1 14.5 47.3 46.83 14.36 30.66 733 879.5 4677.84 262.8 17.52 1.75 0.78 7.63 11 36.2 47.4 14.4 30.4 653 154.3 594.5 8.1 21.2 1.9 JAXW202-2395 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 26 24.8 24.6 24.6 24.74 25.07 24.1 25.71 NA NA 6.28 10.79 15.3 60.6 56.16 14.18 25.25 758 1201.36 4872.65 199.08 3.77 3.14 1.34 9.1 12.2 50.7 55.7 13.4 24.1 631 242 1074.3 5.6 16.2 1.9 JAXW202-2396 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 26.8 25.2 25.4 25.6 25.75 25.66 25.9 27.68 NA NA 5.22 8.29 12.9 39.2 47.29 15.56 32.91 767 728.71 4287.71 198.88 5.22 0 1.92 6.68 11.6 31.2 46.7 17.4 37.2 795 670.1 1001.5 182 64.7 1.7 JAXW202-2397 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 32 31.7 30.8 29.8 29.45 30.1 28.6 29.97 NA NA 8.32 9.68 15 48.6 50.21 15.5 30.86 888 1159.81 6925.57 213.82 12.48 9.15 0.86 8.53 12.7 42.9 50.3 14.9 29.6 822 239.3 597.2 15.8 7.7 0 JAXW202-2398 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 19.8 19 19.4 19.6 19.24 18.96 18.7 20 NA NA 7.8 10.9 15.3 47.3 43.39 14.04 32.35 905 1062.36 6455.28 188.76 94.38 0 2.24 9.15 12.4 40.4 44.2 13.6 30.7 790 251.1 1921.5 54.9 7.2 5.4 JAXW202-2399 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 22.8 21.1 21.1 21.6 21.48 21.16 19.9 20.23 NA NA 6.58 10.52 16.3 65.4 62.17 15.49 24.92 844 1041.61 5083.71 440.86 10.53 3.29 2.14 8.17 12 50.1 61.3 14.7 24 642 949.3 1065.3 111.3 10.7 3.2 JAXW202-2400 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 31.4 30 30 29.1 29.08 29.03 28.7 29.67 NA NA 9.62 11.02 15.1 46.9 42.56 13.7 32.2 965 1985.57 7394.89 193.36 40.4 5.77 0.92 9.4 12.3 39.9 42.4 13.1 30.8 524 107.9 796.4 12.1 0 3.7 JAXW202-2401 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 21.9 19.6 19.8 20.4 20.47 20.75 19.5 20.41 NA NA 6.32 8.96 14.5 50.2 56.03 16.18 28.88 1056 848.14 5293.63 168.11 6.32 3.16 0.98 8.41 12.1 46.5 55.3 14.4 26 1077 249.1 696.7 19.4 14.9 0 JAXW202-2402 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 25.1 23.7 23.6 24.2 24.39 24.51 24.2 25.45 NA NA 9.28 11.27 16.6 68.2 60.51 14.73 24.34 757 1290.85 7709.82 220.86 58.46 0 0.82 8.36 12.1 50.7 60.6 14.5 23.9 429 63.1 710.7 44.3 2 0 JAXW202-2403 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 26.8 25.1 24.6 24.6 24.69 24.74 24.3 24.76 NA NA 9.68 10.56 15.7 46.4 43.94 14.87 33.84 915 1380.37 7937.6 320.41 38.72 3.87 0.58 9.32 13 40.5 43.5 13.9 32.1 392 165.1 351.4 61.2 2.3 0 JAXW202-2404 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 27.9 26.9 26.3 26.5 26.38 26.82 26 27.35 NA NA 8.18 10.03 15 43.7 43.57 14.96 34.32 864 1219.64 6670.79 275.67 11.45 1.64 1.56 8.91 11.9 38.4 43.1 13.4 31 651 99.2 1387.8 69.3 3.7 0 JAXW202-2405 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 28 27.3 27.7 27.4 27.15 27.34 27.2 28.53 NA NA 8.12 11.58 15.7 63.6 54.92 13.56 24.69 830 1061.28 6638.1 303.69 95.82 20.3 2.56 9.3 12.5 51.8 55.7 13.4 24.1 808 776.4 1662 103.7 17.9 0 JAXW202-2406 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 25.2 23.3 21.9 20.4 19.84 19.92 18.8 18.81 NA NA 8.92 10.45 14.7 51 48.8 14.07 28.82 1149 883.08 7765.75 149.86 88.31 33 0.46 8.98 13.5 43.8 48.8 15 30.8 638 25.2 390 34.4 10.4 0 JAXW202-2407 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 19.8 20.3 20.2 20.1 19.7 18.3 17.7 17.6 NA NA 7.36 10.54 15.6 59.9 56.83 14.8 26.04 714 1106.94 5970.43 274.53 8.1 0 1 8.41 12.8 47 55.89 15.22 27.23 518 76.3 855.5 66.5 1.8 0 JAXW202-2408 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 23 22.1 21.5 20.5 20.8 19.6 18.8 19.5 NA NA 4.36 9.57 15.7 47.5 49.63 16.41 33.05 904 952.22 3232.94 163.94 5.23 5.23 1 9.47 14.8 47.5 50.16 15.63 31.16 491 104.2 860.1 24.8 9.1 1.7 JAXW202-2409 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 21.2 20 19.4 20.4 21 20.6 20.1 21.3 NA NA 5.36 10.17 15.9 44.3 43.56 15.63 35.89 614 757.9 4395.2 203.14 3.75 0 1.86 8.39 13.2 36.5 43.5 15.73 36.16 548 338.89 1480.93 34.97 3.53 1.86 JAXW202-2410 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 21.5 20.3 20.3 19.1 19.1 18.8 18.1 18.2 NA NA 4.36 10.28 15.8 61 59.34 15.37 25.9 580 545.87 3563.86 224.1 26.6 0 0.86 7.9 11.8 46.5 58.86 14.94 25.38 411 84.19 730.66 44.46 0.77 0 JAXW202-2411 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 20.9 21.4 21.3 20.7 21.5 20.6 22 20.2 NA NA 7.4 9.83 14.4 41 41.71 14.65 35.12 739 1135.16 5947.38 315.24 1.48 0 2.24 7.24 11.6 30.1 41.57 16.02 38.54 432 190.62 1991.14 51.52 6.94 0 JAXW202-2412 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 17.9 18.1 18.1 17.2 17.5 16.1 15.3 15.7 NA NA 6.98 10.35 16.4 62.3 60.19 15.85 26.32 714 860.63 5875.76 242.21 0 2.09 1.48 8.29 12.8 48.9 58.99 15.44 26.18 192 370.44 1031.56 51.21 26.64 0 JAXW202-2413 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 21.9 20.9 19.4 20 21.4 19.7 19 18.8 NA NA 12.48 9.75 15.6 60.5 62.05 16 25.79 617 2228.93 9511.01 717.6 24.96 0 2.12 8.21 13.6 49.3 60.05 16.57 27.59 483 67.42 2004.46 46.43 0 1.7 JAXW202-2414 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 24.3 22.8 21.6 21.2 22.5 21.5 21.3 21.8 NA NA 8.48 10.56 16.5 64 60.61 15.63 25.78 555 811.54 7299.58 363.79 3.39 1.7 1.42 9.02 14.2 54 59.87 15.74 26.3 384 60.07 1332.81 14.48 10.79 1.85 JAXW202-2415 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 17.9 17.9 17.4 17.9 19 18.4 18.5 19 NA NA 9.04 10.01 18.1 53 52.95 18.08 34.15 678 1071.24 7652.36 300.13 15.37 0 1.86 8.61 15 45.3 52.61 17.42 33.11 507 127.04 1688.69 44.08 0 0 JAXW202-2416 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 20 19.1 19 18.9 20 19.2 18.6 19.1 NA NA 12.64 10.58 15.4 44.8 42.34 14.56 34.38 897 1298.13 10742.74 552.37 37.92 10.11 2.2 8.47 13.1 35.8 42.27 15.47 36.59 707 106.7 2025.32 66.22 0 1.76 JAXW202-2417 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 18.5 19.3 18 17.8 17.5 17.6 16.8 15.9 NA NA 7.32 9.77 14.8 43.7 44.73 15.15 33.87 553 1250.26 5707.4 328.67 32.21 1.46 1.28 8.78 13.4 39.2 44.65 15.26 34.18 413 274.18 944.77 53.63 3.84 3.46 JAXW202-2418 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 16.3 16.2 20.2 15.5 16 15.9 15.5 15.5 NA NA 10.16 7.79 15.6 44.1 56.61 20.03 35.37 520 859.54 8908.29 387.1 5.08 0 1.02 8.07 12.2 44.7 55.39 15.12 27.29 385 16.52 961.15 38.76 3.57 0 JAXW202-2419 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 22.8 23.2 24 22.1 22 21.5 21.6 22.4 NA NA 13.1 10.42 15.9 50 47.98 15.26 31.8 824 1710.86 10880.86 465.05 44.54 0 2.24 8.94 14.2 43.9 49.11 15.88 32.35 572 429.41 1784.61 6.5 17.25 2.02 JAXW202-2420 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 22 17.7 20 18.2 20.3 19.2 18.5 18.9 NA NA 11.14 9.61 15.7 57.9 60.25 16.34 27.12 539 1435.95 9285.19 403.27 15.6 0 1.32 8.17 13.5 49.1 60.1 16.52 27.49 350 194.83 1109.06 8.58 4.09 3.56 JAXW202-2421 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 18.8 20.3 19.7 19.5 19.3 17.7 17.2 18.1 NA NA 4.82 9.89 15 41 41.46 15.17 36.59 694 895.07 3700.31 217.86 6.27 0 1.06 8.21 12.9 33.2 40.44 15.71 38.86 525 92.43 897.71 62.86 4.77 2.33 JAXW202-2422 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 18.6 18.7 18.1 17.6 17.6 17.2 16.5 16.5 NA NA 6 10.15 17.1 62.6 61.67 16.85 27.32 812 626.4 5052 306 11.4 3.6 1.2 8.93 14.1 54.6 61.14 15.79 25.82 457 173.04 1010.4 16.44 0 0 JAXW202-2423 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 20.1 19.7 19.3 19.7 19.7 19.7 19.3 20 NA NA 11.38 9.5 15.1 45.8 48.21 15.89 32.97 738 2321.52 8538.41 506.41 11.38 2.28 2.96 7.91 13.2 37.8 47.79 16.69 34.92 754 396.05 2492.02 64.53 7.4 0 JAXW202-2424 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 17.3 18 17.4 17.4 17.5 17.3 16.7 17.6 NA NA 7 10.13 14.9 41.3 40.77 14.71 36.08 733 920.5 5602.1 465.5 11.9 0 1.12 9.39 13.4 38.1 40.58 14.27 35.17 469 49.06 1024.02 43.23 1.79 1.79 JAXW202-2425 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - A Doxorubicin 2010-07-20 2010-09-15 NA 20.8 20.9 19.7 19 20 19.5 18.6 19.9 NA NA 9.78 10.03 15.8 46 45.86 15.75 34.35 791 1232.28 8102.73 436.19 8.8 0 4.26 10.21 15.4 47.4 46.43 15.08 32.49 608 558.06 3661.04 30.67 6.82 3.83 JAXW202-2426 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 24.3 23.8 23.3 22.6 23.6 23.5 23.04 23.84 NA NA 5.94 10.87 15.5 63.6 58.5 14.3 24.4 744 900.5 4855.95 162.16 21.38 0 2.42 10.04 14.2 57 56.8 14.1 24.9 585 165.29 2214.06 33.88 4.84 1.69 JAXW202-2427 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 21.2 20.9 20.3 20.2 20.6 21.1 22.06 21.11 NA NA 3.86 10.04 14.6 45.2 45 14.5 32.3 1247 739.19 2974.9 135.49 8.49 2.32 2.06 9.1 12.5 40.9 44.9 13.7 30.6 379 80.75 1941.34 30.49 7.42 0 JAXW202-2428 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 20.6 21.2 21.1 20.7 21 20.4 20.17 20.34 NA NA 5.88 9.85 14.9 46.5 47.2 15.1 32 702 729.12 4939.79 203.45 7.64 0 2.1 8.66 12 40.3 46.5 13.9 29.8 526 143.85 1915.2 39.27 1.68 0 JAXW202-2429 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 23.1 22.7 21.7 21 21.7 20.9 20.58 21.2 NA NA 6.22 10.89 15.3 62.7 57.6 14 24.4 1827 1104.05 4820.5 287.99 4.98 1.87 2.26 9.01 13.8 50.4 55.9 15.3 27.4 583 565 1630.36 56.73 7.91 0 JAXW202-2430 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 24.7 23.9 22.2 21.9 22 21.5 21.12 21.41 NA NA 4.94 10.21 16 59.5 58.3 15.7 26.9 2188 650.1 4202.46 67.18 20.25 0 0.86 10.13 14.9 58.6 57.8 14.7 25.4 478 71.98 726.1 42.66 17.46 1.81 JAXW202-2431 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 16.9 15.9 15.1 14.7 14.9 13.8 14.68 14.18 NA NA 5.32 10.47 13.8 42.3 40.4 13.2 32.6 1050 704.9 4306.01 301.64 5.32 1.6 1.3 10.13 13.4 39.9 39.4 13.2 33.6 422 144.43 1113.97 38.09 1.82 1.82 JAXW202-2432 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 19.9 22.5 21.5 20.1 20.1 18.6 18.32 18.78 NA NA 8.32 9.74 15.1 57.6 59.1 15.5 26.2 1579 1056.64 7073.66 146.43 38.27 5.82 2.84 10.05 14.9 57.5 57.2 14.8 25.9 482 382.55 2374.24 48.56 18.18 16.47 JAXW202-2433 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 16.2 16.8 16.3 15.7 15.3 22.4 21.93 22.7 NA NA 7.88 11.3 15.2 62 54.9 13.5 24.5 1591 860.5 6873.72 130.81 13.4 1.58 0.76 11.31 15 60.6 53.6 13.3 24.8 288 87.86 629.66 42.48 0 0 JAXW202-2434 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 22.4 22.6 21.1 20.8 20 18.9 18.77 19.02 NA NA 11.96 10 14.9 48.2 48.2 14.9 30.9 1653 993.88 10595.36 348.04 22.72 0 2.32 9.33 14.6 42.3 45.3 15.6 34.5 335 67.98 2182.42 65.89 0 3.48 JAXW202-2435 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 23.6 19.6 19.2 18.2 18.3 17 16.57 17.47 NA NA 5.62 10.33 15.2 59.5 57.6 14.7 25.5 1508 714.86 4747.78 149.49 7.31 0 1.08 10.87 15.3 60.9 56 14.1 25.1 327 134.46 924.16 14.8 6.59 0 JAXW202-2436 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 25 24.4 23.4 23 23.3 15.7 16.02 15.45 NA NA 4.78 10.34 14.5 43.3 41.9 14 33.5 1566 1032.48 3642.84 101.34 3.82 0 2.46 9.12 11.9 37.1 40.7 13 32.1 624 467.65 1906.99 63.47 12.79 8.86 JAXW202-2437 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 20.4 22 21.8 21.2 17.1 15.7 15.43 14.23 NA NA 4 10.07 15 56.7 56.3 14.9 26.5 788 437.6 3492 67.6 2.8 0 1.32 10.64 14.3 57.7 54.2 13.4 24.8 377 112.07 1136.26 34.19 26 11.62 JAXW202-2438 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 19 19.6 19.1 18.5 18.9 18.6 19.67 19.43 NA NA 10.52 10.59 16.4 66.2 62.5 15.5 24.8 661 2033.52 8198.24 270.36 15.78 2.1 2.66 9.48 13.6 57.1 60.2 14.3 23.8 491 343.94 2257.81 47.61 7.18 3.72 JAXW202-2439 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 18.7 19.7 18.5 17.5 16.9 16 16.21 17.32 NA NA 4.98 10.46 15.3 45.2 43.2 14.6 33.8 988 1064.72 3744.96 166.83 1.99 1.99 1.8 10.5 14.1 44.5 42.4 13.4 31.7 663 603 1158.12 32.22 4.86 1.8 JAXW202-2440 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 22.5 22.4 21.6 21 21 20.7 21.45 21.89 NA NA 4.7 9.16 14.5 46.1 50.3 15.8 31.5 887 1092.75 3361.91 227.01 15.98 1.88 1.92 9.24 13.7 45.7 49.5 14.8 30 607 133.44 1749.31 23.81 13.63 0 JAXW202-2441 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 23 19.2 19.1 21.2 21.7 21.7 22.56 23.29 NA NA 2.1 9.2 12.3 39.1 42.5 13.4 31.5 799 198.24 1826.16 72.24 3.57 0 1.34 8.72 11.1 36.1 41.4 12.7 30.7 441 18.09 1274.34 47.44 0.13 0 JAXW202-2442 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 17.6 17.5 17.6 17.3 17 16.4 16.42 16.7 NA NA 5.04 9.64 14.6 45 46.7 15.1 32.4 964 710.64 4191.77 129.02 8.06 0 3.5 8.46 12.3 38.2 45.2 14.5 32.2 748 380.45 3073.7 38.15 5.95 1.75 JAXW202-2443 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 19.3 19.6 19.4 19.3 18.9 18.5 19.39 19.82 NA NA 7.86 9.75 15.7 48 49.2 16.1 32.7 569 1474.54 6141.8 238.16 3.93 1.57 2.42 9.68 14.1 46.8 48.3 14.6 30.1 575 361.06 2012.96 42.59 1.69 1.69 JAXW202-2444 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 23.5 22.1 22.5 21.5 21.8 21 21.13 22.3 NA NA 3.76 9.87 14.8 54.2 54.9 15 27.3 546 708.01 2914.75 117.69 18.05 1.88 1.4 11.03 14.7 59.8 54.2 13.3 24.6 481 68.04 1278.62 46.48 5.04 1.82 JAXW202-2445 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 23.2 23.2 21.5 20.5 20.8 19.4 19.43 18.88 NA NA 7.18 10.77 15.6 47.5 44.1 14.5 32.8 736 863.04 6051.3 237.66 26.57 1.44 2.58 10.1 15.1 44.2 43.8 15 34.2 444 117.65 2413.07 47.99 1.29 0 JAXW202-2446 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 30.2 27.6 26.8 26.1 25.4 24.2 24.55 24.24 NA NA 3.44 9.78 14.6 49.7 50.8 14.9 29.4 777 659.79 2653.27 123.84 3.44 0 2.2 10.14 15.8 49.5 48.8 15.6 31.9 560 590.04 1566.4 22.44 19.36 1.76 JAXW202-2447 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 23.2 23.7 23.1 22.4 22.1 22 23.08 22.73 NA NA 4.8 9.35 13.7 54.2 58 14.7 25.3 764 472.8 4176 147.84 1.92 1.92 1.88 8.95 11.1 50.5 56.4 12.4 22 654 89.86 1768.33 15.04 6.77 0 JAXW202-2448 Diversity Outbred Female Group 22 - 20 mg/kg Adriamycin (doxorubicin) - B Doxorubicin 2010-07-20 2010-09-16 NA 20.6 20.7 19.7 18.9 18.8 18.2 18.72 17.3 NA NA 2.84 10.6 15.4 60.1 56.7 14.5 25.6 1263 420.6 2265.47 152.22 0 1.7 1.16 10.12 14.3 55.8 55.1 14.1 25.6 408 364.59 757.13 34.68 3.6 0 JAXW202-2449 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 20.7 19.9 20 20.7 21.04 21.07 20.7 21.43 NA NA 9.72 10.26 14.4 57.8 56.34 14.04 24.91 716 1432.73 7615.62 428.65 166.21 77.76 2.2 8.93 12.1 50.8 56.9 13.5 23.8 484 141.7 1973 81.8 3.1 0 JAXW202-2450 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 20.7 19.8 19.3 19 19.67 19.58 19.6 19.96 NA NA 3.58 9.94 14.4 61.7 62.07 14.49 23.34 772 612.18 2840.37 114.92 10.38 1.79 1.9 8.2 12.3 50.7 61.8 15 24.3 793 563.9 1184.1 122 25.7 4.4 JAXW202-2451 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 19.9 19.8 19.4 19.1 19.77 20.1 19.8 20.21 NA NA 5.76 10.53 15.1 48.5 46.06 14.34 31.13 777 961.92 4475.52 301.82 20.74 0 2.22 7.82 11.6 35.6 45.5 14.8 32.6 760 301.7 1759.1 133.4 23.8 1.8 JAXW202-2452 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 19.1 19.1 19.2 19.6 19.91 19.52 19.6 19.76 NA NA 5.38 11.22 16.4 59.4 52.94 14.62 27.61 704 928.05 4321.75 125.35 5.38 0 1.36 8.64 11.2 44.9 52 13 24.9 563 299.3 1023.1 32 0.1 5.6 JAXW202-2453 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 18.3 17.6 17.5 17.4 17.89 17.1 16.8 17.24 NA NA 8.18 9.61 16.2 49.6 51.61 16.86 32.66 1083 1134.57 6732.14 283.85 17.18 12.27 3.74 8.02 12.2 40.7 50.7 15.2 30 824 1984.4 1567.8 169.4 12.7 5.2 JAXW202-2454 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 21.5 20.1 20.2 20.5 20.28 20.2 20.5 21.12 NA NA 3.3 9.12 15.6 42.5 46.6 17.11 36.71 658 719.07 2351.91 217.14 11.88 0 1.12 7.86 12 35.9 45.7 15.3 33.4 954 339.8 678.6 93.3 6.6 1.8 JAXW202-2455 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 22.2 20.7 20.7 20.7 21.34 21.67 20.4 20.87 NA NA 4.96 9.08 16.2 43.4 47.8 17.84 37.33 829 696.88 4113.82 143.84 1.98 3.47 0.6 7.73 12.1 36.4 47.1 15.7 33.2 397 121.8 428.8 34.9 12.3 2.2 JAXW202-2456 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 20.1 19.5 19 19.1 19.67 19.49 18.8 19 NA NA 3.56 10.18 14.3 54.1 53.14 14.05 26.43 691 722.32 2644.72 185.12 4.63 3.56 1.38 7.63 10.7 40.1 52.6 14 26.7 508 764.9 536.3 47.5 26.4 5 JAXW202-2457 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 21.4 20.4 21.2 21.5 21.65 21.56 21.4 21.66 NA NA 7.66 9.28 15.1 54.8 59.05 16.27 27.55 849 1297.6 5993.95 337.81 29.87 0 1.4 9.29 12.7 53.9 58 13.7 23.6 683 227.4 1060.8 108.8 2.9 0 JAXW202-2458 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 27.8 26.5 26.9 27.3 27.24 27.2 27.5 28.34 NA NA 9.36 11.45 16.6 69.4 60.61 14.5 23.92 895 1389.96 7539.48 380.02 44.93 5.62 1.56 9.45 12.9 54.7 57.9 13.7 23.6 763 498.3 1029.3 15.8 9.5 7 JAXW202-2459 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 24.3 23.2 23.1 22.8 22.57 22.74 23.1 23.89 NA NA 6.7 9.39 14.8 39.5 42.07 15.76 37.47 884 725.61 5629.34 320.26 24.12 2.01 1.54 7.9 11 32.6 41.3 13.9 33.7 408 168.8 1293.6 62.5 13.1 1.8 JAXW202-2460 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 21.8 20.5 21 21 21.43 21.66 21 21.01 NA NA 8.54 9.38 15.1 61 65.03 16.1 24.75 583 988.08 7106.13 393.69 51.24 0 1.5 7.23 10.8 45.6 63.1 14.9 23.7 982 174.6 1260.3 47.1 12.6 5.3 JAXW202-2461 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 21.1 21 20.4 20.7 21.98 22.08 21.6 21.8 NA NA 10.32 9.27 15.1 39.8 42.93 16.29 37.94 729 1384.94 8509.87 372.55 50.57 2.06 1.42 7.71 10.5 35.4 45.9 13.6 29.7 915 168.3 1155.5 83.1 11.4 1.8 JAXW202-2462 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 17.3 16.3 16.3 16 16.23 16.9 16.3 17.56 NA NA 9.54 10 16.2 44.9 44.9 16.2 36.08 699 1095.19 8070.84 364.43 9.54 0 2.58 7.58 12.3 32.2 42.5 16.2 38.2 786 183.7 2270.9 121.8 3.6 0 JAXW202-2463 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 13.6 14.3 14.9 14.7 14.61 14.38 14.3 14.57 NA NA 5.68 8.76 14.3 36.6 41.78 16.32 39.07 688 671.38 4583.19 398.74 26.7 0 1.74 6.57 9.2 27.6 42 14 33.3 901 323.3 1339.1 53.9 21.9 1.7 JAXW202-2464 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 18.2 18.5 NA 16.7 17.24 17.36 17.4 17.42 NA NA 8.96 9.92 15.1 58.1 58.57 15.22 25.99 944 1078.78 7555.97 287.62 37.63 0 1.3 7.99 11.1 45.9 57.4 13.9 24.2 809 208 1027.4 58.4 6.1 0 JAXW202-2465 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 15.1 13.8 14.1 13.9 14.32 14.88 13.9 14.55 NA NA 4.48 9.89 14.7 42.7 43.17 14.86 34.43 541 626.3 3686.59 155.46 10.3 1.79 1.3 9.28 12 40.3 43.4 12.9 29.8 430 212 1051.6 30.7 5.7 0 JAXW202-2466 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 20.9 19.8 20.6 19.9 19.97 19.89 19.7 20.53 NA NA 9.72 9.98 15.2 41.3 41.38 15.23 36.8 633 1337.47 7838.21 517.1 26.24 1.94 2.68 9.56 12.7 41.4 43.3 13.3 30.7 685 219.5 2406.1 40.5 13.9 0 JAXW202-2467 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 20.5 20.7 20.6 20.7 21.09 21.56 21.2 22.11 NA NA 9.5 8.65 14.2 42.2 48.79 16.42 33.65 573 943.35 8383.75 171 1.9 0 2.34 7.53 11.1 36.7 48.7 14.7 30.2 795 427.5 1821.9 86.8 2.6 1.2 JAXW202-2468 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 20.1 19.5 19.65 20.6 20.32 20.72 20.1 20.33 NA NA 8.64 9.29 15.4 55.4 59.63 16.58 27.8 703 2380.32 5951.23 290.3 18.14 0 3.06 8.65 12.9 53.6 62 14.9 24.1 836 619.3 2202.9 201.7 28.8 7.3 JAXW202-2469 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 22 21.5 21.7 21.3 21.17 22.34 21.1 21.7 NA NA 7.94 8.87 14.8 43.8 49.38 16.69 33.79 679 1266.43 6349.62 292.19 28.58 2.38 1.42 7.72 10.6 38 49.2 13.7 27.9 764 174.8 1115.1 122.1 8 0 JAXW202-2470 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 21.5 20.5 21.5 20.8 21 21.12 22.1 23.19 NA NA 4.12 9.61 15.8 41.9 43.6 16.44 37.71 613 932.77 3100.3 84.05 3.3 0 2.44 7.92 12 34.9 44.1 15.2 34.4 653 1032.1 1270.3 93.7 39 4.9 JAXW202-2471 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 24.5 23 22.4 22.9 23.41 23.08 22.4 23.04 NA NA 5.14 9.25 14.7 39.2 42.38 15.89 37.5 831 384.47 4474.88 268.31 12.34 0 1.24 7.84 11.9 32.9 42 15.2 36.2 721 236.6 871.1 118.3 10.5 3.6 JAXW202-2472 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 20.5 19.6 19.6 19.3 19.07 19.03 18.5 18.99 NA NA 13.66 8.79 15.5 45.9 52.22 17.63 33.77 802 2432.85 10728.56 438.49 58.74 1.37 2.18 7.37 11.3 38.8 52.6 15.3 29.1 729 752.8 1339.6 79.6 3.1 5.5 JAXW202-2473 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 24.9 23.6 23.5 23.3 24.45 23.74 23.3 24.63 NA NA 4.54 9.69 13.9 38.8 40.04 14.34 35.82 805 995.62 3295.13 245.61 1.82 1.82 1.86 8.1 10.8 32.3 39.9 13.3 33.4 678 589.8 1150.2 98.6 16 5.2 JAXW202-2474 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 20 19.5 19 18.9 19.01 19.48 18.9 19.45 NA NA 6.36 11.35 15.7 45.7 40.26 13.83 34.35 745 877.04 5301.7 181.9 0 0 2.46 9.29 12.8 39.2 42.2 13.8 32.7 958 112.4 2148.1 192.4 6.4 1 JAXW202-2475 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 20.8 19.7 19.7 19.9 19.67 19.22 19.2 19.46 NA NA 4.6 8.98 14.7 59.3 66.04 16.37 24.79 683 661.94 3781.2 149.5 7.36 0 3.02 8.07 12.5 52.5 65.1 15.5 23.8 756 391.1 2498.1 121.4 9.1 0 JAXW202-2476 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 19.8 19.5 19.8 19.6 19.12 19.51 19.5 19.49 NA NA 6.42 8.45 13.8 44.6 52.78 16.33 30.94 612 706.2 5462.14 231.76 17.98 1.93 1.22 6.47 9.7 34.8 53.8 15 27.9 496 175.8 988.4 47.8 8.1 0 JAXW202-2477 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 23.7 23.6 24 23.7 23.85 23.85 23.4 24.62 NA NA 6.1 8.57 14.3 41.7 48.66 16.69 34.29 754 1407.88 4524.98 147.01 20.13 0 2.06 6.38 8.8 31.9 50 13.8 27.6 646 450.5 1457 138.4 5.2 8.9 JAXW202-2478 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 23.8 23.4 22.9 22.8 23.11 22.78 21.8 21.67 NA NA 12.2 10.3 14.9 55.8 54.17 14.47 26.7 826 1449.36 10484.68 261.08 6.1 0 1.8 8.01 10.2 44.7 55.8 12.7 22.8 995 138.8 1573 82.1 4.3 1.8 JAXW202-2479 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 21.6 20.1 20 19.5 19.67 19.11 19.6 19.9 NA NA 8.84 10.91 16.2 45.9 42.07 14.85 35.29 704 1665.46 6908.46 243.1 20.33 1.77 3.96 9.95 13.6 43.3 43.5 13.7 31.4 910 618.6 3155.3 173.8 10.7 1.6 JAXW202-2480 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 18.7 18.1 18.7 18.6 18.42 18.44 18.5 19.93 NA NA 5.98 9.64 14.8 57.9 60.06 15.35 25.56 807 714.61 5031.57 221.86 10.17 1.79 2.02 7.92 11.4 47.4 59.8 14.4 24.1 990 463.6 1415.6 133.5 3.8 3.4 JAXW202-2481 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 16.3 15.6 15.8 15.9 16.09 16.31 15.8 16.45 NA NA 6.28 8.93 14.8 42.2 47.26 16.57 35.07 496 1554.3 4497.11 183.38 43.96 1.88 2.12 8.14 12.6 40.3 49.5 15.5 31.3 586 555 1484.2 69.7 11 0 JAXW202-2487 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 21.6 22.3 22.1 21.9 21.35 21.57 22 21.65 NA NA 5.54 9.72 15.2 54.2 55.76 15.64 28.04 718 1242.62 4051.96 236 5.54 3.32 1.04 8.15 11.1 46.6 57.2 13.6 23.8 402 123.3 812.9 98.5 3.5 1.7 JAXW202-2488 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 22.8 21.9 21 21.2 21.54 21.34 21.2 21.11 NA NA 7.02 10.49 16.9 63.4 60.44 16.11 26.66 868 1489.64 5286.76 214.81 25.27 3.51 0.7 7.8 11.5 46.2 59.2 14.7 24.9 466 129 518.8 50.3 1.8 0 JAXW202-2489 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 21.8 21.7 22.1 21.5 21.78 21.88 22.3 22.34 NA NA 4.52 9.58 14.9 56.9 59.39 15.55 26.19 772 499.91 3820.3 190.29 6.33 2.71 1.06 8.52 12.1 51.3 60.2 14.2 23.6 661 123 904.8 25 5.6 1.6 JAXW202-2490 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 27.1 27 26.2 26.5 27.13 27.06 26.4 27.17 NA NA 7.28 9.11 15.3 43 47.2 16.79 35.58 988 863.41 6217.12 183.46 12.38 3.64 1.72 8.29 12.3 39.4 47.5 14.8 31.2 807 121.6 1528.9 56.6 11.2 1.7 JAXW202-2491 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 31.6 29.6 29.4 29.9 29.76 29.49 29.5 31.02 NA NA 5.58 10.15 15.8 62.1 61.18 15.57 25.44 836 1157.29 4196.16 211.48 16.18 0 0.88 8.3 11.3 48.9 58.9 13.6 23.1 550 187.8 604.4 60.2 23.4 4.1 JAXW202-2492 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 27.4 25.1 24 25.1 25.54 26.07 25.4 26.74 NA NA 8.22 9.49 14.6 38.3 40.36 15.38 38.12 880 987.22 7014.13 209.61 4.11 5.75 1.5 8.39 10.9 33 39.3 13 33 665 388.1 1005.8 96.5 9.8 0 JAXW202-2493 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - C Cyclophosphamide 2010-07-20 2010-09-17 NA 27.7 27 26.9 26.9 26.65 26.91 26 26.18 NA NA 8.9 10.32 16.8 65.5 63.47 16.28 25.65 1025 1677.65 7011.42 163.76 45.39 1.78 1.54 9.22 13.9 57.9 62.8 15.1 24 702 566 945.7 22.9 5.5 0 JAXW202-2494 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 26.4 26.2 26.36 27.59 27.8 26.76 27.3 27 NA NA 3.36 10.09 14.7 42.9 42.5 14.6 34.3 624 623.28 2542.85 187.82 4.37 1.68 1.54 7.06 9.8 29.9 42.4 13.9 32.8 616 378.53 1011.78 123.35 21.1 5.39 JAXW202-2495 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 35.1 33.4 34.08 33.94 33.2 33.2 33 32.4 NA NA 5.14 10.22 15.1 62.2 60.9 14.8 24.3 863 887.68 3993.78 244.66 14.39 0 1.66 7.64 11.8 45 58.9 15.4 26.2 621 263.28 1343.27 48.8 4.48 0 JAXW202-2496 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 32.8 31.4 30.86 29.86 30 29 28.1 28.5 NA NA 5.1 9.43 14.9 46.6 49.4 15.8 32 977 869.04 4057.05 159.63 9.69 4.08 0.62 8.06 12.5 39.5 49 15.5 31.6 669 127.53 451.11 41.29 0 0 JAXW202-2497 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 30.3 30.4 29.94 30.39 31 30.2 30.2 30.4 NA NA 5.44 10.3 14.3 57.4 55.7 13.9 24.9 918 1068.96 4230.14 132.19 8.16 0 1.38 8.17 11.1 43.7 53.5 13.6 25.4 449 146.83 1171.9 52.58 8.83 0 JAXW202-2498 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 29 28.5 29.34 27.6 27.6 27 26.1 26.2 NA NA 3.46 11.12 14.9 53.8 48.4 13.4 27.7 836 641.83 2688.07 128.02 1.73 0 0.9 8.18 10.9 39.8 48.7 13.3 27.4 515 56.97 791.73 47.43 3.87 0 JAXW202-2499 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 24 22.1 22.55 22.25 23.2 21.6 22.8 22.5 NA NA 6.62 9.04 14.4 38.8 42.9 15.9 37.1 1034 1478.91 5004.06 132.4 0 5.3 1.94 8.03 11.3 35.1 43.7 14.1 32.2 789 465.02 1285.83 136.19 37.25 15.91 JAXW202-2500 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 29.8 30 29.13 29 28.3 27.02 27 26.5 NA NA 7.28 9.91 15 42.6 43 15.1 35.2 903 1049.78 5944.12 245.34 37.86 3.64 3.76 7.44 10.2 31.3 42.1 13.7 32.6 471 785.46 2710.96 192.14 62.42 8.65 JAXW202-2501 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 26.7 26.4 26.32 25.08 24.8 24 24.4 24.4 NA NA 8.64 11.16 14.7 58.6 52.5 13.2 25.1 1034 1140.48 7361.28 133.06 5.18 0 0.92 8.19 11 41.4 50.5 13.4 26.6 432 128.71 753.48 23.64 10.58 3.59 JAXW202-2502 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 27.7 25 24.72 27.2 27.2 26.51 26.7 26.4 NA NA 4.46 10.83 14.5 44.9 41.5 13.4 32.3 854 901.81 3433.75 120.87 1.78 1.78 0.48 8.49 11 33.3 39.2 13 33 447 58.13 380.21 28.56 13.15 0 JAXW202-2503 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 31.9 31.1 30.26 30.1 29.5 28.81 29.2 28.5 NA NA 6.22 10.5 14.8 44.5 42.4 14.1 33.3 807 952.28 5189.35 75.88 1.24 1.87 0.88 8.64 11.9 34.8 40.3 13.8 34.2 354 190.7 671.53 16.02 0 1.76 JAXW202-2504 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 24.2 22.4 23.18 22.95 23.1 23.22 23.5 23.9 NA NA 10.14 9.34 14.3 54 57.8 15.3 26.5 760 1295.89 8559.17 234.23 50.7 0 0.78 7.04 9.7 38.3 54.4 13.8 25.3 306 98.51 667.21 2.73 9.52 1.87 JAXW202-2505 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 31.7 30 29.71 27.3 27.5 26.4 26.4 25.8 NA NA 5.66 10.73 16.4 45.4 42.3 15.3 36.1 1212 863.72 4533.66 255.27 5.66 1.7 0.68 7.94 12.7 32 40.3 16 39.7 534 35.09 596.43 44.81 0 3.74 JAXW202-2506 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 20.2 20.1 20.88 20.12 20.6 19.72 20.2 20.5 NA NA 6.12 9.45 15.3 47.3 50.1 16.2 32.3 884 859.25 5007.38 231.95 22.03 0 2.06 7.23 11.8 34.6 47.9 16.3 34.1 570 361.47 1601.44 74.16 17.3 5.15 JAXW202-2507 Diversity Outbred Male Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 23.7 20.1 19.84 23.9 24.1 22.69 22.6 23.3 NA NA 9.12 9.11 15.8 42.4 46.5 17.3 37.3 712 2429.57 6542.69 130.42 16.42 1.82 1.44 6.9 10.8 30.2 43.8 15.7 35.8 329 569.23 758.02 93.6 17.57 1.58 JAXW202-2534 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 26.7 24.57 25.2 25.7 23.26 21.84 21.25 20.59 20.8 20.91 8.62 10.53 15 63.9 60.7 14.3 23.5 788 1301.62 7038.23 265.5 12.07 1.72 12.44 7.79 10.7 45.8 58.8 13.7 23.4 1955 6022.2 5846.8 354.54 196.55 19.9 JAXW202-2535 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 27.6 26.82 25.7 24.9 24.46 23.26 22.87 21.57 21.6 22.64 6.86 10.33 15 46.1 44.6 14.5 32.5 743 896.6 5911.95 42.53 5.49 3.43 10.72 9.1 12.7 43 47.3 14 29.5 1903 4518.5 5167 724.7 244.4 65.4 JAXW202-2536 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 36.1 34.37 33.8 34.1 33.46 32.34 32.94 31.67 31.8 32.53 5.34 9.36 14 46.6 49.8 15 30 716 1045.57 4202.05 90.25 0 1.6 5.08 7.51 10.9 40.3 53.7 14.5 27 1296 1628.14 3305.05 100.58 39.12 7.11 JAXW202-2537 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 25.2 25.63 26.6 27.3 24.68 24.16 24.69 23.5 23.8 24.35 11.3 10.38 14.1 46.5 44.8 13.6 30.3 807 1394.42 9531.55 363.86 10.17 0 7.7 9.42 10.9 45.7 48.5 11.6 23.9 1314 744.59 6716.71 218.68 17.71 2.31 JAXW202-2538 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 26.9 26.32 27.3 27 27.36 27.32 27.51 27.18 26.7 27.25 9.46 10.45 15.1 58.1 55.6 14.5 26 614 1175.88 8076.95 198.66 8.51 0 6.78 9.13 13 50.6 55.4 14.2 25.7 1048 1623.81 4783.29 356.63 14.24 2.03 JAXW202-2539 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 26.6 25.72 26.5 26.1 25.86 25.07 24.97 23.53 24.1 24.88 10.04 10.58 13.5 42.2 39.9 12.8 32 771 1136.53 8604.28 289.15 7.03 2.01 6.6 9.28 11.7 39.7 42.8 12.6 29.5 1417 941.82 5359.2 263.34 31.68 3.3 JAXW202-2540 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 28.2 26.74 26.7 27.2 25.28 24.66 25.21 25.34 25.6 26.15 8.44 9.21 13.9 54.2 58.9 15.1 25.7 670 1679.56 6683.64 58.24 14.35 3.38 7.66 8.43 11.7 46.7 55.4 13.9 25.1 1190 2818.11 4466.55 314.06 57.45 3.06 JAXW202-2541 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 28.2 27.25 27.6 26.6 27.68 26.1 25.64 24.37 24.2 24.78 7.54 10.85 15.9 64.4 59.4 14.7 24.7 731 1126.48 6111.92 287.27 15.08 0 5.16 8.02 10.9 44.5 55.5 13.6 24.5 1518 663.06 4093.94 401.45 1.55 0 JAXW202-2542 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 32.5 32.19 31.5 30.8 30.52 27.87 27.14 25.45 25.2 25.99 8.06 10.15 16.1 48.1 47.4 15.9 33.5 772 1933.59 5909.59 195.05 19.34 1.61 8.18 8.61 12.3 43.2 50.2 14.3 28.5 1686 3613.11 4186.52 335.38 42.54 4.09 JAXW202-2543 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 32.4 30.41 30.3 30.1 30.33 29.87 30.18 28.33 28.8 29.2 4.82 11.04 14.8 45.2 40.9 13.4 32.7 690 659.86 4082.06 74.23 3.86 0 7.16 7.84 11.3 33.4 42.6 14.4 33.8 1297 814.09 5967.14 340.1 32.94 5.73 JAXW202-2544 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 36.6 37.37 36.4 37.2 34.85 31.82 29.52 26.31 25.3 24.59 6.3 10.79 15.5 49 45.4 14.4 31.6 647 1450.26 4762.17 78.12 6.93 1.89 4.48 8.17 10.7 37.7 46.1 13.1 28.4 1033 1858.75 2056.77 444.42 112.45 8.06 JAXW202-2545 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 18 18.34 18.4 17.9 17.63 16.88 17.74 16.94 17.7 18.14 4.88 9.98 14.7 57.7 57.8 14.7 25.5 694 750.54 4028.93 76.62 24.4 0 3.58 6.38 9.2 35.8 56.1 14.4 25.7 1393 660.87 2604.09 300 9.31 5.37 JAXW202-2546 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 23.7 23.92 23.3 23.9 21.94 21.56 21.42 20.47 20.2 20.58 11.94 10.11 14.3 57.5 56.9 14.1 24.9 531 872.81 10830.77 223.28 14.33 0 8.26 6.56 9.4 36.7 55.9 14.3 25.6 926 1364.55 6431.24 436.13 28.08 0 JAXW202-2547 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 34.5 35.2 34.4 35 33.47 32.63 32.56 30.85 31.1 32.02 9.4 10.22 14.9 42.9 42 14.6 34.7 809 1392.14 7697.66 301.74 6.58 1.88 7.42 8.18 11.6 36.2 44.3 14.2 32 1171 1247.3 5517.51 606.96 46.75 1.48 JAXW202-2548 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 20 20.53 20.4 20.2 20.22 19.34 19.81 18.48 19 18.81 4.44 11.35 14.7 58.3 51.4 13 25.2 487 621.6 3686.98 121.66 7.55 1.78 2.9 7.14 8.9 34.3 48 12.5 25.9 1304 468.93 2210.38 210.54 9.86 0 JAXW202-2549 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 20.5 20.34 21.2 21.9 19.85 19.68 19.07 17.85 18.6 18.27 7.72 9.84 14.7 44.3 45 14.9 33.2 494 981.98 6571.26 159.03 6.18 1.54 4.06 7.91 11.1 38.1 48.2 14 29.1 1293 282.98 3659.68 106.37 10.96 0 JAXW202-2550 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 30.5 29.78 29.2 29.5 29.39 27.92 27.44 26.07 25.8 27 6.42 9.13 13.2 39.7 43.5 14.5 33.3 696 1323.8 4938.26 148.94 8.99 0 20.32 7.5 10 34.9 46.5 13.3 28.7 1298 4535.42 13754.61 1944.62 83.31 0 JAXW202-2551 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 28.9 27.94 27.9 27.8 26.96 25.79 25.77 24.2 24.5 24.9 7.96 10.37 15.5 50.1 48.3 15 30.9 766 1366.73 6457.95 123.38 11.94 0 6.1 7.36 11 37.7 51.2 14.9 29.2 1762 697.84 5017.86 356.85 25.62 1.83 JAXW202-2552 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 32.6 30.86 30.4 30.9 31.16 30.07 30.61 29.18 29.2 29.53 12 10.37 15.5 59.2 57.1 15 26.2 1046 3343.2 8514 69.6 68.4 4.8 13.94 7.69 11.4 41.4 53.8 14.8 27.5 2172 6034.63 6748.35 973.01 149.16 36.24 JAXW202-2553 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 35 35.63 34.8 35.5 33.56 31.98 32.25 30.73 30.5 31.62 8.38 10.17 14.9 46.7 45.9 14.7 31.9 644 1472.37 6787.8 107.26 9.22 3.35 11.04 8.52 11.8 41.2 48.4 13.8 28.6 986 5427.26 5053.01 495.7 60.72 4.42 JAXW202-2554 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 24.8 24.44 24.7 25.1 23.36 22.71 23.84 22.08 22.8 23.06 8.48 9.53 13.1 48.4 50.8 13.8 27.1 992 890.4 7429.33 156.03 4.24 0 5.6 8.22 10.9 40.8 49.6 13.3 26.7 1863 628.88 4611.04 312.48 45.92 1.68 JAXW202-2555 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 26.2 25.08 24.1 23.9 24.25 23.57 23.8 22.47 22.7 23.62 5.8 11.06 15.1 62.6 56.6 13.7 24.1 870 466.32 5266.98 64.96 0 1.74 6.78 8.89 11.6 42.9 48.3 13 27 1557 3465.26 2928.28 349.17 36.61 0 JAXW202-2556 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 28.1 28.31 27.9 28.2 25.29 23.87 23.38 22.48 22.7 22.06 10.74 10.84 15 45.5 42 13.8 33 786 1284.5 9285.8 163.25 1.07 5.37 4.08 7.77 9.9 33.1 42.6 12.7 29.9 1669 614.86 3241.97 124.68 90.58 7.75 JAXW202-2557 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 19.7 19.97 20.9 19.5 19.85 19.94 20.42 19.81 20.6 20.01 4.68 10.66 15.9 48.1 45.1 14.9 33.1 696 1158.3 3410.78 90.79 17.78 1.87 5.42 8.46 11.6 45 53.2 13.7 25.8 1530 539.83 4514.86 346.34 15.72 3.79 JAXW202-2558 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 23.2 22.87 22.6 22.1 21.03 19.45 19.75 18.82 19 19.34 5.16 9.83 14.9 46.8 47.6 15.2 31.8 578 978.34 4008.29 148.09 25.28 0 15.94 5.53 8.3 27.9 50.5 15 29.7 1324 2719.36 11523.03 1635.44 60.57 1.59 JAXW202-2559 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 28 27.5 27.1 27.2 26.57 25.8 25.4 24.94 25 25.63 10.86 10.56 15.3 62.4 59.1 14.5 24.5 688 4872.88 5730.82 231.32 21.72 2.17 7.34 9.14 13.3 56.8 62.1 14.6 23.4 1229 1933.36 4977.99 394.89 33.03 1.47 JAXW202-2560 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 28 28.73 28.1 28.6 26.31 25.71 25.24 23.95 24.4 24.98 6.6 9.76 14.6 40.6 41.6 15 36 686 1987.86 4324.97 256.16 26.41 5.94 3.3 6.76 8.9 30 44.4 13.2 29.7 1600 653.73 2327.16 258.72 47.85 12.21 JAXW202-2561 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 30.8 29.98 29.5 29.7 27.5 25.39 23.99 22.18 22.6 22.39 5.2 10.64 15.3 60.6 57 14.4 25.3 564 1033.76 3792.36 342.16 21.32 9.88 4.2 5.32 7 27.3 51.3 13.2 25.6 1173 484.26 3063.9 618.66 31.08 1.68 JAXW202-2562 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 27.1 27.14 27 26.5 27.03 26.24 26.24 24.87 25.3 24.78 8.84 9.27 13.8 45.6 49.2 14.9 30.3 655 2298.4 6116.4 408.41 16.8 0 3.24 7.2 10.7 37.1 51.5 14.9 28.8 1288 354.13 2672.68 196.34 14.9 1.62 JAXW202-2563 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 27.6 27.76 27.5 27.2 25.34 24.62 23.38 21.88 21.5 20.99 6.66 10.13 13.9 43.1 42.6 13.7 32.3 996 1540.46 4921.07 171.16 25.31 2 6.62 7.66 10.8 33 43.1 14.1 32.7 1777 697.75 5305.27 599.11 13.9 3.31 JAXW202-2564 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 31.4 30.63 29.9 30.4 28.25 27.75 27.72 26.41 26.5 27.3 4.68 10.56 16 50.1 47.4 15.2 31.9 937 1021.64 3459.46 139 54.29 5.62 3.64 8.32 12.7 42.2 50.7 15.3 30.1 1499 780.78 2491.58 334.15 25.48 7.64 JAXW202-2565 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 28.7 29.78 28.5 29 26.32 24.83 25.06 23.39 23.3 24.69 9.64 10.8 15.1 46.1 42.7 14 32.8 875 1129.81 8319.32 165.81 14.46 10.6 4.38 7.29 10.3 32.4 44.4 14.1 31.8 1636 693.35 3279.31 346.9 54.75 5.26 JAXW202-2566 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 27.7 27.54 26.8 26.1 24.75 23.72 22.37 20.99 21.6 21.74 8.16 11.07 15.6 44.7 40.4 14.1 34.9 773 1283.57 6742.61 120.77 9.79 2.45 2.26 7.84 10 32.1 40.9 12.8 31.2 1019 228.49 1885.29 111.64 29.15 5.2 JAXW202-2567 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 30.9 30.4 29.5 28.9 27.42 25.75 24.6 23.33 25.4 22.4 4.76 10.35 15.9 49.6 47.9 15.4 32.1 762 880.6 3734.7 129.95 9.52 5.71 1.76 8.19 11.5 41 50.1 14 28 1180 245.7 1437.22 41.01 23.94 12.14 JAXW202-2568 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 26.1 26.34 26.6 27.3 26.66 26.68 25.89 25.32 25.6 25.78 7.76 10.58 14.2 56.5 53.4 13.4 25.1 716 1091.06 6318.19 330.58 17.85 1.55 3.84 8.95 11.8 45.5 50.8 13.2 25.9 1657 264.19 3370.37 170.11 23.81 11.9 JAXW202-2570 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 46 45.84 46 45.5 45.3 43.95 41.83 40.53 38.5 37.61 3.08 10.44 14.5 59.7 57.2 13.9 24.3 754 417.96 2520.06 107.8 23.1 11.4 7.94 7.79 11 41.2 52.9 14.1 26.7 1388 1383.15 5530.21 990.12 34.94 0 JAXW202-2571 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 25 27.01 26.8 26.3 25.3 24.51 24.83 23.72 24.1 24.43 11.22 9.44 13.8 44.6 47.3 14.6 30.9 676 1006.43 9879.21 316.4 19.07 0 5.3 6.18 8.7 30.1 48.7 14.1 28.9 1292 307.4 4689.97 292.56 8.48 1.59 JAXW202-2572 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 32.3 31.67 31.7 32.6 29.34 29.12 27.46 25.63 25.6 26.69 10.92 9.93 14.1 45.4 45.7 14.2 31.1 984 905.27 9675.12 277.37 60.06 2.18 11.24 7.53 9.8 35.3 46.9 13 27.8 1785 2952.75 7525.18 635.51 106.78 20.23 JAXW202-2573 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 29.3 29.35 28.6 29.3 26.37 25.28 25 24.32 24.6 24.09 11.94 10.15 16 61.1 60.2 15.8 26.2 913 1512.8 10281.53 119.4 23.88 2.39 9.4 7.5 10.8 42.5 56.7 14.4 25.4 1594 1689.18 6894.9 775.5 34.78 5.64 JAXW202-2574 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 27.2 27.36 26.6 26.5 25.32 25.09 25.3 23.83 24.7 23.54 9.44 11.64 13.9 58.2 50 11.9 23.9 781 1450.93 7899.39 85.9 4.72 0 5.64 9.5 12.2 45.8 48.2 12.8 26.6 1324 216.58 5321.34 91.93 10.15 0 JAXW202-2575 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 26.3 27.45 28.4 29 25.97 24.4 25.54 24.7 22.5 26.07 12.56 11.13 15 58.2 52.3 13.5 25.8 672 1355.22 10981.21 214.78 7.54 1.26 10.64 7.62 9.8 36.9 48.4 12.9 26.6 1138 1172.53 8692.88 754.38 20.22 0 JAXW202-2576 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 26.8 25.89 24.5 25.1 23.19 22.27 22.5 21.72 20.9 23.6 6.06 8.89 12.9 40.6 45.7 14.5 31.8 479 893.24 5083.73 77.57 3.03 3.64 5.98 6.6 8.6 31.4 47.6 13 27.4 865 704.44 4556.76 707.43 9.57 1.79 JAXW202-2577 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 28.3 27.86 27.9 27.7 26.27 24.21 23.97 23.03 23.1 23.92 10.36 10.99 15.5 66.2 60.2 14.1 23.4 552 923.08 9045.32 329.45 60.09 2.07 6.3 7.24 10.1 33.4 46.1 14 30.2 1092 1698.48 4060.35 514.08 22.68 3.78 JAXW202-2578 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 31.6 31.1 31.67 28.92 28.7 28.4 28.5 28.8 NA NA 9.32 10.57 14.9 61.1 57.8 14.1 24.4 951 1368.18 7692.73 238.59 20.5 0 1 7.94 11.3 44.8 56.4 14.2 25.2 772 157.8 816.6 18.3 5.5 1.8 JAXW202-2579 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 22.5 23.8 24.01 21.74 21.5 21.28 20.9 20.9 NA NA 7.2 8.81 13.5 40.1 45.5 15.3 33.7 871 1024.56 5799.6 313.2 63.36 0 1.06 6 9.5 25.8 43 15.8 36.8 496 203.94 820.65 29.79 3.82 1.8 JAXW202-2580 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 27.2 24.6 23.9 26.96 26.9 26.51 25.7 25.4 NA NA 5.06 11.07 15.4 49 44.3 13.9 31.4 932 699.29 4079.37 235.8 45.03 0 1.04 7.5 11.7 31.3 41.7 15.6 37.4 616 206.13 781.46 48.46 2.18 1.77 JAXW202-2581 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 25.2 27.2 27.42 24.34 24.2 23.51 22.7 22.8 NA NA 6.2 10.78 15 55.4 51.4 13.9 27.1 803 1023 4835.38 300.7 35.96 4.96 0.34 9.2 11.7 45.2 49.1 12.7 25.9 444 30.7 284.27 19.28 1.84 3.91 JAXW202-2582 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 23.9 22.7 23 24.13 24.2 23.79 23.3 22.8 NA NA 8.24 10.67 15.6 49 45.9 14.6 31.8 912 1061.31 6886.99 237.31 50.26 3.3 1.94 7.9 11.7 36.1 45.7 14.8 32.4 961 109.03 1747.16 73.14 7.18 3.49 JAXW202-2583 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 24.4 20.7 21.09 21.54 21.8 20.49 20.6 20.6 NA NA 5.56 9.03 13.6 37.7 41.7 15.1 36.1 968 1458.39 3611.78 409.22 80.06 0 1.32 6.83 9.6 27.7 40.6 14.1 34.7 659 469.92 754.51 82.76 12.8 0 JAXW202-2584 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 17.2 16.4 17.88 16.88 16.7 16.24 16.4 16.4 NA NA 5.56 9.94 13.7 43.9 44.2 13.8 31.2 876 664.42 4678.74 183.48 31.69 1.67 1.24 7.54 10.4 32.3 42.8 13.8 32.2 712 96.84 1074.58 57.91 7.07 3.6 JAXW202-2585 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 20.2 19.7 19.21 20.55 20.1 19.68 19.4 19 NA NA 4.42 9.45 14.2 45.1 47.7 15 31.5 767 647.09 3633.24 113.59 26.08 0 1.16 7.11 10.8 32.6 45.9 15.2 33.1 550 134.33 986.81 27.72 11.14 0 JAXW202-2586 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 20.7 24.4 24.47 23.31 23.2 22.58 23.1 23.3 NA NA 5.44 9.35 14.1 51 54.5 15.1 27.6 1090 972.13 4311.2 126.21 24.48 5.44 0.86 8.48 11.6 45.9 54.1 13.7 25.3 1078 122.64 692.73 34.66 6.19 3.61 JAXW202-2587 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 17.3 16.2 17.1 17 17.6 16.54 16.5 16.6 NA NA 6.4 9.32 14.1 57.9 62.1 15.1 24.4 742 1340.8 4791.04 229.76 36.48 1.92 1.64 6.88 10.8 40.9 59.4 15.7 26.4 588 523.16 1005.16 80.85 25.26 5.74 JAXW202-2588 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 21.3 20.9 21.25 20.39 20.5 20.32 20.4 19.8 NA NA 2.9 10.33 15.6 50.2 48.6 15.1 31.1 749 649.89 2107.72 93.09 45.82 3.48 1.34 8.09 11.8 37.5 46.4 14.6 31.5 640 173.4 1097.06 63.78 5.9 0 JAXW202-2589 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 18.8 18.4 18.83 18.83 18.9 18.45 18.7 18.4 NA NA 4.9 8.64 13.9 38.8 44.9 16.1 35.8 524 459.62 4191.46 237.16 10.29 1.96 1.28 7.53 10.5 32.7 43.4 13.9 32.1 727 181.25 1059.84 31.74 3.71 3.58 JAXW202-2590 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 19.4 19 18.04 19.17 18.9 18.1 17.7 17.6 NA NA 3.98 8.93 15.9 54.3 60.8 17.8 29.3 675 542.47 3327.28 101.49 8.76 0 1.36 7.15 9.9 42.1 58.9 13.8 23.5 535 144.84 1147.98 67.18 0 0 JAXW202-2591 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 23.9 22.7 22.54 24.47 24.9 23.5 24.2 25.3 NA NA 4.56 10.47 15.3 50.4 48.1 14.6 30.4 959 1292.3 2842.7 396.72 24.62 3.19 1.22 6.94 10.8 32.8 47.3 15.6 32.9 779 265.23 854.12 93.45 5.49 1.83 JAXW202-2592 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 19.2 19.5 19.46 18.96 18.6 17.9 18.1 18 NA NA 4.92 10.49 14.6 46.3 44.1 13.9 31.5 1265 1155.71 3537.97 209.59 14.27 1.97 1.6 8.4 11.4 36 42.9 13.6 31.7 877 248.64 1292 57.6 1.28 0.48 JAXW202-2593 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 22.6 21.5 21.88 22.67 22.3 21.33 22 22.2 NA NA 11.16 9.51 14.2 57.6 60.6 14.9 24.7 907 2062.37 8391.2 583.67 122.76 0 1.78 6.48 9.3 40.8 63 14.4 22.8 781 171.95 1476.87 118.73 5.34 7.12 JAXW202-2594 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 19.1 18.8 19.03 24.67 24.4 24.02 24.3 24 NA NA 8.42 8.99 14.1 41 45.6 15.7 34.4 1060 1298.36 6730.95 367.11 24.42 0 1.72 7.01 10.6 30.7 43.8 15.1 34.5 614 355.87 1234.44 103.72 19.09 6.88 JAXW202-2595 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 31.5 31.6 32.12 29.32 29.2 29.05 28.4 28.4 NA NA 12.58 9.46 14.7 62.1 65.6 15.5 23.7 1030 1791.39 10389.82 315.76 76.74 6.29 1.76 9.35 12.7 53.9 57.6 13.6 23.6 406 255.38 1343.76 145.55 11.09 4.22 JAXW202-2596 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 20.6 20.6 21.11 21.79 19.1 19.5 20.8 18.4 NA NA 4.98 9.99 15.6 45.8 45.8 15.6 34.1 1007 1318.7 3203.63 435.25 22.41 0 2.32 7.5 11.1 32.7 43.6 14.8 33.9 543 464.93 1622.61 225.27 4.87 2.09 JAXW202-2597 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 26.3 25.5 25.93 24.96 22.8 19.7 19.1 18 NA NA 7.2 9.86 14.2 47.8 48.5 14.4 29.7 941 1718.64 5313.6 137.52 24.48 5.76 0.68 7.07 10.2 32.2 45.5 14.4 31.7 550 113.56 515.98 48.62 1.84 0 JAXW202-2598 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 24.1 22.3 22.5 25.73 21.1 20.37 20.9 20.8 NA NA 6.94 9.73 15 46.2 47.5 15.4 32.5 986 1322.76 5166.83 310.91 132.55 6.94 2.36 8.32 11.7 37.9 45.6 14.1 30.9 653 380.43 1838.68 126.02 14.87 0 JAXW202-2599 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 19.7 18.6 17.34 19.21 19.3 18.56 18.8 19 NA NA 3.92 10.92 16.3 65.6 60.1 14.9 24.8 826 1340.64 2385.32 149.74 37.63 6.66 0.9 7.74 10.8 45 58.1 14 24 439 160.2 653.76 73.44 7.29 5.31 JAXW202-2600 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 26.9 25.8 25.91 24.25 25.9 23.87 24.4 24.4 NA NA 3.84 8.01 13.1 39.6 49.4 16.4 33.1 1021 995.71 2627.71 175.49 39.94 0.77 3.5 6.68 11.2 32.5 48.7 16.8 34.5 907 293.65 2984.1 216.65 5.6 0 JAXW202-2601 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 23.1 23.6 23.67 22.21 23 22.36 23.4 23.4 NA NA 2.36 10.29 14.7 65.1 63.3 14.3 22.6 922 417.48 1778.73 157.65 6.37 0 1.24 7.72 11.1 47 60.9 14.4 23.6 730 152.15 1033.04 48.24 6.57 0 JAXW202-2602 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 20.1 19.5 19.3 19.88 20 19.32 19.4 19.2 NA NA 5.88 10.25 14.7 49.1 47.9 14.3 29.9 958 929.04 4703.41 197.57 49.98 0 1.6 6.78 10.8 30.8 45.4 15.9 35.1 668 272.48 1188.32 120.32 19.04 0 JAXW202-2603 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 22.8 21.5 21.98 19.86 21.9 21.94 21.6 20.9 NA NA 2.96 11.38 15.4 68.7 60.4 13.5 22.4 942 366.74 2481.96 87.91 18.06 5.33 1 7.82 11.6 46 58.8 14.8 25.2 617 42 892.4 48 13.3 4.4 JAXW202-2604 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 22.5 21.2 20.99 22.07 21.7 20.97 22 22.3 NA NA 4.12 8.95 14.6 58.2 65 16.3 25.1 841 1055.13 2894.3 149.56 17.72 3.71 1.92 7.73 11.7 48.4 62.6 15.1 24.2 630 445.25 1410.82 51.84 10.37 1.73 JAXW202-2605 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 22.4 21.4 21.73 21.32 21.6 20.73 20.2 21.8 NA NA 4.28 8.74 13.4 45.6 52.2 15.3 29.4 826 506.32 3615.32 130.97 18.83 8.99 1.56 6.81 10 33.6 49.3 14.7 29.8 657 251.16 1148.47 142.9 10.45 7.18 JAXW202-2606 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 20.9 20.6 20.69 19.97 20.1 20.08 20.7 20.3 NA NA 8.14 9.49 15 49.3 51.9 15.8 30.4 746 1057.39 6818.88 232.8 28.49 1.63 1.16 8.24 11.5 40.4 49 14 28.5 519 62.87 1009.55 87.7 0 0 JAXW202-2607 Diversity Outbred Female Group 23 - 200 mg/kg Cyclophosphamide - D Cyclophosphamide 2010-07-20 2010-09-23 NA 23.3 23 23.01 22.62 22.2 20.87 21.1 21.4 NA NA 5.52 10.25 13.9 56.3 54.9 13.6 24.7 958 860.02 4507.08 128.62 22.08 2.21 1.84 9.4 11.3 48.6 51.7 12 23.3 908 198.17 1535.48 92.37 13.98 0 JAXW202-2608 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 19.1 18.96 19.1 19.7 18.05 17.52 18.47 17.24 18.1 17.4 10.3 10.73 14.9 65 60.6 13.9 22.9 546 907.43 9109.32 254.41 29.87 0 7.36 7.02 10.3 39.1 55.7 14.7 26.3 1335 595.42 6387.74 358.43 13.98 3.68 JAXW202-2609 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 21.6 21.24 21 21.3 18.83 18.83 20.13 19.44 20.6 20.71 5.2 10.14 14.3 44.2 43.6 14.1 32.4 554 751.92 4188.6 243.88 10.4 5.2 2.34 9.13 12 42.4 46.4 13.1 28.3 1160 68.09 2228.15 39.55 2.34 1.87 JAXW202-2610 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 19.6 19.42 19.2 19 18.69 18.65 17.68 17.47 16.9 17.42 7.6 10.61 14.7 45.9 43.3 13.9 32 524 871.72 6338.4 360.24 24.32 5.32 3.52 7.43 9.9 34.3 46.2 13.3 28.9 1079 173.89 3227.14 115.46 3.52 0 JAXW202-2611 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 18.1 18.68 18.2 18.8 17.64 16.4 16.32 15.57 15.1 16.18 6.68 10.92 15.2 43.1 39.5 13.9 35.3 591 1331.32 5099.51 219.1 27.39 1.34 1.28 6.89 8.7 28.5 41.4 12.6 30.5 825 67.2 1169.79 33.41 9.6 0 JAXW202-2612 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 19.6 19.77 20 21.2 19.05 18.39 19.17 18.04 18.7 18.6 4.84 10.88 15 65.5 60.2 13.8 22.9 660 518.85 4182.24 132.62 6.78 0 6.44 6.98 9.2 37.8 54.2 13.2 24.3 852 300.75 5698.76 409.58 28.34 3.22 JAXW202-2613 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - E Docetaxel 2010-07-20 2010-09-29 NA 25.2 25.41 24.8 23.7 23.69 22.42 22.35 19.99 19.5 18.62 6 8.46 12.7 35.9 42.4 15 35.4 504 814.2 4962.6 215.4 6 1.8 1.58 6.19 7.8 26.9 43.5 12.6 29 625 137.93 1399.25 34.44 6.64 1.74 JAXW202-2614 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 25.8 24.97 24.18 25.74 26.4 21.47 23.3 21.6 20.7 21.3 6.04 10.31 14.8 44 42.7 14.4 33.6 727 972.44 4961.86 85.16 16.91 3.02 8.52 7.12 11.7 31.4 44.1 16.4 37.3 1400 1165.54 6879.9 443.04 30.67 1.7 JAXW202-2615 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 24.3 23.7 24.02 22.66 23.1 21.5 21.2 20.6 20.6 20.8 3.88 10.81 15.3 49.9 46.2 14.2 30.7 575 737.98 3112.92 NA 19.79 0 8.84 7.72 10.8 37.2 48.2 14 29 1409 1758.28 5962.58 1078.48 32.71 7.07 JAXW202-2616 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 24.2 23.66 23.87 22.09 22.5 22.98 23.7 22.7 23 23.5 2.64 7.8 13.6 36.7 47.1 17.4 37.1 641 461.47 2110.42 64.68 1.85 1.85 8.1 6.2 9.4 30.5 49.2 15.2 30.8 2130 1151.82 6135.75 780.84 30.78 0.81 JAXW202-2617 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 21.4 21.53 22.14 23.43 23.3 21.44 21.3 23.4 24.4 22.8 4.86 10.43 14.4 47.1 45.2 13.8 30.6 733 427.19 4240.35 186.14 6.32 0 3.08 6.54 8.7 30.1 46 13.3 28.9 1401 101.33 2897.66 71.76 8.93 0 JAXW202-2618 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 21.3 22.83 22.02 20.41 20.1 19.47 19 17.8 16.9 17.3 7.44 10.75 14.3 43.2 40.2 13.3 33.1 622 654.72 6736.92 35.71 12.65 0 6.1 7.2 8.8 29.4 40.8 12.2 29.9 1461 589.87 5147.79 356.24 6.71 0 JAXW202-2619 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 24.8 23.14 21.66 20.87 21.6 21.41 22.7 23.2 22.7 23.5 5.98 9.77 15 59.9 61.3 15.4 25 738 949.03 4864.13 144.72 16.15 5.98 3.22 7.21 11.6 42.2 58.5 16.1 27.5 1019 416.67 2677.11 108.51 14.17 3.54 JAXW202-2620 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 26.5 26.11 26.2 25.95 26.2 24.81 24 22.4 22.3 22.8 7.02 9.3 15.7 54.1 58.2 16.9 29 582 1180.06 5599.15 227.45 14.04 0 6.38 7.8 10.9 42.7 54.7 14 25.5 1850 717.11 5232.88 396.84 28.07 5.1 JAXW202-2621 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 27.8 26.98 27.12 26.52 26.7 24.41 23.6 23.6 22.8 21.4 5.66 9.89 16.1 56.3 56.9 16.3 28.6 846 721.08 4741.38 186.78 5.09 5.09 5.3 9.21 12.9 49.6 53.9 14 26 1878 333.9 4734.49 217.83 10.07 3.71 JAXW202-2622 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 26.5 27.19 26.78 25.79 25.8 24.46 23.8 23.6 23.4 23.6 6.52 10.95 15.6 53 48.4 14.2 29.4 621 1079.71 5255.12 173.43 12.39 0 4.32 6.83 9.8 33.3 48.8 14.3 29.4 1180 522.72 3337.2 453.17 6.91 0 JAXW202-2623 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 30.4 29.57 29.46 28.47 29.1 26.62 26.3 26.1 26 26.1 8.72 10.81 15.7 63.8 59 14.5 24.6 750 1652.44 6846.94 179.63 24.42 15.7 6.18 7.15 10.3 39.3 55 14.4 26.2 1505 820.7 4879.11 457.32 19.16 3.71 JAXW202-2624 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 23.7 23.12 23.72 23.62 23.8 22.79 22.7 22.8 22.3 22.7 3.18 9.84 14.6 47.2 48 14.8 30.9 700 642.68 2394.86 130.38 9.86 2.23 3.7 9.03 13.1 44.4 49.2 14.5 29.5 1122 662.67 2788.69 228.66 18.87 1.48 JAXW202-2625 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 25.6 24.25 25.01 21.59 21.7 20.68 21.3 21.2 20.8 20.8 3.12 10.06 14.3 43.9 43.6 14.2 32.6 675 388.13 2632.34 93.6 5.93 0 7.56 8.77 11.9 39.9 45.5 13.6 29.8 1324 1456.06 5475.71 605.56 21.92 0 JAXW202-2627 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 19.9 18.79 19.16 18.87 19.6 18.27 18.8 18.6 18.7 18.9 9.64 9.86 14.5 47.6 48.3 14.7 30.5 558 980.39 8398.37 259.32 1.93 0 9.46 7.94 11.2 36.8 46.3 14.1 30.4 919 5106.51 3970.36 332.99 49.19 1.89 JAXW202-2629 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 20.8 20.11 20.72 19.64 20.1 18.67 19.3 19.1 19.7 19.5 5.82 9.35 14.3 41 43.9 15.3 34.9 533 1002.79 4580.92 215.34 17.46 4.07 9.7 6.58 10.9 30 45.6 16.6 36.3 762 4997.44 4190.4 471.42 38.8 1.94 JAXW202-2630 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 24.8 25.09 24.84 24.39 25.1 22.68 22.5 21.3 22 22.9 5.46 9.32 14.2 47.4 50.9 15.2 30 743 521.98 4857.76 72.07 5.46 1.64 2.52 6.47 9.5 32.8 50.7 14.7 29 838 376.74 2000.38 123.73 15.37 3.53 JAXW202-2631 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 19 19.63 18.66 17.88 17.6 16.74 17 17 17.2 17.5 5.68 8.87 14.1 38 42.8 15.9 37.1 591 629.91 4550.82 451.56 46.01 1.7 2.94 7.12 9.6 30.8 43.3 13.5 31.2 1073 438.65 2295.85 178.46 20.58 6.17 JAXW202-2632 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 19.4 20.01 20.19 19.75 19.4 18.61 18.5 19 18.5 19 7.09 10.9 14.8 63.2 58 13.6 23.4 638 1120.22 5840.03 99.97 27.65 2.13 3.46 7.41 9.8 40.9 55.2 13.2 24 1267 305.17 2945.84 192.03 17.3 0 JAXW202-2633 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 24 25.75 26.32 25.44 25.7 23.44 22.2 22.8 22.2 21.8 8.2 9.92 14.1 45.4 45.8 14.2 31.1 646 1135.7 6821.58 234.52 7.38 0 5.68 7.13 10.9 34.7 48.7 15.3 31.4 1391 799.74 4311.69 521.42 44.87 1.7 JAXW202-2634 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 28.3 27.43 28.45 27.31 28 25.74 26.5 26.2 26.1 26.9 4.66 9.19 15.1 44.8 48.7 16.4 33.7 964 663.58 3881.31 109.04 6.06 0 3.34 8.04 12.3 38.7 48.1 15.3 31.8 1841 586.84 2516.69 225.12 11.36 0 JAXW202-2635 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 32.3 31.99 32.19 29.03 28.9 25.43 26.1 25.9 26.2 25.9 9.34 10.03 15.4 61.3 61.1 15.4 25.1 604 926.53 8154.75 254.98 3.74 0 7.02 9.28 13.1 52.9 57 14.1 24.8 1139 1753.6 4751.14 441.56 62.48 10.53 JAXW202-2636 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 26.4 26.93 26.69 26.6 25.9 24.19 24.7 25.1 24.7 24.5 5.32 10.36 14.6 45.7 44.1 14.1 31.9 507 963.45 4203.33 145.24 5.85 1.6 11.52 9.34 12.7 42 45 13.6 30.2 984 3127.68 6910.85 1410.05 65.66 6.91 JAXW202-2637 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 27.7 28.73 28.53 26.73 27.3 25.88 25.7 26.2 26.1 26.2 5.78 10.98 15.8 60.3 54.9 14.4 26.2 1249 520.2 5039.58 213.86 6.36 0 7.6 7.16 11.2 38.1 53.2 15.6 29.4 1281 1327.72 5586.76 534.28 127.68 23.56 JAXW202-2638 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 23.9 24.39 25.16 23.9 23.8 23.6 23.4 23.5 24.1 24.3 5.74 9.18 15.1 45.9 50 16.4 32.9 756 867.89 4709.67 123.41 35.01 5.17 5.38 7 11.3 39.3 56.1 16.1 28.8 1201 470.21 4616.04 268.46 24.21 1.61 JAXW202-2641 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 20.3 20.3 20.29 19.28 19 19.17 19.3 18.7 19.1 18.3 13.42 9.04 14.4 41.7 46.1 15.9 34.5 546 1939.19 11138.6 323.42 16.1 1.34 11.26 8.55 12.1 40.8 47.7 14.2 29.7 992 1096.72 9718.51 371.58 69.81 3.38 JAXW202-2642 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 32.8 30.99 30.89 28.42 29.5 25.13 24 22.9 22.9 22.6 2.5 10.5 15.6 64.4 61.3 14.9 24.2 691 374 1989.75 128 4.75 3.5 4.66 10.44 13.9 59.3 56.8 13.3 23.4 1243 1090.91 3221.92 326.2 15.84 5.13 JAXW202-2643 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 25.1 24.97 24.62 23.52 24.1 23.56 23.6 22.9 23.5 23.4 4.96 8.63 14.9 41.7 48.3 17.3 35.7 709 535.68 4355.87 68.94 0 0 7.98 8.02 12.6 41 51.1 15.7 30.7 1489 1157.1 5886.85 906.53 28.73 0 JAXW202-2644 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 25.4 25.13 25.05 24.03 24.8 23.86 24.1 23.9 24.1 23.8 7.08 10.88 15.5 62.3 57.3 14.2 24.9 764 783.76 6080.3 194.7 21.24 0 7.12 8.8 11.9 48.2 54.8 13.5 24.7 1554 314.7 6469.23 326.81 9.26 0 JAXW202-2645 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 25.8 26.27 25.17 24.44 23.7 21.55 23.8 23.5 23.7 23.1 7.5 10.99 14.7 62.5 56.9 13.4 23.5 736 1142.25 6040.5 296.25 20.25 0 10.56 9.33 12 49.4 52.9 12.9 24.3 1161 2118.34 7133.28 1251.36 51.74 5.28 JAXW202-2646 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 23.9 24.23 26.22 25.88 26.3 25.9 26.2 25.5 25.2 25.3 6.56 10.01 15.2 46.4 46.4 15.2 32.8 758 1037.14 5352.96 148.26 14.43 7.22 4.94 8.96 12.7 43.4 48.4 14.2 29.3 1324 630.84 3978.18 266.27 58.29 5.93 JAXW202-2647 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 28 27.51 27.01 23.53 24.9 23.65 24.2 23.2 23.4 22.8 5.92 9.67 14.3 49.8 51.5 14.8 28.7 648 830.58 4998.85 85.25 5.92 0 5.88 6.64 NA 34.7 52.3 NA NA 1091 625.04 4950.37 272.24 28.81 3.53 JAXW202-2648 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 21.3 21.13 21.25 20.11 20.8 19.91 20.2 20.4 21.2 21.7 7.28 8.91 15 54.3 60.9 16.8 27.6 659 897.62 6118.84 246.79 16.02 1.46 12 8.58 12.1 49.5 57.7 14.1 24.4 1131 2796 7749.6 1413.6 39.6 0 JAXW202-2649 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 30.5 30.24 29.8 29.44 29.3 29.84 29.2 28.6 27.7 27.4 5.04 9.69 15.1 56 57.8 15.6 27 716 435.96 4449.31 138.6 14.62 1.51 4.32 8 11.4 44.9 56.1 14.3 25.4 1255 438.05 3664.66 187.49 29.38 0.43 JAXW202-2650 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 26.5 25.98 25.49 25.4 25.8 24.14 24.1 23.7 23.8 23.4 4.74 10.5 14.6 43.9 41.8 13.9 33.3 646 1311.56 3193.81 232.26 0.95 1.9 3.88 9.67 12.4 43.2 44.7 12.8 28.7 1093 276.64 3395.39 181.58 22.12 3.49 JAXW202-2651 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 26.4 25.9 26 24.17 23.9 20.73 21 21.1 21.1 21 9.02 10.3 15.9 64.4 62.5 15.4 24.7 844 725.21 8118 166.87 10.82 0 5.16 7.04 10.4 40.6 57.7 14.8 25.6 1069 620.23 4057.31 455.63 21.67 5.16 JAXW202-2652 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 18.9 19.12 18.85 18.44 19.5 18.57 18.4 17.9 18.6 18.3 9.6 8.96 14.8 50.2 56 16.5 29.5 659 1209.6 8011.2 337.92 41.28 0 6.28 9.79 12.7 51.1 52.2 13 24.9 1118 248.69 5831.61 175.21 24.49 0 JAXW202-2653 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 27.9 26.85 27.16 27.55 26.7 26.6 27 27.1 26.7 25.8 9.04 10.76 15.8 48.7 45.3 14.7 32.4 828 1785.4 6987.92 229.62 37.06 0 6.46 9.57 12.9 43.4 45.4 13.5 29.7 1051 670.55 5284.93 489.02 15.5 0 JAXW202-2654 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 24.9 24.47 24.72 23.8 22.9 23.51 23.2 21.9 21.9 21.6 10.7 10.33 14.7 62.9 60.9 14.2 23.4 869 1198.4 9267.27 222.56 8.56 3.21 6.06 10.5 NA 56.6 53.9 NA NA 1108 1085.95 4586.81 305.42 69.69 12.12 JAXW202-2655 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 28.4 28.17 29.21 28.08 29.1 27.69 26.4 26.2 26.4 26.4 8.02 11.2 16.1 51 45.5 14.4 31.6 939 1315.28 6445.67 232.58 24.06 1.6 5 10.33 13.6 46.6 45.1 13.2 29.2 1354 569.5 4119 260 42.5 8.5 JAXW202-2656 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 29.7 29.77 29.25 27.5 27 26.22 25.8 24.6 23.7 23.4 4.66 10.06 14.2 46 45.7 14.1 30.9 629 680.83 3797.43 175.22 5.13 1.86 4.52 9.12 12.1 42.2 46.3 13.3 28.7 1154 307.36 4109.13 77.29 20.79 5.42 JAXW202-2657 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 24.9 24.45 24.42 24.04 24.7 23.63 23.5 22.6 22.2 22.2 5.12 10.46 15.6 68.3 65.3 14.9 22.8 872 1295.36 3545.09 244.74 31.23 3.58 6.02 8.08 12.2 48.8 60.4 15.1 25 1091 1500.79 3755.88 729.62 33.71 0 JAXW202-2658 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 19.3 19.07 19.83 19.77 20.6 18.57 18.2 18.2 18.9 18.3 3.82 10.47 15.8 66.2 63.2 15.1 23.9 737 676.52 2957.06 186.42 0 0 3.5 7.09 9.9 42.4 59.8 14 23.3 1239 810.25 2315.25 336.7 30.45 7.35 JAXW202-2659 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 33.8 32.23 32.02 30.8 31.2 30.95 31.7 30.3 28.7 27.9 7.28 11.06 15.1 49.2 44.5 13.7 30.7 924 1201.2 5820.36 254.8 3.64 0 2.94 9.43 12.8 42.6 45.2 13.6 30 928 196.69 2625.13 82.61 24.11 11.76 JAXW202-2660 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 27.8 26.88 26.98 25.81 26.3 25.57 25.7 25.3 24.7 24.5 5.58 10.34 15.2 48.2 46.6 14.7 31.5 860 496.06 4829.49 241.61 5.02 7.25 4.4 7.4 10.6 34.3 46.4 14.3 30.9 1763 412.28 3587.32 374.44 18.04 7.92 JAXW202-2661 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 24.8 24.28 23.94 22.25 22.6 20.68 21.3 20.3 20.6 20.3 8.36 9.82 15.2 46.6 47.5 15.5 32.6 864 1792.38 6351.93 206.49 9.2 0 6.64 9.25 13.1 45.4 49.1 14.2 28.9 1340 2049.77 4126.1 434.26 24.57 5.31 JAXW202-2663 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 21.5 22.53 22.32 20.75 21.8 19.47 19.2 18.4 18.5 17.9 7.52 9.57 14.2 45.6 47.6 14.8 31.1 699 1287.42 6060.37 106.03 62.42 3.76 3.98 6.14 8 28.4 46.3 13 28.2 1009 739.48 2699.63 468.45 61.69 10.35 JAXW202-2665 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 17.6 19.46 19.23 17.05 17.7 16.73 17.7 16.7 16.8 16.2 5.98 8.19 13.3 39.1 47.7 16.2 34 597 572.29 5149.98 255.35 0 1.79 4.2 6.16 8.2 30.1 48.9 13.3 27.2 1169 179.76 3863.16 154.56 2.1 0 JAXW202-2667 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 19 20.72 20.91 20.91 21.5 20.45 20.9 20.3 20.3 19 6.86 10.12 14.6 61.4 60.7 14.4 23.8 599 1575.74 4888.44 340.26 56.25 0 5.38 8.72 12 48.7 55.8 13.8 24.6 927 569.2 4385.24 388.97 27.44 9.15 JAXW202-2669 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 17.6 16.49 17.59 16.9 17 15.88 16.1 16.2 15.7 15.5 4.22 10.53 13.7 41.7 39.6 13 32.9 491 628.36 3464.62 121.54 5.49 0 3.94 9.46 11.5 39 41.2 12.2 29.5 796 277.77 3527.48 131.2 3.55 0 JAXW202-2670 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 20.2 19.73 19.71 18.74 19.4 17.72 17.9 17.5 17.2 17.1 5.2 10.8 15.2 56.4 52.2 14.1 27 690 729.04 4333.68 128.44 7.8 1.56 2.9 7.65 10.2 38 49.7 13.3 26.8 1092 186.76 2610.58 100.63 0 1.74 JAXW202-2671 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 21.5 20.13 20.04 18.85 19 17.72 17.1 18.4 18.3 18.5 8.32 11.17 14.3 50.2 44.9 12.8 28.5 689 945.98 7105.28 258.75 9.98 0 5.68 6.04 8.6 30.9 51.2 14.2 27.8 1626 365.79 4899.57 407.82 6.82 0 JAXW202-2672 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 17.3 17.33 17.41 15.7 16.2 14.6 14.1 13.8 13.5 13.2 11.64 10.19 14.7 60 58.9 14.4 24.5 495 1562.09 9705.43 336.4 32.59 3.49 7.86 7.64 10.9 42.3 55.4 14.3 25.8 1746 226.37 7376.61 234.23 17.29 5.5 JAXW202-2673 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 19.6 20.78 20.6 19.5 20 19.03 19.5 19 18.2 19.1 9.06 10.93 15.4 60.4 55.3 14.1 25.5 685 1236.69 7652.98 156.74 11.78 1.81 6.14 10.78 13.7 58.1 53.9 12.7 23.6 1435 220.43 5779.58 137.54 1.23 0 JAXW202-2674 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 17.5 17.05 17.82 16.88 16.3 16.92 16.9 18.6 19 17.8 5.36 9.66 13.9 41.2 42.7 14.4 33.7 385 744.5 4419.86 180.1 12.33 3.22 2.16 6.04 7.2 26.8 44.4 11.9 26.9 865 90.29 1932.98 122.69 14.26 0 JAXW202-2675 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 20.4 20.19 20.23 19.19 18.9 19.37 20.1 19.8 19.8 19.8 5.62 10.84 14.7 50.2 46.3 13.6 29.3 837 1161.09 4071.13 351.81 35.97 0 5.86 8.72 11.5 41 47 13.2 28 1276 805.75 4273.11 764.73 16.41 0 JAXW202-2676 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 22.8 21.94 22.05 21.3 21.9 22.2 21.9 21.6 20.9 21.1 9.5 9.87 14.9 45.7 46.3 15.1 32.6 567 1430.7 7837.5 210.9 21.85 0 6.26 6.32 9.2 30 47.5 14.6 30.7 1245 401.89 5349.17 490.16 18.78 0 JAXW202-2677 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 20 21.03 20.99 19.87 21 18.92 18.7 17.2 18.2 18.4 11.16 11.83 15.2 62.5 52.8 12.8 24.3 554 1363.75 9478.19 264.49 51.34 3.35 6.22 8.51 10.4 42.5 49.9 12.2 24.5 1174 296.07 5584.32 322.2 18.04 0 JAXW202-2678 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 21.5 21.88 22.1 18.16 19.4 18.03 17.9 17.4 17.2 16.5 6.28 6.98 14.4 47.7 68.3 20.6 30.2 531 666.94 5385.1 216.03 11.3 1.88 2.46 7.9 10.6 39.7 50.3 13.4 26.7 1082 70.6 2270.33 115.62 1.72 1.72 JAXW202-2679 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 20 21.3 21.4 18.43 18.1 17.86 18.4 18.5 18 19.1 5.8 10.54 14.5 48.2 45.7 13.8 30.1 585 885.66 4622.02 272.6 19.14 0.58 2.8 9.35 11.7 45.3 48.4 12.5 25.8 1058 191.8 2413.6 187.04 6.16 1.68 JAXW202-2680 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 16.4 17.13 19.22 15.45 15.2 15.38 15.3 15.3 14.3 14.4 4.62 10.18 14.8 47 46.2 14.5 31.5 574 718.87 3815.2 74.38 9.7 1.85 3.02 8.05 11 39.1 48.6 13.7 28.1 1026 205.06 2679.65 124.12 11.17 0 JAXW202-2681 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-08-10 2010-10-05 NA 22.8 22.76 21.97 20.67 21.3 20.23 19.7 18.8 18.4 18.2 8.7 10.02 14.3 44.8 44.7 14.3 31.9 693 1067.49 7289.73 313.2 27.84 1.74 3.74 10.51 15.1 59.5 56.6 14.4 25.4 967 168.3 3400.03 168.67 3.37 0 JAXW202-2683 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 17.9 17.9 17.9 17.7 18.5 19.53 17.18 17.3 17.9 18.4 4.76 10.35 15.7 63.9 61.6 15.1 24.6 616 767.79 3854.17 125.19 10.47 1.9 4.22 8.62 12 52.7 61.1 13.9 22.8 1310 872.7 3216.91 109.3 21.1 0 JAXW202-2684 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 21.6 21.3 21.3 21.5 20.5 21.36 19.1 19.2 20.5 19.4 5.3 11.11 14.6 50.6 45.5 13.1 28.9 823 587.77 4554.29 142.04 13.78 2.65 6.96 8.12 10.6 35.1 43.2 13.1 30.2 1748 1603.58 5213.04 117.62 24.36 2.09 JAXW202-2685 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 22.1 21.8 22.4 21.8 21.5 21.04 21.22 20.2 21.3 20.1 8.52 9.73 15.4 56.5 58.1 15.8 27.3 572 741.24 7601.54 166.99 5.11 5.11 9.46 8.64 12 51.5 59.6 13.9 23.3 1366 1833.35 7410.02 155.14 61.49 0 JAXW202-2686 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 17.8 18 18.9 19.3 19.9 19.23 18.5 19.4 19 19.3 5.9 10.68 15.2 61.2 57.3 14.2 24.8 639 654.9 5022.08 222.43 0 0 5.74 7.51 11.1 45.9 61.1 14.8 24.2 1435 751.37 4698.76 276.67 10.91 1.72 JAXW202-2687 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 22.1 21 20.5 19.3 18.6 18.24 19.15 19.2 18.3 18.1 12.16 10.01 14.5 60.2 60.1 14.5 24.1 587 1136.96 10727.55 272.38 18.24 3.65 9.46 7.8 11.5 48.4 62.1 14.7 23.8 862 619.63 8670.09 160.82 10.41 0 JAXW202-2688 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 16.9 16.7 16.5 16.9 16.4 16.28 16.03 16.6 16.39 16.7 9.06 11.44 15.4 61.4 53.7 13.5 25.1 800 1872.7 6863.86 260.93 60.7 1.81 6.42 8.87 12.2 49.3 55.6 13.8 24.7 1745 1209.53 4958.17 237.54 14.12 0 JAXW202-2689 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 17 16.8 15.9 16 14.1 16.52 16.66 16 16.2 16.2 5.84 11.56 16.5 63.5 54.9 14.3 26 900 564.73 5063.28 190.97 19.27 1.75 4.8 10.01 13.7 56.5 56.4 13.7 24.2 1488 571.2 4032.96 163.68 26.88 4.8 JAXW202-2690 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 22.8 22.5 21.8 22 20.2 19.16 21.43 21.7 21.7 22.3 6.24 9.52 14.6 47.3 49.7 15.3 30.9 749 1032.1 5008.85 187.82 9.36 1.87 5.08 8.06 10.7 38 47.1 13.3 28.2 2191 1576.83 3238.5 243.33 20.32 0.51 JAXW202-2692 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 20.2 19.6 19.5 19.7 18 19.25 19.19 19.8 20.2 20 4.94 10.37 14 48.2 46.5 13.5 29 698 599.22 4138.24 198.59 3.95 0 5.26 7.51 10.9 35.3 47 14.5 30.9 1709 1630.07 3473.7 144.12 12.1 0 JAXW202-2693 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 27.9 26 25.5 25.1 22.9 22.4 25.86 26 25.6 25.7 2.6 10.14 14.8 52.8 52.1 14.6 28 694 486.98 1993.42 104.52 13 1.82 1.78 7.25 10.7 36.6 50.5 14.8 29.2 1266 180.85 1506.24 90.07 2.85 0 JAXW202-2694 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.3 19.3 19.1 21.3 21.2 20.71 19.22 19.2 18.8 19 5.8 9.45 15.4 46.6 49.3 16.3 33 787 614.22 4944.5 226.2 15.08 0 5.1 7.89 11.9 38.3 48.5 15.1 31.1 1195 785.91 4120.8 170.34 20.91 2.55 JAXW202-2695 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 22.7 22.3 22.1 23.1 21.8 20.73 21.3 21.7 21.5 21.3 7.34 11.02 15.9 54.2 49.2 14.4 29.3 678 899.15 6138.44 289.2 11.74 0.73 3.9 7.88 11.6 36.5 46.3 14.7 31.8 1361 464.49 3281.07 99.84 54.6 0 JAXW202-2696 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 21.1 21.3 21.4 21.3 22 21.89 20.45 20.7 20 20.9 6.74 9.95 14.1 49.4 49.6 14.2 28.5 797 755.55 5688.56 269.6 24.94 2.02 4.22 6.57 9.1 31.1 47.3 13.9 29.3 2178 1216.2 2869.18 119.85 14.77 0 JAXW202-2697 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 20.7 21 21 19.7 19.2 19.04 20.62 20.3 20.8 20.7 5.62 9.01 13.9 47.7 52.9 15.4 29.1 891 563.12 4833.76 221.99 1.12 0 6.94 6.79 10.4 34.8 51.3 15.3 29.9 1241 1020.18 5653.32 169.34 79.12 18.04 JAXW202-2698 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 25.4 22.5 25.4 26.1 26.8 25.94 25.83 25.3 24.8 24.7 6.2 10.9 15.4 59.3 54.4 14.1 26 687 890.94 5084 223.2 1.86 0 4.78 8.3 11.7 45.2 54.5 14.1 25.9 1352 1119.48 3488.92 163.95 8.13 0 JAXW202-2699 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 23.3 23.3 23.9 28.4 28.9 28.2 28.34 28.7 27.5 28.6 9.16 11.35 15.8 52 45.8 13.9 30.4 655 619.22 8393.31 136.48 9.16 2.75 5.36 8.77 12.4 38.8 44.2 14.1 32 1198 571.91 4639.62 145.26 3.75 0 JAXW202-2700 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.2 19.1 18.9 19 17.6 16.62 16.13 16.4 16.6 16.8 5.26 10.07 13.8 46.9 46.6 13.7 29.4 545 512.32 4441.02 296.14 8.94 1.58 3.68 6.34 8.9 27.9 44 14 31.9 1436 1256.35 2247.38 119.6 52.62 3.68 JAXW202-2701 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 25.1 24.8 24.8 25.8 25.4 24.98 25.04 24.7 24.8 25.1 7.32 10.13 14.4 58.1 57.4 14.2 24.8 806 644.16 6517 142.01 12.44 5.12 5.56 7.41 10.5 45 60.7 14.2 23.3 1681 467.6 4861.11 220.73 10.01 0.56 JAXW202-2703 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 28.8 28.4 28.5 28 23.7 22.92 21.86 22.1 21.9 21.7 4.36 10.94 14.7 49.9 45.6 13.4 29.5 555 465.65 3682.02 212.33 0 0 11.76 6.55 9.5 29.9 45.6 14.5 31.8 1250 1826.33 9018.74 811.44 94.08 8.23 JAXW202-2704 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 20.5 19.4 20 20.1 20.2 21.35 19.27 18.3 18.3 18.8 3.64 9.68 13.9 46.9 48.5 14.4 29.6 466 484.48 2873.78 265.72 10.92 5.46 5.1 9.21 12.7 41.6 45.2 13.8 30.5 1097 973.08 3918.33 174.93 24.99 9.18 JAXW202-2705 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.1 19.2 19.3 18.9 17.3 17.88 21.46 15.1 15.1 15.9 5.46 10.58 15.3 49.1 46.4 14.5 31.2 794 756.76 4636.63 67.16 0 0 9.34 6.78 9.8 30.4 44.8 14.5 32.2 1759 2807.6 6345.6 138.23 42.96 4.67 JAXW202-2706 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 23.1 22.7 22.3 22.6 22.3 22.71 20.43 20.5 20.4 21.1 9.18 10.31 13.7 53.6 52 13.3 25.6 582 429.62 8536.48 212.06 1.84 0 9.94 7.62 10.1 41.1 53.9 13.3 24.6 1245 1357.8 8313.82 225.64 40.75 1.99 JAXW202-2707 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 18.7 18.8 18.5 18.6 18.3 17.32 20.63 16.6 16.8 17.3 8.82 9.84 14.7 58.3 59.2 14.9 25.2 772 1340.64 7056.88 406.6 14.11 1.76 11.72 7.91 11.5 47.5 60.1 14.5 24.2 1727 2079.13 9070.11 503.96 65.63 1.17 JAXW202-2708 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 28.9 28 28.2 28.1 28.3 27.47 27.38 27.2 25.9 26.5 7.34 11.51 15.9 59.2 51.4 13.8 26.9 772 921.17 6161.2 257.63 0 0 6.36 9.4 12.6 49.8 53 13.4 25.3 1634 773.38 5336.68 207.34 38.8 3.18 JAXW202-2709 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 20.7 19.8 19.3 19.7 18.8 18.12 17.81 17.3 17.7 18.7 9.98 9.46 13.9 40.2 42.5 14.7 34.6 779 867.26 8639.69 456.09 12.97 3.99 2.64 8.76 12.6 39.2 44.7 14.4 32.1 1313 272.45 2333.76 30.1 1.85 1.85 JAXW202-2710 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.6 20.3 21.3 21.5 18.9 18.29 17.93 17.9 17.6 17.7 7.22 11.48 15.5 53.5 46.6 13.5 29 591 875.79 5962.28 361.72 18.77 1.44 5.7 7.37 10.4 33.8 45.9 14.1 30.8 1709 844.17 4578.24 228.57 49.02 0 JAXW202-2711 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.9 20.1 20.1 20.4 19.8 20.26 19.36 19.9 19.5 20.2 6.7 9.88 14.1 46.2 46.8 14.3 30.5 571 712.88 5662.84 297.48 20.1 6.03 5.88 7.32 10.6 33.7 46 14.5 31.5 1407 596.82 4870.99 360.44 51.16 0 JAXW202-2712 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 18.6 18.6 18.9 19.3 18.5 18.25 17.26 17.3 17.6 17.6 12.7 10.06 14.9 60 59.6 14.8 24.8 582 1363.98 10796.27 509.27 31.75 0 6.88 6.97 10.9 43.3 62.1 15.6 25.2 1340 969.39 5654.67 218.1 32.34 4.82 JAXW202-2713 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 21.7 20.9 20.5 22.5 22.5 21.46 20.54 20.9 19.9 20.1 9.22 10.23 15.7 51.9 50.7 15.3 30.3 520 1254.84 7628.63 319.01 17.52 0 6.64 9.26 13.7 45.3 48.9 14.8 30.2 811 1169.97 5179.86 227.75 61.15 0 JAXW202-2714 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 17.9 16.5 16.9 17.5 16.9 16.98 16.46 17.3 15.9 16.2 9.5 10.5 13.9 45.6 43.4 13.2 30.5 712 766.65 8209.9 512.05 7.6 5.7 10.14 8.2 10.4 33.6 41 12.7 31 1503 1755.23 8032.91 293.05 54.76 3.04 JAXW202-2715 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 22.6 22.6 23 22.5 22.9 22.01 21.28 21 21.1 21.4 5.16 9.56 14.8 58.4 61.1 15.5 25.3 744 780.71 4137.8 237.88 4.13 0 6.08 6.47 10.6 40.4 62.4 16.4 26.2 1708 2102.46 3472.29 468.77 35.87 0.61 JAXW202-2716 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 21.7 20 20.5 20.2 20.4 20.54 20.46 20.5 20 20.1 6.6 9.57 14.3 49.7 51.9 14.9 28.8 778 1154.34 5239.08 203.28 3.3 0 4.04 8.05 11.4 40.7 50.6 14.2 28 1881 786.99 3128.58 103.42 19.39 1.62 JAXW202-2717 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 25.3 23.5 23.6 23.5 22.5 22.52 21.62 21.5 20.9 21.9 4.16 NA NA NA NA NA NA 456 89.86 3939.1 114.82 12.9 3.74 4.46 8.72 11.7 37.1 42.5 13.4 31.5 2714 491.94 3753.98 211.4 2.23 0 JAXW202-2718 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 20.3 20.8 20.7 20 18.9 19.14 17.3 16.6 16.8 17.7 6.82 11.54 15.1 59.4 51.5 13.1 25.4 590 922.06 5619.68 278.26 0 0 3.04 6.48 8.5 34.7 53.5 13.1 24.5 1333 929.94 1968.1 82.38 54.72 4.86 JAXW202-2719 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 18.6 19 18.9 18.7 20.3 21.66 19.32 19.3 19 19.5 7.86 9.68 14 58.3 60.2 14.5 24 600 987.22 6565.46 293.96 12.58 0 4.84 6.67 9.4 41.6 62.4 14.1 22.6 1906 278.78 4396.66 136.49 27.1 0.48 JAXW202-2720 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 22.1 19.2 19.5 18.6 18.5 17.92 17.17 17 16.3 16.1 3.68 10.99 14.3 51.9 47.2 13 27.6 615 342.98 2990 341.14 5.52 0 1.28 8.11 10.8 39.3 48.5 13.3 27.5 1855 141.95 1052.8 54.14 23.94 7.3 JAXW202-2721 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 21.7 20.2 21.3 21.6 21.1 21.6 20.55 21.1 20.9 21.6 4.24 10.52 15.4 51.5 49 14.6 29.9 734 517.28 3510.72 201.4 8.9 1.7 7.58 8.09 11.6 40 49.4 14.3 29 2230 1848 5325.71 351.71 40.93 14.4 JAXW202-2722 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19 19.2 19.8 19.4 19.7 19.98 18.89 19.8 19.2 19.5 3.78 10.36 14.9 60.4 58.3 14.4 24.7 601 495.94 3057.26 202.99 18.9 5.29 3.36 7.49 11.7 47.6 63.6 15.6 24.6 1184 719.71 2389.01 244.27 7.39 0 JAXW202-2723 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.1 22 21.9 22 21.9 22.07 19.35 21 21.6 22.2 7.34 11.29 14.3 46.3 41 12.7 30.9 670 1123.75 5835.3 373.61 5.87 1.47 8.14 8.04 11.9 33.4 41.5 14.8 35.6 1576 1257.63 6545.37 303.62 33.37 0 JAXW202-2724 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.2 19.7 19.7 18.7 19.1 19.86 19.21 19.4 19.9 20.6 10.04 10.56 15.2 55.9 52.9 14.4 27.2 678 1657.6 7902.48 452.8 21.08 7.03 7.12 8.28 11.1 47.5 57.4 13.4 23.3 1672 1124.96 5678.91 287.65 19.22 8.54 JAXW202-2725 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 17.6 18.3 19.2 18.9 18.2 18.62 20.32 20.4 20.5 20.2 9.64 10.77 15.1 57.4 53.3 14 26.3 814 1310.08 7818.04 505.14 6.75 0 4.5 8.41 12.2 46.3 55.1 14.5 26.3 1571 580.5 3732.3 136.8 50.4 0 JAXW202-2726 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 23.4 24.9 24.8 23.4 23 21.98 22.97 22.9 22.4 22.6 7.18 10.24 14 54.5 53.2 13.7 25.7 575 453.06 6534.52 189.55 2.15 0 5.5 8.07 10.5 45.8 56.8 13 22.9 1545 480.15 4924.7 95.15 0 0 JAXW202-2727 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 23.1 23.2 23.8 24 24.2 22.75 22.73 22.4 21.9 21.8 5.08 10.84 14.8 48.9 45.1 13.7 30.3 560 325.12 4537.46 193.04 22.86 2.03 4.06 9.75 12.7 44.3 45.4 13 28.7 1185 763.28 3090.07 190.01 13.4 2.84 JAXW202-2728 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.9 19.5 19.3 17.5 17.6 17.42 18.22 18.2 17.7 18.6 9.94 10.6 15.7 55.1 52 14.8 28.5 635 841.92 8742.23 353.86 0 1.99 6.78 7.68 11.5 41.1 53.5 15 28 1492 527.48 5735.88 483.41 31.87 1.36 JAXW202-2729 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 17.7 18.7 18.7 19 19.4 18.47 18.59 17.7 17.7 17.7 2.92 11.2 15.4 53.1 47.4 13.8 29 775 335.51 2395.86 169.94 11.39 7.3 4.36 7.94 12 37.1 46.7 15.1 32.3 1472 727.68 3457.92 110.74 50.58 13.08 JAXW202-2730 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 17.7 18.9 18.5 18.8 18.3 19.39 17.81 17 17.5 17.8 3.84 10.35 14.8 61 58.9 14.3 24.3 648 274.94 3346.56 193.54 21.5 3.46 2.56 7.07 10.1 43.6 61.7 14.3 23.2 1203 366.34 2103.3 59.9 23.3 7.17 JAXW202-2731 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.1 20.1 20.2 20.2 20.2 20.24 19.54 19.2 19.3 20.5 4.4 10.29 14.7 56 54.4 14.3 26.3 776 572.88 3562.24 253.44 7.92 3.52 6.6 8.01 11.3 46 57.4 14.1 24.6 2284 1852.62 4269.54 434.28 40.92 1.98 JAXW202-2732 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 24.2 24.1 24.3 23.4 22.9 22.55 21.79 22.1 21.5 22.1 6.18 10.35 15.9 54.3 52.5 15.4 29.3 661 594.52 5300.59 258.94 22.25 3.71 6.76 7.94 12.5 41 51.6 15.7 30.5 1455 1335.1 5012.54 386 24.34 2.03 JAXW202-2733 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 21.9 22.5 22.7 21.7 20.7 20.3 17.89 18.7 19.4 21.8 6.08 10.12 15.3 61.4 60.7 15.1 24.9 741 435.94 5250.69 393.38 0 0 6.8 9.17 13.3 56.6 61.7 14.5 23.5 1903 1607.52 4957.2 170.68 47.6 16.32 JAXW202-2734 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 16.1 16 15.3 15.7 15.6 15.61 15.2 15.2 15.2 14.8 6.04 9.86 15.4 59.1 59.9 15.6 26.1 712 474.14 5219.77 344.28 1.81 0 7.94 7.36 10.6 41.5 56.4 14.4 25.5 1654 795.59 6829.99 305.69 3.18 5.56 JAXW202-2735 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 17.1 17.1 16.8 16.1 15.8 15.16 14.97 14.8 15 15.4 4.1 10.37 14.4 47.4 45.7 13.9 30.4 624 567.03 3294.35 226.73 10.25 1.23 6.38 9.18 12.6 41 44.7 13.7 30.7 1166 898.94 5223.31 225.85 27.43 5.1 JAXW202-2736 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 23.6 24.1 24.6 24.6 24.8 24.42 23.41 23.6 22.9 23.7 6.3 9.49 13.4 44 46.4 14.1 30.5 588 549.99 5557.86 185.85 2.52 3.78 6.34 8.46 12.1 38.7 45.7 14.3 31.3 1130 379.77 5751.65 181.32 25.36 1.9 JAXW202-2737 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.6 18.6 19 19.8 19.6 19.3 18.73 18.4 18.1 18.5 5.9 10.9 15.1 52.9 48.5 13.9 28.5 633 362.26 5371.36 164.02 1.77 0 13.76 6.99 9.8 33.6 48.1 14 29.2 2090 3828.03 8472.03 681.12 591.68 188.51 JAXW202-2738 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 22.4 22.1 22.4 22 22.2 21.99 21.79 21.2 21 20.6 12.06 9.3 14 44.4 47.7 15.1 31.5 645 1291.63 10493.41 266.53 8.44 0 5.96 6.11 8.6 29.1 47.6 14.1 29.6 1670 606.73 5233.48 85.23 30.99 2.98 JAXW202-2739 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 17.9 17.9 18.4 18.4 17.5 18.2 17.85 17.4 17.6 17.8 10.06 9.62 14.8 56 58.2 15.4 26.4 596 1428.52 8027.88 594.55 5.03 4.02 3.84 6.64 9.9 41.4 62.3 14.9 23.9 1045 290.3 3368.06 140.54 41.09 0 JAXW202-2740 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 21 21 21.8 20.5 20.7 20.53 20.13 19.3 19.1 19.5 6.66 9.96 14.2 51.2 51.4 14.3 27.7 603 594.74 5845.48 207.13 10.66 2 4.34 8.3 11.7 40.7 49 14.1 28.7 1357 985.61 3177.31 138.01 34.72 4.34 JAXW202-2741 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 22 22.1 22.6 22.9 22.9 22.18 22.15 21.9 21.7 21.6 8.06 10.87 15.6 55.5 51.1 14.4 28.1 890 948.66 6785.71 315.15 8.87 1.61 5.14 6.7 10.1 34.7 51.8 15.1 29.1 1709 982.25 3898.18 188.64 53.46 17.48 JAXW202-2742 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 20.5 20.2 21.2 20 20.9 21.19 20.35 20.5 20.5 20.1 6.1 9.42 15.7 46.8 49.7 16.7 33.5 663 520.33 5318.59 239.12 21.35 0 3.08 8.87 13.1 44.3 49.9 14.8 29.6 1388 212.21 2798.49 60.68 3.39 5.24 JAXW202-2743 Diversity Outbred Male Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - F Docetaxel 2010-07-20 2010-10-05 NA 23.3 21.19 22 21.9 22.5 20.31 19.4 18.5 18.4 18.5 5.08 9.72 13.9 43.1 44.3 14.3 32.3 793 1172.97 3687.06 211.84 8.64 0 3.88 7.37 10.1 33.9 46 13.7 29.8 1437 926.93 2573.22 322.04 54.32 3.88 JAXW202-2744 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 21.7 22.2 22.2 21.6 20 20.25 19.71 20.6 19.5 20.4 6.64 10.26 14.2 46.4 45.2 13.8 30.6 589 403.71 5966.7 269.58 0 0 9.4 5.93 8.3 28.6 48.2 14 29 1148 1613.04 7249.28 478.46 55.46 3.76 JAXW202-2745 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 15.2 15.5 15.9 15.4 15.1 15.44 14.92 15.7 14.9 15.5 3.8 10.59 14.4 55.2 52.1 13.6 26.1 421 343.14 3280.54 172.52 3.42 0 2.32 5.5 6.8 29.1 52.9 12.4 23.4 1412 518.75 1661.35 120.41 17.86 1.62 JAXW202-2746 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 22 21.2 21.3 21.4 17.9 17.06 15.59 16.2 14.5 14.5 5.36 10.33 14.4 59.4 57.5 13.9 24.2 835 417.01 4694.29 239.06 10.18 0 7.08 8.14 12 47.1 57.9 14.7 25.5 1653 1270.15 5643.47 130.27 36.11 0 JAXW202-2747 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 18.3 18.5 18 17.8 18.6 18.27 17.91 17.1 17.1 17.6 10.34 10.71 15.1 48.9 45.7 14.1 30.9 502 761.02 9087.83 482.88 5.17 2.07 3.88 8.08 9.9 35.4 43.8 12.3 28 1137 522.64 3265.41 51.99 38.02 2.33 JAXW202-2748 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.7 19.6 19.2 19.1 19 18.59 17.81 17.3 16.4 16.9 10.22 10.68 16.2 50.6 47.4 15.2 32 559 618.31 9324.73 276.96 0 0 1.26 7.37 9.2 34 46.1 12.5 27.1 943 221.13 970.96 31.88 32.51 3.53 JAXW202-2749 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 19.8 19.1 19.4 19.7 19.8 18.85 18.86 19 18.9 19.4 7.58 10.5 15.4 50.7 48.3 14.7 30.4 621 782.26 6479.38 299.41 8.34 10.61 6.4 7.65 10.9 38.3 50.1 14.2 28.5 1282 1051.52 4982.4 334.72 29.44 1.28 JAXW202-2753 Diversity Outbred Female Group 24 - 30 mg/kg X 3 Taxotere (docetaxel) - G Docetaxel 2010-08-10 2010-10-11 NA 28 26.9 28.7 28 26.8 25.48 23.5 23.8 23.8 24.2 9.18 11.44 14.2 60.9 53.2 12.4 23.3 664 934.52 7846.15 399.33 0 0 3.72 7.35 8.5 39.5 53.7 11.6 21.5 1525 1076.2 2454.83 101.18 74.03 14.14 JAXW202-3001 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 31.68 NA NA NA NA NA 32.83 NA NA NA 6 8.74 14.4 37.2 42.6 16.5 38.7 720 975 4930.8 93 0 1.8 0.7 10.34 14.4 43.8 42.4 13.9 32.9 182 49.42 609.63 30.17 7.35 3.43 JAXW202-3002 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 28.77 NA NA NA NA NA 24.16 NA NA NA 6.14 8.7 13.6 46.8 53.8 15.6 29.1 824 676.6 5321.5 139.4 2.5 0 1.1 10.21 17.1 53.7 52.6 16.7 31.8 501 151.58 930.6 10.78 5.17 1.76 JAXW202-3003 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 25.78 NA NA NA NA NA 21.7 NA NA NA 5.24 10.31 15.6 52.6 51 15.1 29.7 651 811.7 4231.3 189.2 7.9 0 1.84 11.19 17.6 54.9 49.1 15.7 32.1 403 406.64 1339.89 86.85 3.31 3.5 JAXW202-3004 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 27.29 NA NA NA NA NA 25.43 NA NA NA 6.92 8.83 13.5 37.8 42.8 15.3 35.7 469 698.2 6055.7 154.3 9.7 2.1 0.84 11.17 16 47.7 42.7 14.3 33.5 203 42.34 786.32 11.09 0.25 0 JAXW202-3005 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 21.48 NA NA NA NA NA 19.23 NA NA NA 5.96 9.29 14.9 44.3 47.7 16 33.6 663 312.9 5449.2 185.4 13.1 0 1.1 10.87 15.8 50.3 46.3 14.5 31.4 415 64.35 1000.12 12.87 19.36 3.41 JAXW202-3006 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 32.2 NA NA NA NA NA 28.77 NA NA NA 5.76 9.59 14 47.2 49.2 14.6 29.7 645 391.1 5159.8 200.4 8.1 0 1.38 10.17 14.7 48.4 47.6 14.5 30.4 423 368.18 969.59 40.57 1.79 0 JAXW202-3007 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 28.4 NA NA NA NA NA 26.16 NA NA NA 5.02 8.43 13.1 34.8 41.3 15.5 37.6 414 426.2 4490.4 92.9 8.5 1.5 0.54 7.96 12.2 32.5 40.8 15.3 37.5 269 53.14 448.04 27.59 9.29 1.89 JAXW202-3008 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 25.09 NA NA NA NA NA 20.07 NA NA NA 6.9 9.3 14.8 49.4 53.1 15.9 30 638 924.6 5549 400.2 22.1 3.5 1.52 10.44 17 53.8 51.5 16.3 31.6 574 284.09 1172.53 46.51 15.2 1.82 JAXW202-3009 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 31.27 NA NA NA NA NA 26.23 NA NA NA 6.48 10.01 15.4 45.6 45.6 15.4 33.8 638 1358.9 4585.2 307.2 194.4 33.7 0.7 12.29 15.5 46.3 37.7 12.6 33.5 228 87.43 550.13 31.01 25.9 5.6 JAXW202-3010 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 29.76 NA NA NA NA NA 26 NA NA NA 13.36 9.3 14.9 43.5 46.8 16 34.3 549 1102.2 11966.6 249.8 42.8 0 3.26 10.45 18.4 48.3 46.2 17.6 38.1 398 870.42 2264.72 108.88 14.34 1.63 JAXW202-3011 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 31.7 NA NA NA NA NA 25.84 NA NA NA 7.86 9.73 14.7 42.3 43.5 15.1 34.8 632 725.5 6888.5 237.4 7.1 1.6 1.84 12.88 18.5 54.2 42.1 14.4 34.1 342 333.78 1460.59 33.3 9.02 3.5 JAXW202-3012 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 29.51 NA NA NA NA NA 27.09 NA NA NA 7.58 11.12 15.1 48.9 44 13.6 30.9 695 1255.2 5989 316.1 15.9 3.8 0.58 13.08 17.9 55.6 42.5 13.7 32.2 140 89.2 475.37 4.81 8.7 1.86 JAXW202-3013 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 31.47 NA NA NA NA NA 27.53 NA NA NA 5.32 9.04 14.6 40.6 44.9 16.2 36 605 521.9 4514 254.8 22.3 6.9 0.56 11.58 17.7 51.1 44.1 15.3 34.6 307 92.46 413.56 51.91 2.07 0 JAXW202-3014 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 30.01 NA NA NA NA NA 26.71 NA NA NA 9.7 9.73 14 40.3 41.4 14.4 34.7 718 843.9 8270.2 576.2 3.9 4.9 1.28 9.28 12.8 37.5 40.4 13.8 34.1 425 71.04 1184.51 16.26 8.06 0 JAXW202-3015 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 27.57 NA NA NA NA NA 23.93 NA NA NA 7.2 9.25 14 42.3 45.7 15.1 33.1 607 643 6341 192.2 22.3 1.4 1.12 9.79 15 43.3 44.2 15.3 34.6 243 162.29 893.65 35.5 13.1 15.34 JAXW202-3016 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 28.78 NA NA NA NA NA 25.15 NA NA NA 5.3 9.82 15.5 51.7 52.6 15.8 30 781 697 4246.9 323.8 31.3 1.6 0.74 9.9 16.5 49.9 50.4 16.7 33.1 154 142.15 551.52 11.47 27.9 7.03 JAXW202-3017 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 26.01 NA NA NA NA NA 23.66 NA NA NA 3.68 9.68 14.9 46.4 47.9 15.4 32.1 710 157.9 3370.5 146.5 2.2 2.9 0.62 12.65 18.8 58.8 46.5 14.9 32 227 61.57 508.15 46.81 0 3.47 JAXW202-3018 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 29.59 NA NA NA NA NA 28.22 NA NA NA 3.9 9.37 13.7 38.2 40.8 14.6 35.9 670 587 3051.8 253.9 2 5.1 0.94 10.3 15.4 41.5 40.3 15 37.1 196 24.53 884.35 29.42 0 1.79 JAXW202-3019 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 24.06 NA NA NA NA NA 24.05 NA NA NA 7.44 11.09 14.7 51.6 46.5 13.3 28.5 632 654.7 6414.8 353.4 18.6 0 1.04 10.42 15.9 46.6 44.7 15.3 34.1 272 134.16 891.9 8.22 3.74 1.87 JAXW202-3020 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 27.27 NA NA NA NA NA 21.79 NA NA NA 7.66 9.02 16.9 41.1 45.6 18.7 41.1 495 1287.6 6043.7 293.4 26 8.4 0.68 12.56 19.2 55.8 44.4 15.3 34.4 274 141.78 532.78 2.04 1.7 1.7 JAXW202-3021 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 32.55 NA NA NA NA NA 28.58 NA NA NA 6.4 10.97 18.4 48.5 44.2 16.8 37.9 604 649 5582.7 160 6.4 1.9 1.72 10.18 17.3 43.9 43.1 17 39.4 199 206.06 1436.72 39.73 32.68 4.99 JAXW202-3025 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 23.22 NA NA NA NA NA 21.15 NA NA NA 4.36 10.08 18.7 51 50.6 18.6 36.7 468 622.2 3631 93.3 13.5 0 0.74 10.41 15.3 51 49 14.7 30 174 47.29 664 10.51 16.13 2.07 JAXW202-3026 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 29.73 NA NA NA NA NA 28.64 NA NA NA 3.3 11.97 17.9 62.6 52.3 15 28.6 639 431.6 2710 143.9 10.9 3.3 1.7 9.41 16.7 47 49.9 17.7 35.5 325 345.78 1277.21 73.27 2.04 1.7 JAXW202-3027 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 30.78 NA NA NA NA NA 28.26 NA NA NA 6.22 8.92 15.6 40.1 45 17.5 38.9 524 1004.5 4757.7 414.3 38.6 5 1.16 9.93 17.1 43.7 44 17.2 39.1 414 493.35 585.1 72.38 7.66 1.62 JAXW202-3028 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 34.74 NA NA NA NA NA 27.9 NA NA NA 6.22 9.14 14.6 45.6 49.9 16 32 670 669.3 5222.9 307.3 20.5 0 0.68 12.39 19.3 60.3 48.7 15.6 32 208 151.44 494.84 18.84 11.36 3.4 JAXW202-3029 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 23.25 NA NA NA NA NA 19.75 NA NA NA 2.54 11.22 18.4 49.5 44.1 16.4 37.2 425 486.9 1928.1 115.1 9.9 0 1 10.53 15.1 45.1 42.8 14.3 33.5 349 63.2 905.6 20.3 9.1 1.9 JAXW202-3030 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 26.06 NA NA NA NA NA 22.99 NA NA NA 5.06 10.86 19.1 53.1 48.9 17.6 36 518 582.4 4283.3 192.3 2 0 0.9 9.78 15.5 45.6 46.6 15.8 34 297 54.18 817.83 21.78 4.5 1.71 JAXW202-3031 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 28.62 NA NA NA NA NA 24.68 NA NA NA 7.74 9.01 14.4 41.6 46.2 16 34.6 639 548.8 6968.3 216.7 3.9 3.1 2.16 10.01 14.2 44.9 44.9 14.2 31.6 593 266.76 1761.91 110.38 17.71 3.24 JAXW202-3032 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 22.44 NA NA NA NA NA 20.63 NA NA NA 6.42 8.67 14.6 46 53.1 16.8 31.7 629 932.8 5283.7 187.5 10.3 5.1 1.24 10.47 17.5 54 51.6 16.7 32.4 258 185.88 988.53 46.62 17.24 1.86 JAXW202-3033 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 22.33 NA NA NA NA NA 21.65 NA NA NA 5.1 10.03 13.9 53.6 53.4 13.9 25.9 975 514.1 4351.8 228 4.6 1.5 1.1 10.24 16 51.8 50.6 15.6 30.9 226 38.72 1038.18 18.04 4.18 0.88 JAXW202-3034 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 23.03 NA NA NA NA NA 20.99 NA NA NA 3.12 11.05 17.3 50.1 45.3 15.7 34.5 530 282.7 2699.1 129.5 1.9 6.9 0.78 13.7 17.6 59.6 43.5 12.8 29.5 297 46.41 702.86 27.38 0 3.35 JAXW202-3035 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 32.79 NA NA NA NA NA 27.72 NA NA NA 6 11.17 18.2 60.9 54.5 16.3 29.9 497 677.4 5043.6 272.4 5.4 1.8 1.58 9.96 16.3 52.4 52.6 16.4 31.1 445 181.07 1290.7 103.49 4.74 0 JAXW202-3036 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 24.53 NA NA NA NA NA 22.77 NA NA NA 8.4 8.2 13.6 37.6 45.9 16.6 36.2 702 809.8 7250 331.8 5.9 1.7 1.86 10.6 16.7 46.7 44.1 15.8 35.8 334 552.98 1093.49 188.42 20.09 5.21 JAXW202-3037 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 24.43 NA NA NA NA NA 24.69 NA NA NA 4.4 9.21 14.6 43.1 46.8 15.9 33.9 666 396.4 3887.4 110.4 4 1.8 1.46 11.97 18.3 54 45.1 15.3 33.9 277 153.3 1280.71 16.21 5.26 4.38 JAXW202-3038 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 21.64 NA NA NA NA NA 20.5 NA NA NA 8.12 9.8 14.5 43.5 44.4 14.8 33.3 659 570.8 7290.9 249.3 7.3 1.6 0.98 13.84 17.8 58.7 42.4 12.9 30.3 241 21.46 930.8 17.15 10.68 0 JAXW202-3039 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 22.92 NA NA NA NA NA 21.18 NA NA NA 4.2 11.5 18.9 53.8 46.8 16.4 35.1 430 866 3213 117.6 3.4 0 1.18 8.74 13.4 39.1 44.7 15.3 34.3 363 139.71 969.49 55.81 13.33 1.65 JAXW202-3040 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 18.56 NA NA NA NA NA 18.35 NA NA NA 3.42 8.82 14.7 36.6 41.5 16.7 40.2 569 566.4 2754.8 89.3 9.2 0 1.2 10.03 15.8 40.7 40.6 15.8 38.8 241 78.96 1089.84 26.88 2.64 1.68 JAXW202-3041 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 27.49 NA NA NA NA NA 27.44 NA NA NA 6.58 10.27 15.3 51.9 50.5 14.9 29.5 634 831.7 5464.7 276.4 6.6 0 1.54 10.45 16.4 51.5 49.3 15.7 31.8 311 118.43 1383.54 34.5 3.39 0 JAXW202-3042 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 29.01 NA NA NA NA NA 27.79 NA NA NA 12.68 8.93 14.8 41.9 46.9 16.6 35.3 650 1690.2 10532 440 16.5 1.3 1.36 12.56 19.8 57.8 46 15.8 34.3 142 251.33 984.93 72.35 36.04 15.37 JAXW202-3043 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 34.53 NA NA NA NA NA 28.81 NA NA NA 6.34 8.84 14.1 42.9 48.5 16 32.9 732 580.1 5577.9 176.9 5.1 0 1.98 11.85 16.6 56.5 47.7 14 29.4 439 653.2 1244.23 79 1.98 1.58 JAXW202-3044 Diversity Outbred Male Group 21 - Set A - Adriamycin Doxorubicin 2010-10-26 2010-12-28 NA 33.37 NA NA NA NA NA 27.95 NA NA NA 9.44 11.08 15.2 50.4 45.5 13.7 30.2 841 1224.4 7955.1 250.2 8.5 1.9 1.1 10.09 15.3 44.1 43.7 15.2 34.7 310 48.84 1010.57 21.34 13.75 5.61 JAXW202-3045 Diversity Outbred Male Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 34.6 NA NA NA NA NA 30.36 NA NA NA 7.12 9.61 15.3 48.4 50.4 15.9 31.6 748 771.81 6169.48 137.42 31.33 9.26 0.58 9.67 14.8 46.6 48.2 15.3 31.8 160 96.28 454.49 24.77 2.61 1.86 JAXW202-3046 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 22 NA 21.1 NA NA NA 20 NA NA NA NA 11.25 16.2 52.7 46.8 14.4 30.7 491 NA NA NA NA NA 11.98 8.46 15.9 41.5 49 18.8 38.3 499 1584.95 9901.47 489.98 3.59 0 JAXW202-3047 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 28.84 NA 27.18 NA NA NA 23.9 NA NA NA NA 8.02 11.6 34.4 42.9 14.5 33.7 415 NA NA NA NA NA 5.52 9.4 13.9 42.6 45.3 14.8 32.6 617 448.78 4744.44 324.58 2.21 0 JAXW202-3048 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 33.33 NA 31.16 NA NA NA 27.9 NA NA NA NA 10.11 15 43.3 42.8 14.8 34.6 263 NA NA NA NA NA 8.78 11.82 15.1 55.4 46.9 12.8 27.3 543 985.99 7410.32 370.52 11.41 1.76 JAXW202-3049 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 32.5 NA 31.32 NA NA NA 30.1 NA NA NA NA 9.22 12.9 44.5 48.3 14 29 301 NA NA NA NA NA 4.34 8.93 14.4 43.9 49.2 16.1 32.8 506 489.12 3684.23 166.66 0 0 JAXW202-3050 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 26.98 NA 26.09 NA NA NA 24.7 NA NA NA NA 10 13.9 40.8 40.8 13.9 34.1 412 NA NA NA NA NA 5.2 12.02 14.9 53.4 44.4 12.4 27.9 808 611.52 4407.52 178.36 2.08 0 JAXW202-3051 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 28.93 NA 27.13 NA NA NA 22.4 NA NA NA NA 7.03 10.2 32.2 45.8 14.5 31.7 432 NA NA NA NA NA 6.44 9.65 14.6 46.7 48.4 15.1 31.3 747 511.98 5752.85 168.73 3.86 3.22 JAXW202-3052 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 34.53 NA 33.14 NA NA NA 29.8 NA NA NA NA 10.1 13.4 44.1 43.7 13.3 30.4 587 NA NA NA NA NA 4.52 8.72 14 40 45.9 16.1 35 816 577.66 3777.82 161.36 1.81 1.81 JAXW202-3053 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 20.61 NA 20.43 NA NA NA 20.1 NA NA NA NA 9.39 12.7 40.1 42.7 13.5 31.7 368 NA NA NA NA NA 5.4 10.93 15.1 50.9 46.6 13.8 29.7 685 1110.24 4150.98 125.28 8.1 5.4 JAXW202-3054 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 20.95 NA 20.17 NA NA NA 18.8 NA NA NA NA 10.02 14.8 52.2 52.1 14.8 28.4 486 NA NA NA NA NA 9.42 10.16 15.9 55.3 54.4 15.6 28.8 660 1025.84 8078.59 296.73 15.07 3.77 JAXW202-3055 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 22.26 NA 21.89 NA NA NA 20.9 NA NA NA NA 10.07 13.6 46.4 46.1 13.5 29.3 458 NA NA NA NA NA 5.18 10.29 14.8 50.2 48.8 14.4 29.5 844 310.28 4734 135.2 0 0 JAXW202-3056 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 25.1 NA 25.71 NA NA NA 23.1 NA NA NA NA 10.2 14.4 47.1 46.2 14.1 30.6 309 NA NA NA NA NA 4.44 10.12 15.2 49.1 48.5 15 31 550 698.41 3636.8 102.56 1.78 0 JAXW202-3057 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 28.21 NA 29 NA NA NA 22.9 NA NA NA NA 10.84 15.4 47.9 44.2 14.2 32.2 377 NA NA NA NA NA 5.76 11.12 15.5 53.3 47.9 13.9 29.1 773 492.48 5150.59 99.07 14.4 3.46 JAXW202-3058 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 27.32 NA 28.1 NA NA NA 22.9 NA NA NA NA 10.53 14 42.1 40 13.3 33.3 487 NA NA NA NA NA 4.68 10.14 15.4 43.9 43.3 15.2 35.1 649 871.42 3663.5 141.34 3.28 0 JAXW202-3059 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 34.21 NA 34.61 NA NA NA 28.6 NA NA NA NA 9.22 14 44.8 48.6 15.2 31.3 393 NA NA NA NA NA 9.56 8.4 14.7 42.3 50.3 17.5 34.8 722 1278.17 7967.3 309.74 2.87 1.91 JAXW202-3060 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 23.59 NA 24.11 NA NA NA 20.4 NA NA NA NA 9.15 13.6 40 43.7 14.9 34 367 NA NA NA NA NA 10.5 9.48 14.7 43.9 46.3 15.5 33.5 642 1317.75 8731.8 417.9 32.55 0 JAXW202-3061 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 34.62 NA 34.99 NA NA NA 29.4 NA NA NA NA 8.39 13.4 35.2 42 16 38.1 188 NA NA NA NA NA 6.53 9.23 13.9 43.3 46.9 15.1 32.1 654 305.6 6076.82 143.66 4.57 0 JAXW202-3062 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 28.86 NA 28.17 NA NA NA 25.5 NA NA NA NA 9 12.4 45.5 50.6 13.8 27.3 468 NA NA NA NA NA 3.54 11.14 15.6 58.5 52.5 14 26.7 661 245.68 3210.07 81.07 1.42 1.77 JAXW202-3063 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 31.72 NA 30.78 NA NA NA 25.3 NA NA NA NA 11.18 14.1 48.6 43.5 12.6 29 401 NA NA NA NA NA 7.8 8.68 14.5 41.8 48.2 16.7 34.7 785 891.54 6605.82 291.72 10.92 0 JAXW202-3065 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 30.5 NA 30.44 NA NA NA 30.9 NA NA NA NA 10.96 13.8 42.4 38.7 12.6 32.5 553 NA NA NA NA NA 4.92 8.61 13 35.6 41.4 15.1 36.5 555 254.36 4468.84 188.44 7.38 0 JAXW202-3066 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 32.49 NA 32.76 NA NA NA 26.7 NA NA NA NA 8.87 11.3 37.7 42.5 12.7 30 482 NA NA NA NA NA 5.4 9.32 14 43 46.1 15 32.6 713 534.06 4700.7 146.88 14.58 3.78 JAXW202-3067 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 29.81 NA 30 NA NA NA 27.6 NA NA NA NA 10.25 14.3 37.5 36.6 14 38.1 412 NA NA NA NA NA 4.42 10.97 15 43.3 39.5 13.7 34.6 596 709.41 3596.55 112.27 0 1.77 JAXW202-3070 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 30.65 NA 30.25 NA NA NA 26 NA NA NA NA 9.92 13.7 43.1 43.4 13.8 31.8 544 NA NA NA NA NA 2.6 9.98 14.7 47.8 47.9 14.7 30.8 696 338 2170.48 86.58 3.12 1.82 JAXW202-3071 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 28.31 NA 28.35 NA NA NA 23.2 NA NA NA NA 9 13.6 33.6 37.3 15.1 40.5 437 NA NA NA NA NA 6.4 10.69 14.1 43.3 40.5 13.2 32.6 666 730.88 5398.4 246.4 21.12 3.2 JAXW202-3072 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 25.85 NA 26.1 NA NA NA 24 NA NA NA NA 9.39 12.2 35.6 37.9 13 34.3 612 NA NA NA NA NA 9.48 10.13 13.9 41.3 40.8 13.7 33.7 738 571.64 8642.92 242.69 14.22 8.53 JAXW202-3073 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 24.48 NA 24.12 NA NA NA 21.7 NA NA NA NA 9.7 14.1 47.2 48.7 14.5 29.9 596 NA NA NA NA NA 9.5 8.51 14.6 43.4 51 17.2 33.6 608 945.25 8209.9 335.35 8.55 1.9 JAXW202-3074 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 37.92 NA 37.86 NA NA NA 29.4 NA NA NA NA 9.94 14.5 42.2 42.5 14.6 34.4 312 NA NA NA NA NA 5.84 9.89 14.8 46 46.5 15 32.2 640 544.29 5111.17 177.54 5.26 1.75 JAXW202-3075 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 33.29 NA 34.18 NA NA NA 27.9 NA NA NA NA 8.98 13.1 40.2 44.8 14.6 32.6 459 NA NA NA NA NA 7.46 9.85 14.7 47.5 48.2 14.9 30.9 550 713.18 6580.47 146.96 16.41 3.73 JAXW202-3076 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 23.99 NA 24.37 NA NA NA 20.4 NA NA NA NA 8.29 12.6 35.8 43.2 15.2 35.2 535 NA NA NA NA NA 6.4 9.97 15 46.5 46.6 15 32.3 762 591.36 5471.36 327.04 10.24 0 JAXW202-3077 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 26.65 NA 27.16 NA NA NA 21.7 NA NA NA NA 8.74 13 32.9 37.6 14.9 39.5 379 NA NA NA NA NA 4.52 9.39 14.3 39.3 41.8 15.2 36.4 540 364.76 4040.43 101.7 11.3 1.81 JAXW202-3078 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 34.57 NA 33.68 NA NA NA 30.4 NA NA NA NA 7.74 11.2 29.5 38.1 14.5 38 NA NA NA NA NA NA 5.34 11.06 13.8 47.2 42.7 12.5 29.2 823 472.06 4704.01 155.93 8.54 0 JAXW202-3079 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 36.68 NA 37.21 NA NA NA 31.9 NA NA NA NA 9.22 13.4 41 44.5 14.5 32.7 706 NA NA NA NA NA 6.46 8.95 14.8 43.7 48.8 16.5 33.9 780 849.49 5327.56 258.4 15.5 8.4 JAXW202-3080 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 33.38 NA 32.87 NA NA NA 30.3 NA NA NA NA 9.93 15.4 53.1 53.5 15.5 29 462 NA NA NA NA NA 8.48 9.65 15.5 53.4 55.3 16.1 29 834 1194.83 6776.37 461.31 40.7 5.94 JAXW202-3081 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 27.89 NA 26.24 NA NA NA 23.6 NA NA NA NA 10.19 13.9 41.9 41.1 13.6 33.2 241 NA NA NA NA NA 10.64 10.75 15.9 48.8 45.4 14.8 32.6 636 2036.5 8197.06 369.21 37.24 0 JAXW202-3082 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 28.74 NA 28.57 NA NA NA 24.1 NA NA NA NA 9.85 12.7 42.3 42.9 12.9 30 602 NA NA NA NA NA 8.6 8.68 13.1 39.9 46 15.1 32.8 637 1123.16 7058.02 409.36 9.46 0 JAXW202-3083 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 25.76 NA 26.11 NA NA NA 25.3 NA NA NA NA 8.09 10.9 30.2 37.3 13.5 36.1 NA NA NA NA NA NA 6.56 9.66 14.5 41.6 43.1 15 34.9 473 1943.07 4409.63 188.27 18.37 0 JAXW202-3084 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 29.08 NA 29.52 NA NA NA 24.9 NA NA NA NA 9.98 12.7 37.4 37.5 12.7 34 491 NA NA NA NA NA 5.08 8.59 13.9 36 41.9 16.2 38.6 552 975.36 3892.8 193.04 16.76 1.52 JAXW202-3085 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 38.03 NA 37.99 NA NA NA 31.5 NA NA NA NA 11.03 13.8 47.8 43.3 12.5 28.9 702 NA NA NA NA NA 6.92 9.72 14.4 45 46.3 14.8 32 753 729.37 5951.2 226.28 9.69 3.46 JAXW202-3086 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 26.69 NA 25.84 NA NA NA 23.3 NA NA NA NA 8.41 12.1 43.4 51.6 14.4 27.9 202 NA NA NA NA NA 5.66 9.15 14 50.9 55.6 15.3 27.5 557 626.56 4821.75 201.5 7.36 2.83 JAXW202-3087 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 31.48 NA 30.71 NA NA NA 28.4 NA NA NA NA 8.99 11.4 37.3 41.5 12.7 30.6 432 NA NA NA NA NA 7.44 9.88 14.5 45.1 45.6 14.7 32.2 646 839.98 6321.77 265.61 8.93 3.72 JAXW202-3088 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 26.82 NA 25.24 NA NA NA 22.7 NA NA NA NA 9.88 13.3 41.2 41.7 13.5 32.3 300 NA NA NA NA NA 6.02 9.76 14.9 45.4 46.5 15.3 32.8 605 798.25 5037.54 156.52 24.68 3.61 JAXW202-3089 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 20.8 NA NA NA NA NA 20.38 NA NA NA 3.72 8.97 15 45.2 50.4 16.7 33.2 651 714.24 2871.1 125.36 7.81 1.86 1.78 7.76 13.5 38.6 49.7 17.4 35 518 356.71 1320.94 91.85 7.12 3.38 JAXW202-3090 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 27.1 NA NA NA NA NA 23.96 NA NA NA 2.26 8.96 13.9 41.9 46.8 15.5 33.2 460 392.11 1770.71 78.87 18.08 0 1.14 10.53 13.6 48.3 45.9 12.9 28.2 300 156.64 931.49 38.65 8.55 4.67 JAXW202-3091 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 26 NA NA NA NA NA 24.02 NA NA NA 3.48 9.7 14.8 50.4 52 15.3 29.4 637 645.89 2760.34 57.77 11.48 4.18 1.22 7.52 13.2 37.3 49.6 17.6 35.4 214 366.24 758.6 86.74 8.42 0 JAXW202-3092 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 20.4 NA NA NA NA NA 20.75 NA NA NA 3.3 8.99 13.7 41 45.6 15.2 33.4 508 283.14 2870.01 121.44 17.16 7.92 1.42 8.47 12.3 41.2 48.6 14.5 29.9 595 203.2 1152.9 62.34 1.7 0 JAXW202-3093 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 20.1 NA NA NA NA NA 18.45 NA NA NA 3.7 10.31 14.1 52.7 51.1 13.7 26.8 607 450.29 3109.85 138.38 1.48 0 1.32 9.25 13.4 47.5 51.3 14.5 28.2 303 85.67 1216.38 16.24 1.72 0 JAXW202-3094 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 26.1 NA NA NA NA NA 21.63 NA NA NA 5.02 9.72 14.8 51.8 53.3 15.2 28.6 555 431.22 4392.5 170.68 20.58 5.02 0.92 8.5 12.4 39.1 46 14.6 31.7 362 182.07 691.38 38.55 8 0 JAXW202-3095 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 32.2 NA NA NA NA NA 29.46 NA NA NA 2.5 9.55 14.4 45.2 47.3 15.1 31.9 560 380.5 2002.75 80.5 29 7.25 2.02 6.66 13.7 33.2 49.8 20.6 41.3 289 454.7 1373.2 187.05 5.05 0 JAXW202-3096 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 25.8 NA NA NA NA NA 23.83 NA NA NA 4.84 8.69 13.6 44.9 51.7 15.7 30.3 585 186.82 4469.74 173.27 7.26 3.39 2.02 8.43 13.4 42.5 50.4 15.9 31.5 318 442.58 1344.51 213.51 14.14 4.85 JAXW202-3097 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 25.2 NA NA NA NA NA 24.67 NA NA NA 4.18 9.76 16.4 51.2 52.5 16.8 32 743 453.53 3610.68 101.99 11.7 1.67 2.78 9.4 14.2 47.8 50.8 15.1 29.7 804 478.72 1971.58 308.3 14.46 6.95 JAXW202-3098 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 26.4 NA NA NA NA NA 24.29 NA NA NA 6.2 9.21 14.7 49.1 53.3 16 29.9 748 1269.14 4718.82 195.3 7.44 8.68 1.6 8.02 12.9 40.8 50.9 16.1 31.6 490 241.92 1325.12 31.2 1.92 0 JAXW202-3099 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 24 NA NA NA NA NA 19.3 NA NA NA 5.36 10.51 14.8 51.6 49.1 14.1 28.7 558 254.6 4979.98 112.56 9.11 3.22 1.1 9.45 13.4 42.2 44.7 14.2 31.8 241 36.63 1032.57 25.74 3.3 1.76 JAXW202-3100 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 24.3 NA NA NA NA NA 22.15 NA NA NA 4.06 9.04 14 37.1 41 15.5 37.7 510 321.55 3535.45 197.72 3.65 1.62 0.9 8.93 12.6 36 40.3 14.1 35 488 77.85 811.62 7.29 0 3.42 JAXW202-3101 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 23.1 NA NA NA NA NA 20.52 NA NA NA 6.5 8.37 15.1 36.7 43.9 18 41.1 455 596.05 5704.4 193.05 4.55 1.95 2.56 10.24 14.6 43.6 42.6 14.3 33.5 501 851.2 1582.85 123.9 0 1.79 JAXW202-3102 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 24.1 NA NA NA NA NA 25.88 NA NA NA 3.8 9.72 14.6 43.8 45.1 15 33.3 612 563.16 3031.26 179.74 23.94 1.9 2.06 8.75 13.2 38.4 43.9 15.1 34.4 706 343.81 1556.12 141.52 13.6 4.94 JAXW202-3103 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 30 NA NA NA NA NA 16.92 NA NA NA 4 9.12 15 43.3 47.5 16.4 34.6 499 377.6 3523.2 94 5.2 0 0.7 8.48 14.5 38.7 45.6 17.1 37.5 147 173.53 478.59 41.51 6.37 0 JAXW202-3104 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 20.7 NA NA NA NA NA 26.81 NA NA NA 3.88 9.24 14.8 42.4 45.9 16 34.9 629 278.2 3469.11 107.48 25.22 0 1.58 8.52 12.8 38.1 44.7 15 33.6 569 166.53 1384.71 25.44 1.74 1.74 JAXW202-3105 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 26.3 NA NA NA NA NA 17.9 NA NA NA 5.96 10.25 14.7 44.7 43.6 14.3 32.9 440 353.43 5288.9 286.68 25.63 5.36 0.84 9.46 13.3 40.3 42.6 14.1 33 304 65.6 753.98 20.41 0 0 JAXW202-3106 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 21.1 NA NA NA NA NA 23.07 NA NA NA 4.12 9.26 14.4 41 44.3 15.6 35.1 568 746.96 3180.23 173.86 13.18 5.36 1.12 9.35 13 40.6 43.4 13.9 32 359 210.11 838.88 57.68 11.54 1.68 JAXW202-3107 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 26.1 NA NA NA NA NA 15.13 NA NA NA 6.22 8.56 12.6 42.7 49.9 14.7 29.5 407 455.93 5407.05 351.43 4.98 0 1.28 9.49 14.1 45.6 48.1 14.9 30.9 325 157.18 1088.9 29.06 4.86 0 JAXW202-3108 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 17.6 NA NA NA NA NA 19.67 NA NA NA 4.82 9.77 14.9 43.2 44.2 15.3 34.5 576 552.85 3985.66 244.37 33.74 3.37 2.2 8.33 12.5 35.7 42.8 15 35 651 319.88 1706.1 167.86 6.16 0 JAXW202-3109 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 19.8 NA NA NA NA NA 18.86 NA NA NA 4.42 9.17 15.3 40.2 43.8 16.7 38.1 530 335.48 3900.65 173.71 6.63 3.54 1.22 9.37 13.2 39.8 42.5 14.1 33.2 515 91.99 1101.17 25.13 1.71 0 JAXW202-3110 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 19.7 NA NA NA NA NA 25.34 NA NA NA 4.16 9.44 15.4 51.6 54.7 16.3 29.8 673 543.3 3503.97 91.52 21.63 0 1.1 9.81 14.4 52.2 53.2 14.7 27.6 493 93.17 983.95 16.17 1.65 5.17 JAXW202-3111 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 27.7 NA NA NA NA NA 20.71 NA NA NA 12.64 9.56 15.5 44.9 47 16.2 34.5 548 1006.14 11239.49 352.66 39.18 1.26 2.46 10.25 14.5 46.7 45.6 14.1 31 550 61.99 2346.35 48.22 3.2 0 JAXW202-3112 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 25 NA NA NA NA NA 20.02 NA NA NA 6.18 9.74 15.3 44.2 45.4 15.7 34.6 527 833.68 5044.12 275.01 24.72 3.71 0.62 8.31 12.6 36.4 43.8 15.2 34.6 227 110.98 448.82 30.88 27.34 2.05 JAXW202-3113 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 21.1 NA NA NA NA NA 19.31 NA NA NA 5.76 9.99 15.1 49.3 49.3 15.1 30.6 557 786.24 4814.78 153.79 3.46 1.73 3.18 8.16 12.6 38.5 47.2 15.4 32.7 856 380.01 2544.64 237.23 18.44 0 JAXW202-3114 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 18.9 NA NA NA NA NA 16.74 NA NA NA 8.36 9.69 14.5 37.8 39 15 38.4 579 735.68 7221.37 395.43 8.36 0 1.54 10.77 14.7 41.2 38.3 13.6 35.7 859 338.65 1044.74 130.44 20.94 5.39 JAXW202-3115 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 22.1 NA NA NA NA NA 17.92 NA NA NA 4.7 9.42 14 44.5 47.2 14.9 31.5 489 657.53 3866.69 175.31 0 0 0.98 9.09 16.2 41.2 45.3 17.8 39.3 453 285.57 617.79 41.26 35.28 0 JAXW202-3116 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 21.9 NA NA NA NA NA 18.95 NA NA NA 7.02 9.35 14.7 42.4 45.4 15.7 34.7 500 577.75 6121.44 291.33 23.87 4.91 1.52 9.74 14.1 43.5 44.7 14.5 32.4 392 193.5 1296.41 21.43 2.43 6.08 JAXW202-3117 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 26.3 NA NA NA NA NA 23.8 NA NA NA 5.76 9.46 14.8 46.9 49.6 15.6 31.6 635 902.02 4583.81 254.02 14.98 4.61 1.84 8.21 12.8 39.7 48.4 15.6 32.2 524 212.34 1567.86 46 10.67 3.31 JAXW202-3118 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 22.3 NA NA NA NA NA 20.33 NA NA NA 9.24 9.89 14.7 50.5 51.1 14.9 29.1 526 464.77 8358.5 409.33 2.77 5.54 1.62 10.93 13.9 54.4 49.8 12.7 25.6 387 92.66 1498.82 26.89 1.62 0 JAXW202-3119 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 23.8 NA NA NA NA NA 19.83 NA NA NA 6.52 9.75 14.9 40.7 41.7 15.3 36.6 520 685.9 5658.71 163 11.08 1.96 1.32 10.34 13.4 42.7 41.3 13 31.4 534 210.41 1035.28 72.73 0 1.72 JAXW202-3120 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 26.1 NA NA NA NA NA 23.36 NA NA NA 4.9 9.35 14.7 42.3 45.2 15.7 34.8 469 486.57 4163.53 222.95 24.01 3.43 1.42 7.64 13.1 34.5 45.2 17.1 38 421 282.58 1056.48 55.66 13.49 11.93 JAXW202-3121 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 22.3 NA NA NA NA NA 19.99 NA NA NA 7.64 9.4 14.8 44.7 47.6 15.7 33.1 518 685.31 6703.34 229.96 14.52 6.11 2.76 8.6 12.9 39.6 46.1 15 32.6 458 261.1 2445.08 49.4 4.42 0 JAXW202-3122 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 20.8 NA NA NA NA NA 18.76 NA NA NA 5.98 9.48 15.4 47.9 50.5 16.2 32.2 715 697.27 4960.41 286.44 29.3 6.58 1.16 8.26 13.8 40 48.4 16.7 34.5 801 210.89 878.35 63.34 5.57 1.74 JAXW202-3123 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 22.3 NA NA NA NA NA 21.31 NA NA NA 3.68 10.38 14 44.6 43 13.5 31.4 440 345.92 3117.7 201.66 9.2 5.15 1.3 8.74 12.6 36.6 41.9 14.4 34.4 387 75.53 1190.02 31.07 1.69 1.69 JAXW202-3124 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 24.6 NA NA NA NA NA 20.78 NA NA NA 5.44 9.43 15.4 49.3 52.3 16.3 31.2 561 529.86 4746.94 143.62 17.95 1.63 0.78 8.96 14.7 44.8 50 16.4 32.8 437 59.67 704.81 15.52 0 0 JAXW202-3125 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 20.5 NA NA NA NA NA 19.5 NA NA NA 7.4 9.51 14 43.7 46 14.7 32 533 524.66 6595.62 267.88 11.84 0 1.02 7.32 11.6 32.9 44.9 15.8 35.3 240 21.52 964.92 31.93 0 1.73 JAXW202-3126 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 27.2 NA NA NA NA NA 22.7 NA NA NA 12.64 10.66 15.2 51.4 48.2 14.3 29.6 528 661.07 11619.95 341.28 15.17 1.26 0.42 9.04 12.6 41.4 45.8 13.9 30.4 266 49.85 363.26 4.79 2.06 0 JAXW202-3127 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 19.6 NA NA NA NA NA 19.84 NA NA NA 4.68 10.06 14.4 47.7 47.4 14.3 30.2 609 446.47 4065.98 145.08 20.12 2.34 1.94 8.7 11.3 39.2 45.1 13 28.8 610 72.94 1838.54 23.47 5.04 0 JAXW202-3128 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 20.3 NA NA NA NA NA 19.65 NA NA NA 7.84 10.5 14.9 45 42.9 14.2 33.1 564 1439.42 5943.5 429.63 26.66 1.57 0.98 9.78 13.7 40.7 41.6 14 33.7 240 199.82 678.06 97.12 5 0 JAXW202-3129 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 22.9 NA NA NA NA NA 20.84 NA NA NA 5.9 10.71 16.2 53.8 50.2 15.1 30.1 494 738.68 4740.65 410.05 10.03 1.18 1.14 7.16 11.4 34.4 48.1 15.9 33.1 254 133.27 963.3 36.37 7.18 0 JAXW202-3130 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 18.7 NA NA NA NA NA 14.18 NA NA NA 11.64 10.44 14.4 46.9 44.9 13.8 30.7 669 1086.01 9906.8 618.08 20.95 9.31 1.16 9.81 15.1 43.1 43.9 15.4 35 461 47.91 1079.15 32.94 0 0 JAXW202-3131 Diversity Outbred Female Group 21 - Set B - Adriamycin Doxorubicin 2010-10-26 2010-12-29 NA 23.1 NA NA NA NA NA 22.53 NA NA NA 4.46 10.17 15.7 51.4 50.5 15.4 30.5 671 382.67 3712.95 336.73 22.3 5.79 1.34 8.53 10.1 41.2 48.3 11.8 24.5 631 72.09 1219.94 46.23 1.74 0 JAXW202-3132 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 28.29 NA NA NA NA NA 23.14 NA NA NA 7.26 10.89 14.6 54.5 50 13.4 26.8 1331 876.28 6130.34 249.02 3.63 0 0.88 9.47 12.8 44.9 47.4 13.5 28.5 341 212.43 644.6 4.66 11.09 7.22 JAXW202-3133 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 21.99 NA NA NA NA NA 19.29 NA NA NA 8.16 10.16 14.6 45.5 44.8 14.4 32.1 594 571.2 7275.46 296.21 16.32 1.63 1.04 8.69 11.3 36.7 42.2 13 30.8 152 63.23 927.26 25.06 12.9 11.65 JAXW202-3134 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 18.74 NA NA NA NA NA 16.56 NA NA NA 6.62 9.68 15 49.3 50.9 15.5 30.4 678 729.52 5790.51 97.98 0 1.99 2.04 8.71 12 41.8 48 13.8 28.7 492 397.8 1540.61 67.32 30.4 3.67 JAXW202-3135 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 21.93 NA NA NA NA NA 18.85 NA NA NA 5.68 10.23 14.1 47.3 46.2 13.8 29.8 593 597.54 4955.8 103.94 14.77 6.82 1.42 8.68 10.9 37 42.6 12.6 29.5 292 212.43 1123.36 43.45 40.75 0 JAXW202-3136 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 22.19 NA NA NA NA NA 21.59 NA NA NA 4.1 9.39 14.3 42.6 45.4 15.2 33.6 854 480.93 3535.02 82.41 1.64 0 3.68 8.53 10.9 35.4 41.5 12.8 30.8 814 1509.17 2052.34 103.41 15.09 0 JAXW202-3137 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 20.55 NA NA NA NA NA 20.51 NA NA NA 5.7 9.52 13 41.2 43.3 13.7 31.6 670 429.78 4973.25 295.83 1.71 0 6.08 7.5 9.8 29.4 39.2 13.1 33.3 584 3177.41 2754.24 79.65 58.37 9.73 JAXW202-3138 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 23.65 NA NA NA NA NA 19.57 NA NA NA 2.86 8.73 15.7 42.6 48.8 18 36.9 810 423.85 2307.45 125.27 3.43 0 6.46 9.9 16.3 44.1 44.5 16.5 37 322 4742.93 1361.77 184.11 158.92 12.27 JAXW202-3139 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 27.19 NA NA NA NA NA 23.93 NA NA NA 5.84 7.99 13 36.4 45.6 16.3 35.7 631 370.26 5187.67 276.82 1.75 3.5 4.96 8.79 11.8 36 41 13.4 32.8 550 2973.52 1841.15 97.22 43.15 4.96 JAXW202-3140 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 21.78 NA NA NA NA NA 18.77 NA NA NA 7.14 8.65 14.5 39.1 45.2 16.8 37.1 967 537.64 6236.08 352 10 3.57 7.48 9.15 13.3 37.2 40.7 14.5 35.8 356 4387.02 2758.62 246.84 74.8 12.72 JAXW202-3141 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 20.87 NA NA NA NA NA 21.71 NA NA NA 12.64 8.87 15.5 47 53 17.5 33 815 1295.6 10721.25 585.23 35.39 3.79 4.16 9.82 13 48.2 49.1 13.2 27 543 415.17 3647.9 68.64 28.29 0 JAXW202-3142 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 22.29 NA NA NA NA NA 18.73 NA NA NA 5.52 8.72 15.6 44 50.5 17.9 35.5 660 440.5 4752.17 296.98 23.74 6.62 20.74 8.64 13.1 38.4 44.4 15.2 34.1 466 17033.76 2988.63 365.02 282.06 68.44 JAXW202-3143 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 22.38 NA NA NA NA NA 20.27 NA NA NA 2.54 10.2 13.2 48.3 47.4 12.9 27.3 719 332.49 2049.02 135.64 20.57 1.78 8.46 8.36 10 36.4 43.5 12 27.5 517 6135.19 1917.04 354.47 51.61 1.69 JAXW202-3144 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 25.39 NA NA NA NA NA 17.97 NA NA NA 10.26 10.72 14 53.2 49.6 13.1 26.3 568 1310.2 8558.89 386.8 4.1 0 7.62 9.14 11.7 40.2 44 12.8 29.1 316 5628.89 1657.35 277.37 56.39 0 JAXW202-3145 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 24.08 NA NA NA NA NA 20.37 NA NA NA 2.66 8.2 13.4 36.1 44 16.3 37.1 456 380.38 2072.94 199.23 7.71 0 40.36 8.16 11.2 30.7 37.6 13.7 36.5 367 36614.59 1981.68 770.88 795.09 197.76 JAXW202-3147 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 28.44 NA NA NA NA NA 23.57 NA NA NA 1.98 8.42 14.4 38.5 45.7 17.1 37.4 591 239.98 1593.31 143.35 3.56 0 5.94 8.57 14.5 34.2 39.9 16.9 42.4 419 4039.79 1742.2 123.55 20.79 13.66 JAXW202-3148 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 26.69 NA NA NA NA NA 23.19 NA NA NA 7 7.74 15 34.4 44.4 19.4 43.6 388 717.5 5783.4 473.9 25.9 0 2.36 10.54 16.4 43.1 40.9 15.6 38.1 362 380.43 1876.91 62.3 38.7 1.65 JAXW202-3149 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 26.48 NA NA NA NA NA 22.38 NA NA NA 2.9 10.53 14.2 44.9 42.6 13.5 31.6 574 212.57 2401.78 247.08 24.36 14.5 NA 8.55 12.7 32.6 38.1 14.9 39 290 78689.28 2402.08 826.25 2788.79 477.01 JAXW202-3150 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 27.94 NA NA NA NA NA 23.01 NA NA NA 6.82 8.59 13.2 38.2 44.5 15.4 34.6 467 510.82 5687.2 599.48 9.55 12.28 2.12 9.66 15.6 43 44.5 16.1 36.3 252 621.8 1421.04 33.5 40.28 3.6 JAXW202-3151 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 24.73 NA NA NA NA NA 19.7 NA NA NA 4.6 NA NA NA NA NA NA 394 499.1 3834.56 254.38 3.22 8.74 0.58 NA NA NA 36.8 12.8 34.9 NA 62.23 486.97 6.15 19.66 4.93 JAXW202-3152 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 26.73 NA NA NA NA NA 20.75 NA NA NA 4.06 8.64 15.2 43 49.8 17.6 35.3 653 550.54 3270.33 202.59 27.61 8.93 0.56 7.79 13.8 37.3 47.9 17.7 37 253 106.29 420.11 5.15 19.99 8.46 JAXW202-3153 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 21.17 NA NA NA NA NA 17.38 NA NA NA 6.46 8.93 14.2 46.6 52.2 15.9 30.5 556 327.52 5890.23 235.79 3.23 3.23 1.88 8.95 15.5 37.3 41.7 17.3 41.6 321 165.25 1644.62 38.16 32.15 0 JAXW202-3154 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 21.48 NA NA NA NA NA 17.6 NA NA NA 7.16 9.6 15.1 44.9 46.8 15.7 33.6 467 730.32 6000.08 413.85 12.17 3.58 27.38 10.4 15.7 42 40.4 15.1 37.4 390 19335.76 6998.33 654.38 317.61 71.19 JAXW202-3155 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 19.45 NA NA NA NA NA 17.53 NA NA NA 3.94 9.03 13.7 37.7 41.7 15.2 36.3 458 296.68 3380.91 254.52 7.88 0 2.68 8.7 12.2 32.3 37.1 14 37.8 397 1502.14 1072.27 97.82 7.77 0 JAXW202-3156 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 28.28 NA NA NA NA NA 24.71 NA NA NA 10.7 8.22 12.1 36.2 44 14.7 33.4 813 781.1 9444.89 468.66 6.42 0 8.7 8.16 12.2 32.8 40.2 15 37.2 698 4017.66 4309.11 321.03 49.59 1.74 JAXW202-3157 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 35.2 NA NA NA NA NA 26.39 NA NA NA 7.66 9.39 13.6 43.7 46.5 14.5 31.1 590 562.24 6605.22 481.81 9.96 0 1.76 11.8 16.6 49.4 41.9 14.1 33.6 361 836.18 739.38 137.46 43.82 3.34 JAXW202-3158 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 25.77 NA NA NA NA NA 23.83 NA NA NA 4.86 9.03 13.5 41.4 45.8 15 32.6 807 654.64 3757.27 394.63 52.49 1.94 2.06 9.92 14 41.9 42.2 14.1 33.4 570 262.65 1729.58 48.62 15.66 3.5 JAXW202-3159 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 21.47 NA NA NA NA NA 21.83 NA NA NA 7.36 8.69 15.1 46.1 53 17.4 32.8 637 918.53 6015.33 405.54 18.4 1.47 2.62 8.12 14.6 40 49.3 18 36.5 376 778.93 1718.72 74.93 46.11 1.83 JAXW202-3160 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 21.56 NA NA NA NA NA 18.07 NA NA NA 5.7 9.59 14 46 48 14.6 30.4 547 1935.15 3161.79 572.85 28.5 1.71 8.04 8.41 14.3 36.1 42.9 17 39.6 323 4556.27 3210.37 157.58 91.66 24.12 JAXW202-3161 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 28.51 NA NA NA NA NA 23.43 NA NA NA 2.78 8.67 14.7 43.4 50.1 17 33.9 594 320.81 2249.3 197.1 11.12 1.67 1.16 10.07 16.2 47.4 47.1 16.1 34.2 445 629.65 459.71 36.77 23.43 10.32 JAXW202-3162 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 14.89 NA NA NA NA NA 14.27 NA NA NA 3.84 9.02 13.6 38.3 42.5 15.1 35.5 529 241.54 3323.9 272.64 1.92 0 0.72 9.79 13.5 37.3 38.1 13.8 36.2 307 110.09 545.76 44.78 17.42 1.8 JAXW202-3163 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 19.57 NA NA NA NA NA 16.88 NA NA NA 3.96 9.97 13.9 50.8 51 13.9 27.4 702 574.2 3018.71 363.92 3.56 0 10.54 8.86 15 41.3 46.6 16.9 36.3 375 7598.29 2481.12 266.66 170.75 23.19 JAXW202-3164 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 18.03 NA NA NA NA NA 18.02 NA NA NA 4.74 8 13.9 40.1 50.1 17.4 34.7 455 440.82 4100.1 195.29 1.9 1.9 0.74 8.12 12.3 38.1 46.9 15.1 32.3 323 156.66 517.04 33.52 26.05 6.66 JAXW202-3165 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 21.17 NA NA NA NA NA 19.59 NA NA NA 5.92 8.65 13.3 43 49.7 15.4 30.9 431 297.78 5382.46 231.47 8.88 0 26.88 10.27 14 43.2 42.1 13.6 32.4 377 19611.65 6553.34 462.34 220.42 29.57 JAXW202-3166 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 19.83 NA NA NA NA NA 18.67 NA NA NA 5.96 9.66 13.6 48.4 50.1 14.1 28.1 538 336.14 5446.84 171.65 4.17 1.79 2.84 8.12 13.7 36.2 44.6 16.9 37.8 191 563.74 2141.93 82.36 45.72 6.25 JAXW202-3167 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 22.41 NA NA NA NA NA 20.18 NA NA NA 6.54 9.41 13.6 43.9 46.7 14.5 31 438 599.06 5493.6 431.64 10.46 4.58 1.4 8.88 14.2 37.1 41.8 16 38.3 359 179.62 1143.24 45.5 31.78 0 JAXW202-3168 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 21.35 NA NA NA NA NA 19.72 NA NA NA 5.72 7.39 13.8 37.4 50.6 18.7 36.9 493 477.62 5063.34 174.46 4.58 0 7.78 7.93 13.8 37.3 47 17.4 37 241 4661.78 2894.16 165.71 52.13 6.22 JAXW202-3169 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 21.73 NA NA NA NA NA 19.09 NA NA NA 4.74 9.89 15.1 49.5 50.1 15.3 30.5 474 374.93 4220.97 130.35 8.06 5.21 1.48 10.33 15.7 49 47.4 15.2 32 322 74.15 1358.79 39.37 7.84 0 JAXW202-3170 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 20.44 NA NA NA NA NA 19.13 NA NA NA 4.1 10.52 15.4 53.1 50.5 14.6 29 735 574.41 3316.08 205.82 3.69 0 1.38 8.25 13 32.4 39.3 15.8 40.1 279 331.75 999.81 40.43 6.35 1.66 JAXW202-3171 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 22.08 NA NA NA NA NA 19.16 NA NA NA 9.46 10.55 15.9 57.8 NA 15.1 27.5 671 715.18 8406.16 334.88 3.78 0 2.34 10.38 15.6 52.4 50.5 15 29.8 363 292.73 1998.13 12.17 33.7 3.28 JAXW202-3172 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 21.59 NA NA NA NA NA 18.11 NA NA NA 8.6 8.38 14.1 40.7 48.6 16.8 34.6 387 666.5 7561.98 353.46 13.76 5.16 1.74 8.62 14.5 38.2 44.3 16.8 38 305 224.81 1452.73 52.72 7.83 1.74 JAXW202-3173 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 20.9 NA NA NA NA NA 22.45 NA NA NA 5.48 8.72 14.8 41.9 48.1 17 35.3 686 381.96 4782.4 310.72 5.48 0 1.02 9.48 15.8 40 42.2 16.7 39.5 340 190.84 773.57 48.04 7.55 0 JAXW202-3174 Diversity Outbred Female Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 23.26 NA NA NA NA NA 18.83 NA NA NA 8.88 9.94 14.4 50.3 50.6 14.5 28.6 670 906.65 7431.67 530.14 10.66 0 2.7 9.59 15.1 44.2 46.1 15.7 34.2 441 1355.13 1267.11 54.54 13.5 9.72 JAXW202-3175 Diversity Outbred Male Group 25 - set D - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-06 NA 33.15 NA NA NA NA NA 24.71 NA NA NA 8.46 7.73 13.7 34.9 45.1 17.7 39.3 558 1444.12 6498.13 459.38 52.45 6.77 0.86 10.63 16.4 42.9 40.4 15.4 38.2 260 71.9 732.12 41.62 6.79 7.57 JAXW202-3176 Diversity Outbred Male Group 25 - set C - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-10-26 2011-01-05 NA 31.75 NA 32 NA NA NA 25.8 NA NA NA NA 10.2 14.3 46.9 46 14 30.5 520 NA NA NA NA NA 8 9.69 14.4 47.5 49 14.9 30.3 689 619.2 7217.6 156.8 4.8 1.6 JAXW202-3177 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 23.43 NA NA NA NA NA 23.73 NA NA NA 8.86 11.44 16.9 66.6 58.2 14.8 25.4 845 2582.69 5731.53 497.93 40.76 8.86 3.68 8.88 13.2 51.1 57.5 14.9 25.8 442 1628.03 1569.15 116.66 333.78 32.38 JAXW202-3178 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 26.1 NA NA NA NA NA 22.28 NA NA NA 6.32 10.28 15.6 57.4 55.8 15.2 27.2 803 757.14 5447.84 91.64 17.06 6.95 12.98 9.42 15.4 51.4 54.6 16.3 30 397 9875.18 1726.34 175.23 1166.9 37.64 JAXW202-3179 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 33.31 NA NA NA NA NA 28.65 NA NA NA 6.14 10.94 15.4 51.2 46.8 14.1 30.1 837 817.23 5136.72 178.06 8.6 0 0.8 11.24 16.4 51.7 46 14.6 31.7 306 193.6 521.36 38.08 38.88 8.16 JAXW202-3180 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 31.33 NA NA NA NA NA 25.61 NA NA NA 7.14 10.09 14.9 46.4 46 14.8 32.1 922 1147.4 5821.24 152.08 19.99 0 1.28 10.37 15.6 47.3 45.6 15 33 258 311.04 859.39 35.33 72.32 1.79 JAXW202-3181 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 26.11 NA NA NA NA NA 21.72 NA NA NA 8.64 9.62 15.4 50.7 52.7 16 30.4 1008 1275.26 7119.36 216 25.92 3.46 1.76 10.07 16.3 52.6 52.2 16.2 31 509 341.97 1309.79 72.86 29.39 6.16 JAXW202-3182 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 28.07 NA NA NA NA NA 28.3 NA NA NA 7.12 9.51 14.3 47.3 49.7 15 30.2 1005 1374.16 5582.08 150.94 7.83 5.7 3.44 8.91 13.4 44.1 49.5 15 30.4 611 2051.27 1069.84 122.46 178.54 17.89 JAXW202-3183 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 32.02 NA NA NA NA NA 24.88 NA NA NA 6.68 9.54 14 47.1 49.4 14.7 29.7 917 502.34 6072.12 98.86 6.01 0 2.78 10.65 15.9 52.8 49.6 14.9 30.1 372 1328.84 1169.27 36.7 242.42 2.78 JAXW202-3184 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 25.09 NA NA NA NA NA 23 NA NA NA 4.56 9.71 14.4 43.3 44.6 14.8 33.3 832 650.26 3763.37 134.52 11.86 0 0.62 9.47 13.4 41.2 43.5 14.1 32.5 273 88.72 514.85 10.73 4.15 1.61 JAXW202-3185 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 29.29 NA NA NA NA NA 26.78 NA NA NA 4 9.41 13.6 48.7 51.8 14.5 27.9 729 422.4 3505.6 68.4 3.6 0 25.1 8.08 12.1 41.9 51.9 15 28.9 667 20034.82 3380.97 436.74 1009.02 238.45 JAXW202-3186 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 25.15 NA NA NA NA NA 26.45 NA NA NA 5.2 10.65 15.8 49.6 46.6 14.8 31.9 649 558.48 4468.88 171.08 1.56 0 1.16 8.42 13.4 38.5 45.7 15.9 34.8 460 225.39 902.71 30.74 1.04 0 JAXW202-3187 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 29.76 NA NA NA NA NA 26.49 NA NA NA 4.96 10.98 14.9 44.9 40.9 13.6 33.2 811 960.26 3912.94 74.4 12.4 0 1.26 10.94 15.2 44.3 40.5 13.9 34.3 459 311.09 832.61 29.61 82.53 4.03 JAXW202-3188 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 29.87 NA NA NA NA NA 28.77 NA NA NA 3.44 9.55 14.7 52.2 54.7 15.4 28.2 639 561.75 2811.17 56.42 8.6 1.72 1.4 10.03 14.6 54.7 54.5 14.6 26.7 426 58.66 1297.38 34.86 9.1 0 JAXW202-3189 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 20.97 NA NA NA NA NA 18.16 NA NA NA 6.34 9.95 16.7 64.9 65.2 16.8 25.7 655 1266.1 4751.2 318.9 3.8 0 22.76 9.64 16.4 62.3 64.6 17 26.3 503 18028.2 3138.6 518.93 1001.44 72.83 JAXW202-3190 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 28.09 NA NA NA NA NA 25.76 NA NA NA 5.38 9.55 15 51.5 53.9 15.7 29.1 801 1086.76 4050.6 213.05 25.82 3.77 2.28 8.06 14 42.9 53.2 17.4 32.6 502 1087.33 1058.83 62.93 70.91 0 JAXW202-3191 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 33.68 NA NA NA NA NA 28.17 NA NA NA 6.62 11.19 16 54 48.3 14.3 29.6 713 797.05 5457.53 354.83 8.61 1.32 1.52 10.62 15.9 50.6 47.6 15 31.4 230 606.48 782.95 58.37 67.18 5.02 JAXW202-3192 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 29.6 NA NA NA NA NA 24.29 NA NA NA 2.96 10.33 15.6 57.6 55.8 15.1 27.1 745 337.74 2488.47 118.4 10.66 4.44 1.06 9.41 15 50.2 53.3 15.9 29.9 272 206.49 773.8 58.94 17.81 2.97 JAXW202-3193 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 30.52 NA NA NA NA NA 24.89 NA NA NA 5 9.59 14.6 43.8 45.7 15.2 33.3 650 959.5 3906 118.5 15 1 2.58 10.09 17 44.9 44.5 16.8 37.9 458 1599.08 702.53 70.69 195.05 12.38 JAXW202-3194 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 23.26 NA NA NA NA NA 21.08 NA NA NA 5.34 9.83 14.5 44.3 45.1 14.8 32.7 815 899.26 4230.35 200.25 8.01 1.6 1.9 8.18 12.7 36.1 44.1 15.5 35.2 460 940.12 780.33 94.81 80.37 4.37 JAXW202-3195 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 29.58 NA NA NA NA NA 27.09 NA NA NA 5.28 10.31 15.2 56.3 54.6 14.7 27 931 531.7 4546.61 183.74 17.95 0 22.2 9.2 13.4 49 53.3 14.6 27.3 534 18568.08 2490.84 592.74 459.54 88.8 JAXW202-3196 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 30.75 NA NA NA NA NA 27.51 NA NA NA 8 10.03 16.1 56.8 56.6 16.1 28.3 691 930.4 6808 246.4 14.4 0 2.1 9.91 16.5 54.3 54.8 16.6 30.4 258 740.25 1239 70.77 48.51 1.68 JAXW202-3197 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 26.69 NA NA NA NA NA 21.59 NA NA NA 4.88 10.81 15.5 58.8 54.4 14.3 26.4 802 319.15 4397.86 148.84 10.74 3.42 0.86 10.17 16.1 53.4 52.5 15.8 30.1 430 114.38 701.93 22.62 21.07 0 JAXW202-3198 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 30.49 NA NA NA NA NA 26.7 NA NA NA 3.66 9.01 14.8 45 49.9 16.4 32.9 674 513.86 2996.08 122.98 27.08 0 23.62 8.65 14.2 43 49.7 16.4 33 353 19689.63 2579.3 795.99 477.12 77.95 JAXW202-3199 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 28.32 NA NA NA NA NA 25.13 NA NA NA 7.62 10.39 14.6 45.2 43.5 14.1 32.3 584 970.03 6248.4 372.62 28.19 0 1.18 9.81 14 42.6 43.4 14.3 32.9 262 142.9 999.11 20.53 17.46 0 JAXW202-3200 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 27.04 NA NA NA NA NA 24.6 NA NA NA 9.28 10.56 15.8 53.9 51 15 29.3 817 1436.54 7642.08 185.6 12.06 2.78 0.86 6.09 8.6 30 49.3 14.1 28.7 284 167.18 672.18 12.64 7.91 0 JAXW202-3201 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 28.75 NA NA NA NA NA 22.53 NA NA NA 5.36 9.07 13.2 43.7 48.2 14.6 30.2 645 444.34 4803.63 102.38 7.5 1.61 3.4 8.81 14.7 41.5 47.1 16.7 35.4 300 1977.44 1095.48 89.42 236.3 1.36 JAXW202-3202 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 29.44 NA NA NA NA NA 26.04 NA NA NA 4.68 9.64 14.7 48.2 50 15.2 30.5 814 506.38 4020.12 143.68 9.83 0 2.68 9.01 13.3 44.4 49.3 14.8 30 355 942.82 1637.75 49.85 47.97 1.88 JAXW202-3203 Diversity Outbred Female Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 26.38 NA NA NA NA NA 21.15 NA NA NA 6.58 11.49 15.9 56.2 48.9 13.8 28.3 714 806.71 5412.05 337.55 11.84 11.84 2.02 9.97 16.2 48.1 48.2 16.2 33.7 503 1124.74 819.11 49.69 23.23 3.23 JAXW202-3204 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 28.28 NA NA NA NA NA 24.84 NA NA NA 3.62 8.73 16.1 51.4 58.9 18.4 31.3 895 553.5 2948.85 104.98 10.86 1.81 5.36 9.43 14.3 53.7 56.9 15.2 26.6 518 3531.7 1520.1 236.38 58.96 11.79 JAXW202-3205 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 23.59 NA NA NA NA NA 23.37 NA NA NA 8.98 10.01 15.4 55.9 55.8 15.4 27.5 800 1150.34 7539.61 256.83 23.35 8.98 2.26 9.21 13.6 50.2 54.5 14.8 27.1 416 1071.69 1046.38 96.28 45.65 0 JAXW202-3206 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 25.05 NA NA NA NA NA 22.78 NA NA NA 6 10.38 16.1 61.8 59.5 15.5 26.1 892 834.6 4941.6 219.6 3.6 0 1.68 9.56 15.1 54.5 57 15.8 27.7 260 576.24 1048.49 10.92 42.5 1.85 JAXW202-3207 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 31.35 NA NA NA NA NA 26.31 NA NA NA 7.54 10.36 15.2 49.5 47.8 14.7 30.7 742 947.02 6071.21 488.59 32.42 0 NA 8.74 15.1 40.6 46.5 17.3 37.2 653 51168.7 3178.64 1155.35 1620.94 362.12 JAXW202-3208 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 26.54 NA NA NA NA NA 26.98 NA NA NA 4.38 10.42 14.6 57.2 54.9 14 25.5 789 522.97 3727.82 117.82 11.39 0 1.18 8.16 12.9 43.6 53.4 15.8 29.6 193 149.51 911.08 43.07 66.32 10.03 JAXW202-3209 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 23.29 NA NA NA NA NA 20.74 NA NA NA 7.94 11.24 16.2 62.9 56 14.4 25.8 875 1305.34 6406.79 213.59 13.5 0.79 1.06 10.45 15.6 57.6 55.1 14.9 27.1 423 240.3 760.23 42.93 11.24 5.19 JAXW202-3210 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 30.59 NA NA NA NA NA 28.79 NA NA NA 4.48 9.58 14.9 48.8 50.9 15.6 30.5 485 557.76 3716.16 188.16 10.3 7.17 1.12 8.06 12.7 40.1 49.8 15.8 31.7 298 131.49 919.86 59.36 9.41 0 JAXW202-3211 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 25.07 NA NA NA NA NA 22.14 NA NA NA 3.96 11 15.2 52.9 48.1 13.8 28.7 674 422.14 3369.56 117.61 41.98 8.71 1.62 7.63 13 35.3 46.3 17 36.8 155 226.96 1305.23 35.32 49.25 3.4 JAXW202-3212 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 28.87 NA NA NA NA NA 26.8 NA NA NA 6.06 10.78 16.2 56.4 52.3 15 28.7 821 1064.74 4869.82 104.23 19.39 1.82 1.24 8.79 12.6 45.2 51.4 14.3 27.9 324 367.91 779.96 31.12 57.54 3.47 JAXW202-3213 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 29.75 NA NA NA NA NA 22.77 NA NA NA 8.56 10.87 16.5 56.9 52.3 15.2 29 814 1566.48 6790.65 175.48 26.54 1.71 18.76 10.89 16.1 55.5 51 14.8 29 323 15946 2011.07 388.33 337.68 76.92 JAXW202-3214 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-28 NA 25.89 NA NA NA NA NA 21.33 NA NA NA 7.66 8.58 14.1 38.4 44.8 16.4 36.7 433 824.98 6548.53 278.06 6.89 1.53 0.98 9.94 14.7 43.6 43.9 14.8 33.7 337 194.04 739.8 16.76 24.01 5.39 JAXW202-3215 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 26.02 NA NA NA NA NA 19.8 NA NA NA 4.64 10.19 14.5 53.8 52.8 14.2 27 774 709.92 3773.25 144.77 12.53 0 2.6 10.48 15.7 54.2 51.7 15 29 537 696.8 1783.86 73.84 41.86 3.64 JAXW202-3216 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 27.62 NA NA NA NA NA 22.2 NA NA NA 3.2 9.6 15.5 53.7 55.9 16.1 28.9 891 547.2 2447.68 198.08 5.76 1.6 1.96 10.84 15.3 59.6 55 14.1 25.7 576 1121.9 725.79 22.74 74.68 14.9 JAXW202-3217 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 26.82 NA NA NA NA NA 24.29 NA NA NA 9.58 10.35 15.2 49.7 48 14.7 30.6 693 1086.37 8284.78 201.18 7.66 0 1.58 9.77 14.3 44.6 45.6 14.6 32.1 396 256.91 1248.04 24.33 49.45 1.26 JAXW202-3218 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 27.13 NA NA NA NA NA 25.4 NA NA NA 16.74 10.33 15.8 59.6 57.7 15.3 26.5 790 2683.42 13644.77 386.69 23.44 1.67 3.28 8.91 13.7 49.9 56 15.4 27.5 444 458.54 2712.23 71.18 38.38 0 JAXW202-3219 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 28.92 NA NA NA NA NA 24.32 NA NA NA 4.06 9.28 15.6 48.6 52.4 16.8 32.1 548 645.95 3287.79 120.99 5.28 0 1.98 9.66 14.1 49 50.7 14.6 28.8 254 873.38 948.02 50.29 105.34 2.77 JAXW202-3220 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 27.93 NA NA NA NA NA 26.28 NA NA NA 7.24 9.51 16.5 59.2 62.3 17.4 27.9 1027 1045.46 5969.38 211.41 14.48 0 1.58 9.25 14.8 55.1 59.6 16 26.9 343 158 1336.52 58.78 24.81 1.74 JAXW202-3221 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 26.66 NA NA NA NA NA 26.33 NA NA NA 4.2 8.92 16.2 57.3 64.2 18.2 28.3 717 286.02 3816.12 81.06 16.8 0 11.74 9.01 14.8 55.9 62 16.4 26.5 476 9161.9 1993.45 381.55 187.84 15.26 JAXW202-3222 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 24.12 NA NA NA NA NA 24.53 NA NA NA 3.84 10.36 15.8 59.6 57.5 15.3 26.5 864 873.22 2779.01 187.01 1.15 0 1.26 10.42 16.1 57.6 55.3 15.5 28 387 471.37 695.77 81.9 10.84 0 JAXW202-3223 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 28.04 NA NA NA NA NA 24.56 NA NA NA 4.84 9.78 16.1 51.3 52.5 16.5 31.4 603 1085.61 3569.5 176.66 7.74 0 1.46 9.79 14.8 49.7 50.8 15.1 29.8 373 396.39 992.51 42.34 28.76 0 JAXW202-3224 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 29.82 NA NA NA NA NA 24.55 NA NA NA 4.46 8.97 15.4 47 52.4 17.2 32.8 810 600.32 3577.37 266.71 11.6 3.57 1.88 8.39 14 42.6 50.8 16.7 32.9 505 958.42 764.41 90.8 55.65 10.9 JAXW202-3225 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 32.38 NA NA NA NA NA 28.15 NA NA NA 6.94 10.27 15.9 64.5 62.8 15.5 24.7 1008 859.87 5941.33 125.61 11.1 2.08 7.18 9 14.3 53.9 59.9 15.9 26.5 444 5570.24 1191.88 191.71 202.48 23.69 JAXW202-3226 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 26.74 NA NA NA NA NA 22.35 NA NA NA 9.32 10.35 15.4 52.1 50.3 14.9 29.6 630 1512.64 7567.84 229.27 10.25 0 3.24 10.5 15.7 50.3 47.9 15 31.2 327 1777.79 1234.76 77.44 148.72 1.3 JAXW202-3227 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 29.32 NA NA NA NA NA 25.4 NA NA NA 8.58 9.44 15.7 54 57.2 16.6 29.1 758 1003 7390.81 175.89 7.72 1.72 0.9 10.33 15.1 57.5 55.7 14.6 26.3 275 336.87 505.71 29.25 22.59 5.49 JAXW202-3228 Diversity Outbred Male Group 21 - Set H - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-28 NA 27.06 NA NA NA NA NA 24.25 NA NA NA 4 9.78 15.8 51.6 52.8 16.2 30.6 817 337.2 3542.8 116.4 1.6 1.6 2.1 9.99 16.2 50.5 50.6 16.2 32.1 412 847.14 1130.22 80.22 40.74 1.68 JAXW202-3229 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 26.78 NA NA NA NA NA 24.94 NA NA NA 9 12.97 18.5 72.4 55.8 14.3 25.6 1095 1694.7 7073.1 224.1 3.6 3.6 3.04 10.69 16.9 60.7 56.8 15.8 27.8 620 979.18 1991.81 48.94 15.81 4.56 JAXW202-3230 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 26.71 NA NA NA NA NA 27.32 NA NA NA 7.14 10.56 14.6 53 50.2 13.8 27.5 814 1700.75 5276.46 156.37 5.71 0 1.46 8.55 13 42.2 49.4 15.2 30.8 460 302.8 1142.6 10.51 3.94 0 JAXW202-3231 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 32.92 NA NA NA NA NA 26.08 NA NA NA 9.4 10.75 14.9 60 55.8 13.9 24.8 1012 1795.4 7366.78 230.3 3.76 3.76 3.26 10.76 17 59.5 55.3 15.8 28.6 583 370.34 2821.53 55.75 12.39 0 JAXW202-3232 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 37.82 NA NA NA NA NA 29.99 NA NA NA 5.32 11.15 15.2 57.1 51.2 13.6 26.6 1031 1123.58 4060.22 125.02 9.04 1.6 1.96 10.75 17.1 54.3 50.5 15.9 31.5 569 714.22 1163.06 62.52 15.48 4.7 JAXW202-3233 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 32.77 NA NA NA NA NA 24.44 NA NA NA 3.66 10.62 15.5 51 48 14.6 30.4 957 1128.01 2269.57 235.7 22.33 4.76 1.1 9.72 15.9 45.4 46.7 16.4 35 397 435.93 625.9 18.48 17.93 1.76 JAXW202-3234 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 26.3 NA NA NA NA NA 21.98 NA NA NA 5.84 10.98 17.2 56.8 51.7 15.7 30.3 922 1333.27 4362.48 143.66 0 0 1.16 9.76 15.4 49.2 50.4 15.8 31.3 467 272.02 843.55 25.75 16.12 2.67 JAXW202-3235 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 27.33 NA NA NA NA NA 23.91 NA NA NA 3.26 11.25 17.3 61.9 55 15.4 27.9 969 311.98 2854.13 94.21 0 0 1.84 8.68 13.8 46.1 53.1 15.9 29.9 503 552.37 1221.39 59.8 6.44 0 JAXW202-3236 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 30.35 NA NA NA NA NA 22.5 NA NA NA 6.06 11.03 16.8 61.5 55.8 15.2 27.3 1018 1019.29 4856.48 159.38 20 5.45 0.86 10.87 17.5 59.1 54.4 16.1 29.6 494 182.32 657.13 14.19 4.39 1.89 JAXW202-3237 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 31.23 NA NA NA NA NA 27.04 NA NA NA 6.36 10.17 16.2 50.5 49.7 15.9 32.1 796 816.62 5468.96 61.69 10.18 1.91 2.06 10.36 15.4 49.7 48 14.9 31 579 663.11 1337.76 50.68 4.94 3.5 JAXW202-3238 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 35.18 NA NA NA NA NA 28.17 NA NA NA 9.24 10.4 17.4 66.6 64 16.7 26.1 1146 1404.48 7738.5 93.32 3.7 0 1.06 9.56 15.6 59.5 62.2 16.3 26.2 631 218.47 794.89 41.34 5.41 0 JAXW202-3239 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 29.33 NA NA NA NA NA 27.62 NA NA NA 7.96 9.65 16.1 48.4 50.2 16.7 33.3 796 1844.33 5809.21 286.56 17.51 1.59 1.74 9.61 14.7 47 48.9 15.3 31.3 474 349.22 1365.9 21.4 0 3.48 JAXW202-3240 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 25.57 NA NA NA NA NA 21.95 NA NA NA 6.2 10.57 16.8 49.2 46.5 15.9 34.1 632 1244.96 4876.92 58.28 17.36 1.86 0.54 10.22 15.8 46.3 45.3 15.5 34.1 227 120.53 399.76 0 8.91 10.75 JAXW202-3241 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 32.96 NA NA NA NA NA 28.84 NA NA NA 2.88 11.01 15.8 55.2 50.1 14.4 28.6 892 508.32 2306.3 59.9 5.76 0 0.94 8.58 13.3 42.6 49.7 15.5 31.2 391 103.68 795.62 38.92 1.79 0 JAXW202-3242 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 30.43 NA NA NA NA NA 24.86 NA NA NA 5.22 11.72 16.8 53.8 45.9 14.3 31.2 776 1419.32 3688.97 102.31 5.74 4.18 1.1 10.86 16.4 48.9 45 15.1 33.5 391 503.8 513.37 64.68 14.41 3.63 JAXW202-3243 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 27.8 NA NA NA NA NA 22.26 NA NA NA 4.22 10.13 17.7 52.5 51.8 17.5 33.7 729 926.71 3170.06 107.19 15.61 0 1 9.1 14.4 46.2 50.8 15.8 31.2 363 76.6 875.8 45.4 0.2 1.9 JAXW202-3244 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 27.73 NA NA NA NA NA 23.66 NA NA NA 5.38 11.78 16.7 66 56 14.2 25.3 940 766.65 4448.72 136.11 26.36 1.61 1.44 9.81 16.4 53.1 54.1 16.7 30.9 488 428.11 969.98 38.59 3.31 0 JAXW202-3245 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 22.75 NA NA NA NA NA 18.53 NA NA NA 4.88 10.89 17.3 49 45 15.9 35.3 806 1013.09 3784.44 72.71 9.76 0 1.84 10.12 14.6 44.2 43.7 14.4 33 445 229.82 1605.58 4.6 0 0 JAXW202-3246 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 27.76 NA NA NA NA NA 22.41 NA NA NA 6.4 9.74 16.4 51.4 52.8 16.8 31.9 793 547.84 5681.92 168.32 1.92 0 1.02 9.7 15.1 50.1 51.6 15.6 30.1 495 185.95 814.27 16.42 1.84 1.63 JAXW202-3247 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 29.78 NA NA NA NA NA 27.44 NA NA NA 8.62 8.37 15.7 42.5 50.8 18.8 36.9 832 1258.52 7164.94 190.5 6.03 0 2.64 7.43 12.5 37.2 50.1 16.8 33.6 366 322.34 2269.34 35.11 8.18 5.28 JAXW202-3248 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 30.01 NA NA NA NA NA 26.07 NA NA NA 2.46 11.71 16.7 67.7 57.8 14.3 24.7 688 380.07 1980.3 94.46 0 5.41 0.96 9.44 14.6 53.3 56.5 15.5 27.4 335 87.36 844.22 20.06 4.22 4.13 JAXW202-3249 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 31.44 NA NA NA NA NA 26.2 NA NA NA 6.54 10.35 19.3 45.7 44.2 18.6 42.2 738 1009.12 5199.3 325.04 3.27 3.92 2.82 9.93 15.9 43.3 43.6 16 36.7 709 548.49 2135.59 119.29 14.38 1.69 JAXW202-3250 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 31.7 NA NA NA NA NA 27.86 NA NA NA 4.1 9.34 15.1 41 43.9 16.2 36.8 895 624.84 3253.35 213.61 8.2 0 2.32 9.7 15 42 43.3 15.5 35.7 683 752.38 1510.09 46.17 11.14 0 JAXW202-3251 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 31.41 NA NA NA NA NA 28.25 NA NA NA 4.26 10.19 15.9 55.5 54.5 15.6 28.6 1098 611.31 3528.13 96.28 20.87 3.41 0.66 7.94 12.6 41.9 52.8 15.9 30.1 709 136.88 499.75 17.82 3.7 1.78 JAXW202-3252 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 25.84 NA NA NA NA NA 20.64 NA NA NA 6.36 10.23 17.9 60.2 58.8 17.5 29.7 710 964.18 5264.81 127.2 3.82 0 1.4 10.14 15.1 58.2 57.4 14.9 25.9 520 185.92 1183.98 7.7 22.4 0 JAXW202-3253 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 27.46 NA NA NA NA NA 25.4 NA NA NA 6.88 9.64 15.7 49.4 51.2 16.3 31.8 817 808.4 5971.84 90.13 6.88 2.06 2.38 9.19 14.5 46.2 50.3 15.8 31.4 579 761.36 1514.16 102.82 1.67 0 JAXW202-3254 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 29.68 NA NA NA NA NA 26.61 NA NA NA 3.98 10.36 16.7 57 55 16.1 29.3 705 265.86 3601.5 107.46 5.17 0 1.3 8.77 14.2 47.4 54 16.2 30 231 68.9 1202.5 20.93 7.67 0 JAXW202-3255 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 33.49 NA NA NA NA NA 29.22 NA NA NA 10.72 10.18 16.7 50.2 49.3 16.4 33.3 830 1208.14 9277.09 219.76 15.01 0 2.78 10.66 15.3 51.2 48 14.4 29.9 1123 725.3 1956.56 89.52 5 3.61 JAXW202-3256 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 28.92 NA NA NA NA NA 25.36 NA NA NA 4.32 9.59 16.4 50.5 52.7 17.1 32.5 748 423.36 3783.46 98.5 6.05 9.07 1.22 9.82 14.6 50.6 51.5 14.9 28.9 554 136.4 1067.74 13.66 2.2 0 JAXW202-3257 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 25.72 NA NA NA NA NA 22.54 NA NA NA 5.82 10.59 15.6 53.5 50.5 14.7 29.2 749 573.27 5080.86 161.21 4.66 0 1.38 8.96 14.4 44.4 49.6 16.1 32.4 298 201.07 1170.24 2.62 6.21 0 JAXW202-3258 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 26.47 NA NA NA NA NA 20.38 NA NA NA 4.74 10.84 18.4 63.2 58.3 17 29.1 787 1060.81 3590.08 83.9 5.21 0 1.28 11.05 17.8 63.1 57.1 16.1 28.2 610 332.16 890.24 43.01 12.8 1.79 JAXW202-3259 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 29.77 NA NA NA NA NA 26.09 NA NA NA 5.42 10.88 17.2 58 53.3 15.8 29.7 784 805.95 4333.29 256.91 21.14 1.63 3.28 9.83 16.4 51 51.9 16.7 32.2 560 1209.34 1718.06 334.56 18.04 0 JAXW202-3260 Diversity Outbred Female Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 19.9 NA NA NA NA NA 20.43 NA NA NA 7.9 13.12 19.1 71.4 54.4 14.6 26.8 859 1142.34 6621.78 124.03 5.53 5.53 2.84 8.35 12.4 43.8 52.5 14.9 28.3 584 106.22 2690.05 43.74 0 0 JAXW202-3261 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 34.69 NA NA NA NA NA 27 NA NA NA 8.82 9.44 16.7 57.4 60.8 17.7 29.1 883 799.09 7736.02 280.48 4.41 0 2.4 10.26 15.6 61 59.5 15.2 25.6 715 265.68 2103.12 23.04 6.72 1.68 JAXW202-3262 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 32.64 NA NA NA NA NA 29.98 NA NA NA 6.46 11.4 16.4 56.2 49.3 14.4 29.2 775 771.32 5453.53 227.39 6.46 1.94 1.9 8.43 13.8 40.6 48.2 16.4 34 422 177.46 1633.24 89.3 0 0 JAXW202-3263 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 27.1 NA NA NA NA NA 21.63 NA NA NA 6.62 10.98 16.7 54.4 49.5 15.2 30.7 747 476.64 5916.29 225.08 1.99 0 1.2 11.36 16.7 56 49.3 14.7 29.8 580 282.96 857.76 45.36 14.04 0 JAXW202-3265 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 36.51 NA NA NA NA NA 28.01 NA NA NA 7.6 12.24 17.5 65.9 53.8 14.3 26.6 793 633.08 6722.2 232.56 12.16 0 1.7 10.9 16.8 57.6 52.8 15.4 29.2 535 306.17 1267.52 96.22 26.69 3.06 JAXW202-3266 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-19 2011-01-27 NA 28.4 NA NA NA NA NA 25.69 NA NA NA 6.28 9.6 16.1 53.2 55.4 16.8 30.3 482 829.59 5351.19 92.94 5.02 1.88 1.3 8.33 13.2 45 54 15.8 29.3 239 193.18 1071.85 34.45 0.39 0 JAXW202-3267 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 16.39 NA NA NA NA NA 15.8 NA NA NA 7.92 10.61 14.5 48.2 45.4 13.7 30.1 697 963.07 6608.45 332.64 15.84 0 7.76 9.04 12.7 40.3 44.6 14 31.5 691 3552.53 3934.32 207.19 59.75 6.21 JAXW202-3268 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 24.31 NA NA NA NA NA 21.3 NA NA NA 3.56 9.37 13.9 48.4 51.7 14.8 28.7 619 407.26 3050.21 83.66 15.66 3.2 9.64 8.71 13.5 44.9 51.5 15.5 30.1 394 6629.43 2655.82 307.52 30.85 16.39 JAXW202-3269 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 20.91 NA NA NA NA NA 16.8 NA NA NA 6.3 9.75 15 49.9 51.2 15.4 30.1 763 697.41 5393.43 182.7 21.42 5.04 20.98 10.74 15 55.6 51.8 14 27 659 14016.74 6082.1 667.16 195.11 18.88 JAXW202-3270 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 20.28 NA NA NA NA NA 18.3 NA NA NA 6.2 10.55 14.5 54.4 51.6 13.7 26.7 761 551.8 5384.7 228.16 31.62 3.72 7.32 8.91 11.6 45.3 50.8 13 25.6 513 3806.4 3264.72 234.97 13.91 0 JAXW202-3271 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 27.86 NA NA NA NA NA 25 NA NA NA 2.08 9.04 14.4 49.4 54.6 15.9 29.1 613 338.83 1595.36 139.36 6.66 0 14.84 9.5 13.7 51.2 53.9 14.4 26.8 369 12432.95 1684.34 598.05 105.36 20.78 JAXW202-3272 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 25.85 NA NA NA NA NA 24.5 NA NA NA 8.88 9.23 14.3 44.7 48.4 15.5 32 685 2096.57 6076.58 563.88 129.65 13.32 1.42 9.06 12.2 44 48.6 13.5 27.7 459 279.03 1038.45 47.85 51.55 3.27 JAXW202-3273 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 23.06 NA NA NA NA NA 21.4 NA NA NA 5.44 9.78 14.5 53.8 55 14.8 27 591 1126.62 4063.68 176.8 60.93 12.51 8.54 8.74 12.6 47.9 54.8 14.4 26.3 481 4925.02 3258.86 229.73 125.54 0.85 JAXW202-3274 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 24.89 NA NA NA NA NA 22.3 NA NA NA 5.28 11.66 15.3 67.5 57.9 13.1 22.7 693 1333.73 3707.09 183.74 40.66 14.78 2.22 9.46 15.5 53.9 57 16.4 28.8 430 1106.23 1049.62 27.53 34.63 1.78 JAXW202-3275 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 18.4 NA NA NA NA NA 17.4 NA NA NA 4.04 10.08 14.7 49.5 49.1 14.6 29.7 663 963.54 2897.08 155.54 18.58 5.25 2.02 9.99 15.7 50 50.1 15.7 31.4 547 817.9 1061.91 93.93 38.99 7.47 JAXW202-3277 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 18.62 NA NA NA NA NA 17.3 NA NA NA 7.74 9 15.1 50 55.6 16.8 30.2 598 1323.54 6168.01 242.26 6.19 0 3.38 9.06 14.3 50.8 56.1 15.8 28.1 305 967.69 2308.88 78.75 16.56 8.11 JAXW202-3278 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 23.44 NA NA NA NA NA 20.8 NA NA NA 5.56 9.25 13.9 46 49.7 15 30.2 708 1081.98 4323.46 121.21 26.69 6.12 5.18 9.33 14.1 46.1 49.4 15.1 30.6 431 2769.23 1977.72 198.39 216.52 18.13 JAXW202-3279 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 24.69 NA NA NA NA NA 22.5 NA NA NA 7.04 10.48 14.8 56.3 53.7 14.1 26.3 645 1024.32 5872.06 115.46 26.75 2.11 5.3 9.78 14.2 52.4 53.6 14.5 27.1 348 2205.33 2828.61 108.65 146.81 10.07 JAXW202-3280 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 22.8 NA NA NA NA NA 20.1 NA NA NA 4.02 8.4 11.8 44.3 52.7 14 26.6 580 194.97 3619.21 200.2 5.63 0 1.76 9.04 14.5 49.6 54.9 16 29.2 509 673.02 998.45 77.44 11.09 0 JAXW202-3281 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 29.01 NA NA NA NA NA 24.9 NA NA NA 9.88 9.18 13.4 45 49 14.6 29.8 830 1805.08 7460.39 564.15 42.48 7.9 3.28 10.32 14.9 50.9 49.3 14.4 29.3 341 1261.82 1851.89 120.05 35.1 11.15 JAXW202-3282 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 21.42 NA NA NA NA NA 20.2 NA NA NA 5.02 9.83 15.1 48.8 49.6 15.4 30.9 494 676.19 4214.29 107.93 22.09 0 1.18 9.63 14.5 47.3 49.1 15.1 30.7 136 46.37 1103.77 18.41 11.09 0.35 JAXW202-3283 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 25.21 NA NA NA NA NA 21.2 NA NA NA 6.42 9.94 14.3 44.9 45.2 14.4 31.8 674 768.47 5508.36 116.2 21.83 5.78 1.88 9.54 14.3 43.4 45.5 15 32.9 442 457.03 1328.6 61.1 31.58 1.88 JAXW202-3284 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 19.38 NA NA NA NA NA 17.1 NA NA NA 3.9 8.68 15.1 47.3 54.5 17.4 31.9 686 535.86 3255.72 104.52 3.51 0 4.72 8.13 12.7 44 54.1 15.6 28.9 620 2669.16 1843.16 135.46 58.06 14.16 JAXW202-3285 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 19.03 NA NA NA NA NA 18.2 NA NA NA 3.84 11.22 15.3 47.2 42.1 13.6 32.4 582 564.48 3181.82 85.63 8.45 0 1.46 8.65 12.3 36.7 42.4 14.2 33.5 303 31.97 1371.23 42.49 12.41 1.9 JAXW202-3286 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 26.07 NA NA NA NA NA 21.3 NA NA NA 4.7 9.95 15.2 48 48.2 15.3 31.7 600 621.34 3835.67 221.37 21.62 0 0.64 10.14 15 49.3 48.6 14.8 30.4 264 100.16 478.59 26.82 26.18 8.19 JAXW202-3287 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 23.73 NA NA NA NA NA 19.5 NA NA NA 2.82 9 15.5 49.8 55.3 17.2 31.1 587 416.23 2263.61 121.54 14.66 3.67 1.24 9.63 14.4 53.9 56 15 26.7 173 132.43 1053.26 40.42 8.18 5.83 JAXW202-3288 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 18.44 NA NA NA NA NA 18.6 NA NA NA 5.4 10.8 15.2 59.3 54.9 14.1 25.6 675 824.04 4425.3 147.42 1.62 1.62 2.92 7.73 12.3 42.3 54.7 15.9 29.1 381 818.48 1983.56 107.16 10.8 0 JAXW202-3289 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 23.89 NA NA NA NA NA 17.6 NA NA NA 12.98 11.12 15.4 56.7 51 13.8 27.2 775 2915.31 9483.19 445.21 132.4 1.3 34.48 9.88 15.3 50.6 51.2 15.5 30.2 581 25042.82 7495.95 1599.87 317.22 24.14 JAXW202-3290 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 21.33 NA NA NA NA NA 20.5 NA NA NA 5.16 10.12 15.7 62.3 61.6 15.5 25.2 669 514.97 4401.48 237.88 5.68 0 3.38 7.85 13.1 47.5 60.5 16.7 27.6 496 1490.92 1699.8 159.54 25.35 4.06 JAXW202-3291 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 25.17 NA NA NA NA NA 22.92 NA NA NA 6.74 10.03 15.9 50.5 50.3 15.9 31.5 567 775.77 5655.53 249.38 56.62 3.37 1.36 8.69 14.4 43.3 49.8 16.6 33.3 416 217.74 1119.01 16.32 3.4 3.54 JAXW202-3292 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 29.25 NA NA NA NA NA 25.89 NA NA NA 3.92 10.84 14.9 58.5 54 13.7 25.5 731 604.46 3201.86 96.82 9.41 7.06 1.36 9.78 12.7 51.5 52.7 13 24.7 437 54.67 1300.84 4.49 0 0 JAXW202-3293 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 29.7 NA NA NA NA NA 25.45 NA NA NA 8.36 11.01 16.1 49.7 45.1 14.6 32.4 813 743.2 7416.99 181.41 18.39 0 2.18 10.46 14 46.3 44.3 13.4 30.2 493 81.31 2067.95 27.03 3.71 0 JAXW202-3294 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 27.97 NA NA NA NA NA 24.97 NA NA NA 4.04 10.57 16.4 61.3 58 15.5 26.8 893 294.92 3677.21 56.16 8.48 3.23 1.32 10.2 15.5 57.8 56.7 15.2 26.8 346 134.9 1142.46 40.79 1.98 0 JAXW202-3295 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 26.93 NA NA NA NA NA 24.66 NA NA NA 5.26 9.68 14.5 46.9 48.5 15 30.9 866 633.3 4453.64 159.9 13.15 0 2.24 11.4 16.2 54.5 47.8 14.2 29.7 380 453.38 1717.18 67.87 0 1.79 JAXW202-3296 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 26.14 NA NA NA NA NA 21.96 NA NA NA 5.36 10.4 16.4 55.2 53.1 15.8 29.7 632 675.36 4529.74 154.9 0 0 1.32 9.46 14.5 49.1 51.9 15.3 29.5 360 141.11 1115.4 43.82 15.97 3.83 JAXW202-3297 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 30.41 NA NA NA NA NA 21.41 NA NA NA 4.5 10.79 17 51.6 47.8 15.8 32.9 667 865.8 3586.05 26.1 19.8 1.8 2.92 10.78 16.2 50.3 46.7 15 32.2 607 1573.3 1002.44 325.87 16.35 1.75 JAXW202-3298 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 30.56 NA NA NA NA NA 23.83 NA NA NA 6.82 10.18 16.8 58.9 57.9 16.5 28.5 620 1034.59 5627.18 147.31 7.5 3.41 0.98 9.28 13.8 51.8 55.8 14.9 26.6 273 207.86 731.96 28.22 11.96 0 JAXW202-3299 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 34.24 NA NA NA NA NA 29.45 NA NA NA 7.28 10.26 15.5 50.5 49.2 15.1 30.7 696 1121.85 6011.1 133.95 13.1 0 2.02 9.12 14.8 43.3 47.5 16.2 34.2 523 452.08 1457.23 84.84 17.17 8.48 JAXW202-3300 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 32.35 NA NA NA NA NA 29.31 NA NA NA 6.54 11.82 17.5 69 58.4 14.8 25.4 940 939.14 5375.88 222.36 2.62 0 1.38 8.17 12.5 46.7 57.2 15.3 26.8 315 78.8 1257.18 31.74 10.49 1.79 JAXW202-3301 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 25.06 NA NA NA NA NA 25.07 NA NA NA 2.54 10.68 17.3 59 55.2 16.2 29.3 906 1016.25 1268.98 166.88 78.74 8.89 1.34 8.1 12.7 43 53.1 15.7 29.5 448 226.06 992.94 105.59 8.84 6.57 JAXW202-3302 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 26.39 NA NA NA NA NA 23.97 NA NA NA 4.54 10.05 16.6 45.4 45.2 16.5 36.6 776 1024.22 3234.3 249.7 29.96 2.27 1.76 8.78 12.8 39.1 44.5 14.6 32.7 371 146.78 1551.62 50.16 7.92 3.7 JAXW202-3303 Diversity Outbred Male Group 25 - set G - Adriamycin Doxorubicin 2010-11-26 2011-01-27 NA 24.52 NA NA NA NA NA 24.17 NA NA NA 8.16 8.42 13 41.2 48.9 15.4 31.6 1252 4459.44 3048.58 526.32 109.34 17.14 2.78 6.41 9.9 30 46.8 15.4 33 328 1523.72 1108.66 49.76 76.73 21.13 JAXW202-3304 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 24.79 NA NA NA NA NA 22 NA NA NA 2.82 12.22 16.1 60.4 49.4 13.2 26.7 887 533.26 2066.5 195.43 24.53 0 3.02 10.05 15.4 47.4 47.2 15.3 32.5 138 1688.48 1101.39 109.63 116.87 3.62 JAXW202-3305 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 22.78 NA NA NA NA NA 20 NA NA NA 4.06 9.87 15.7 52.2 52.9 15.9 30.1 628 695.48 3008.87 326.83 26.8 1.62 1.98 9.59 15 50.4 52.6 15.6 29.8 252 925.25 1007.03 27.52 20.59 0 JAXW202-3307 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 19.96 NA NA NA NA NA 19.4 NA NA NA 4.48 10.32 14.4 51.9 50.3 14 27.7 575 606.14 3728.26 119.62 17.47 8.51 7.96 8.2 12.1 40.6 49.5 14.8 29.8 276 4465.56 3125.1 348.65 8.76 11.94 JAXW202-3308 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 20.98 NA NA NA NA NA 19.4 NA NA NA 4.56 9.68 15.4 61.4 63.4 15.9 25.1 766 656.64 3732.82 139.54 25.08 5.47 2.04 9.05 14.8 56.4 62.3 16.4 26.2 450 501.84 1425.35 55.49 55.28 1.84 JAXW202-3309 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 25.85 NA NA NA NA NA 20.9 NA NA NA 4.5 10.21 14.7 49.1 48.1 14.4 29.9 742 412.2 3823.2 247.5 16.65 0 3.54 10.24 16 48.8 47.7 15.6 32.8 484 2177.45 1229.09 122.48 8.85 1.77 JAXW202-3310 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 20.91 NA NA NA NA NA 18.7 NA NA NA 3.06 8.63 15.3 47.5 55 17.7 32.2 699 306.61 2613.55 112.61 23.87 3.67 6.1 8.88 13.7 48 54.1 15.4 28.5 584 4218.76 1556.72 283.65 21.96 18.3 JAXW202-3311 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 20.2 NA NA NA NA NA 15.9 NA NA NA 7.48 10.36 14.1 53.3 51.4 13.6 26.5 598 855.71 6364.73 234.12 25.43 0 1.3 9.33 15 46.9 50.3 16.1 32 339 174.07 1073.93 32.63 17.55 1.82 JAXW202-3312 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 24.4 NA NA NA NA NA 20.7 NA NA NA 6.16 9.12 15.2 54.8 60.1 16.7 27.7 793 1130.36 4644.64 345.58 38.81 0 8.38 8.03 13.5 48 59.8 16.8 28.1 367 5716.84 2097.51 476.82 79.61 10.06 JAXW202-3313 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 19.44 NA NA NA NA NA 18.7 NA NA NA 5.12 10.7 13.9 50.2 46.9 13 27.7 840 496.13 4477.95 130.05 10.75 5.63 5.08 7.55 11.7 34.5 45.7 15.5 33.9 485 1395.98 3450.34 216.41 15.75 2.03 JAXW202-3314 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 21.42 NA NA NA NA NA 18.2 NA NA NA 5.76 9.67 15.2 49.8 51.5 15.7 30.5 617 827.14 4671.94 255.17 6.34 0 2.12 8.42 13.3 43.8 52 15.8 30.4 298 467.67 1565.83 49.82 32.65 3.82 JAXW202-3315 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 27.08 NA NA NA NA NA 24.2 NA NA NA 4.04 9.73 14.7 48.5 49.8 15.1 30.3 845 656.1 3279.27 91.3 11.31 1.62 4.44 8.61 12.4 42.9 49.8 14.4 28.9 633 1406.59 2910.86 91.46 23.09 8.44 JAXW202-3316 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 17.24 NA NA NA NA NA 16.2 NA NA NA 6.74 10.61 13.7 51 48.1 12.9 26.9 644 653.11 5734.39 336.33 14.15 2.02 14.7 9.19 12 43.1 46.9 13.1 27.8 389 10303.23 3528 777.63 77.91 14.7 JAXW202-3317 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 22.7 NA NA NA NA NA 19.9 NA NA NA 4.52 9.9 15.1 44.5 44.9 15.3 33.9 577 642.29 3708.66 147.8 15.82 5.42 23.34 10.08 15.2 45.7 45.3 15.1 33.3 319 18856.39 3531.34 777.22 144.71 28.01 JAXW202-3318 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 19.03 NA NA NA NA NA 17.1 NA NA NA 3.86 10.43 14.3 53 50.8 13.7 27 776 547.35 3085.68 204.58 22 0 4.24 10.53 17.7 53 50.3 16.8 33.4 375 2090.32 1957.18 169.6 19.93 2.97 JAXW202-3319 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 22.26 NA NA NA NA NA 21.4 NA NA NA 6.16 11.93 15.1 60.1 50.4 12.7 25.1 744 501.42 5308.07 328.33 22.18 0 4.74 9.35 13.2 46.4 49.6 14.1 28.4 578 1597.38 2907.52 202.4 32.71 0 JAXW202-3320 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 22.8 NA NA NA NA NA 19.2 NA NA NA 5.5 10.47 16.6 61.4 58.6 15.9 27 760 483.45 4791.6 217.25 5.5 1.65 9.98 8.91 16.3 51.4 57.7 18.3 31.7 383 5986 3506.97 435.13 50.9 2 JAXW202-3321 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 22.33 NA NA NA NA NA 20.8 NA NA NA 7.66 11.86 16 64.9 54.7 13.5 24.7 763 1097.68 6092 418.24 48.26 3.83 26.06 10.62 17.6 56.8 53.5 16.6 31 489 19133.25 6030.28 641.08 218.9 36.48 JAXW202-3322 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 26.55 NA NA NA NA NA 23.1 NA NA NA 5.12 9.72 14 47 48.4 14.4 29.8 516 505.86 4393.98 216.06 0 3.58 2.98 9.15 14 43.4 47.4 15.3 32.3 366 901.45 1994.22 63.77 19.07 1.49 JAXW202-3323 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 15.44 NA NA NA NA NA 14.6 NA NA NA 2.8 9.38 15.1 48.5 51.7 16.1 31.1 482 483.84 2211.72 102.48 1.96 0 11.38 7.53 9.3 37.1 49.3 12.4 25.1 106 7177.37 3211.44 877.4 112.66 0 JAXW202-3324 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 20.22 NA NA NA NA NA 17.2 NA NA NA 3 10.07 15.4 49.3 49 15.3 31.2 451 720.3 2194.8 76.8 8.4 0 16.36 7.61 10.7 36.4 47.8 14.1 29.4 172 12512.13 2795.92 914.52 135.79 3.27 JAXW202-3325 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 21.63 NA NA NA NA NA 21.1 NA NA NA 2.88 9.93 14.7 48.8 49.1 14.8 30.1 643 631.01 2170.08 74.3 4.32 0 5.4 11.06 18.1 54 48.8 16.4 33.5 126 4045.14 1108.08 136.08 83.7 27.54 JAXW202-3326 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 18.99 NA NA NA NA NA 17.4 NA NA NA 3.04 8.82 14.6 45.2 51.2 16.6 32.3 604 529.26 2394.3 103.36 11.25 1.82 1.46 10.27 13.7 52.2 50.8 13.3 26.2 422 404.13 1002.58 16.21 36.79 0 JAXW202-3327 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-19 2011-01-25 NA 23.96 NA NA NA NA NA 22.3 NA NA NA 5.04 10.59 15.9 54.9 51.8 15 29 497 428.4 4473.5 123.98 14.62 0 3.66 9.38 13.9 48 51.2 14.8 29 325 1392.26 2131.22 127 9.52 0 JAXW202-3328 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-25 NA 22.08 NA NA NA NA NA 18.2 NA NA NA 3.08 9.26 15.1 43.7 47.2 16.3 34.6 523 383.46 2591.82 101.02 3.7 0 0.78 8.07 13.6 37.2 46.1 16.9 36.6 128 119.18 653.17 2.34 3.43 1.79 JAXW202-3329 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-25 NA 20.78 NA NA NA NA NA 19.1 NA NA NA 4.04 10.2 14.7 49.2 48.2 14.4 29.9 795 705.38 3069.59 255.33 7.68 1.62 3.2 8.98 12.9 43.1 48 14.4 29.9 366 1265.28 1784.64 106.24 43.2 0.96 JAXW202-3330 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-25 NA 24.83 NA NA NA NA NA 20.6 NA NA NA 4.14 11.11 15.2 56.2 50.6 13.7 27 868 445.46 3495.4 192.1 5.38 1.66 6.76 9.32 14.5 46.7 50.1 15.6 31 661 4012.74 2266.63 428.58 45.97 5.41 JAXW202-3331 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-25 NA 19.05 NA NA NA NA NA 16.6 NA NA NA 3.9 9.66 14.2 44.4 46 14.7 32 907 386.49 3399.24 109.2 5.07 0 4 9.43 13.9 43 45.6 14.7 32.3 351 749.6 3090.4 132.4 19.6 8.8 JAXW202-3332 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-25 NA 20.09 NA NA NA NA NA 18.7 NA NA NA 4.16 9.03 14.9 43.2 47.8 16.5 34.5 452 620.26 3372.51 165.57 1.66 0 5.72 9.65 14.9 46.3 48 15.4 32.2 370 4249.39 1277.28 163.59 29.17 0 JAXW202-3333 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 22.08 NA NA NA NA NA 20.15 NA NA NA 5.54 11.45 15 52.3 45.7 13.1 28.7 629 857.59 4487.4 175.06 12.19 7.2 1.2 10.16 13.8 45.5 44.8 13.6 30.3 428 76.56 1071.96 42.96 6.72 1.8 JAXW202-3334 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 18.02 NA NA NA NA NA 15.92 NA NA NA 6.08 9.75 16.8 55.3 56.7 17.2 30.4 414 718.66 5190.5 148.96 14.59 7.3 2.64 10.06 14.3 57.6 57.3 14.2 24.8 337 605.35 1979.21 29.83 23.76 1.85 JAXW202-3335 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 22.52 NA NA NA NA NA 19.2 NA NA NA 6.06 9.73 14.9 50.5 51.9 15.3 29.5 700 1201.7 4589.24 212.71 38.18 18.18 3.68 10.7 15.2 56.4 52.7 14.2 27 860 741.89 2834.34 95.68 8.1 0 JAXW202-3336 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 19.94 NA NA NA NA NA 16.63 NA NA NA 4.78 9.61 17.3 53 55.2 18 32.6 539 634.31 4009.46 130.02 4.78 1.91 1.56 9.29 13.8 51.8 55.8 14.9 26.6 631 313.87 1184.66 39.47 15.44 6.55 JAXW202-3337 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 19.7 NA NA NA NA NA 18.89 NA NA NA 4.34 9.66 16 47.9 49.6 16.6 33.4 631 771.22 3432.51 110.67 16.06 9.55 3.26 9.29 13.7 46.4 49.9 14.7 29.5 733 616.79 2596.92 43.03 3.59 0 JAXW202-3338 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 27.17 NA NA NA NA NA 21.94 NA NA NA 4.1 10.38 15.5 51.8 49.9 14.9 29.9 460 613.77 3295.99 188.6 1.64 0 1.28 10.16 13.7 51.1 50.3 13.5 26.8 289 89.34 1122.94 58.11 7.68 1.79 JAXW202-3339 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 21.18 NA NA NA NA NA 21.2 NA NA NA 6.88 9.9 14.5 47.2 47.7 14.6 30.7 693 967.33 5742.74 155.49 13.07 1.38 1.56 7.9 12.8 37.7 47.7 16.2 34 472 194.38 1284.35 79.56 1.72 0 JAXW202-3340 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 17.17 NA NA NA NA NA 16.32 NA NA NA 5.46 11.5 17.6 50.6 44 15.3 34.8 535 992.63 4410.59 51.32 1.64 3.82 2.92 8.42 12.3 36.8 43.7 14.6 33.4 762 332.88 2536.6 48.76 0 1.75 JAXW202-3341 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 20.91 NA NA NA NA NA 18.84 NA NA NA 4.28 11.62 19.2 53.8 46.3 16.5 35.7 522 363.37 3754.42 153.22 8.99 0 1.52 10.58 14.4 49.8 47.1 13.6 28.9 367 67.34 1399.16 35.26 16.11 1.82 JAXW202-3342 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 21.46 NA NA NA NA NA 20.53 NA NA NA 3.02 11.57 17.7 52.2 45.1 15.3 33.9 584 791.54 2118.83 109.63 0 0 1.68 7.6 11.2 33.7 44.3 14.7 33.2 556 182.95 1424.47 63.17 7.06 2.35 JAXW202-3343 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 21.2 NA NA NA NA NA 17.85 NA NA NA 3.48 12.74 18.8 57.3 45 14.8 32.8 487 582.2 2829.24 68.56 0 0 1.22 10.62 14.3 46.9 44.2 13.5 30.5 399 183.85 1003.33 29.16 3.54 0 JAXW202-3344 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 21.37 NA NA NA NA NA 19.24 NA NA NA 4.3 11.6 19.5 57.4 49.5 16.8 34 606 801.09 3262.84 232.63 3.44 0 2.5 11.26 17.6 56.5 50.2 15.6 31.2 1206 734.25 1683.5 72.75 9 0 JAXW202-3345 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 18.55 NA NA NA NA NA 17.83 NA NA NA 5.94 10.33 15.4 54 52.3 14.9 28.5 538 745.47 4983.66 188.3 20.79 1.78 1.38 9.93 15.6 53.6 54 15.7 29.1 310 342.38 1018.44 15.87 1.52 1.79 JAXW202-3346 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 31.28 NA NA NA NA NA 23.8 NA NA NA 5.48 11.68 16.9 63.3 54.2 14.5 26.7 818 830.22 4445.38 190.16 10.96 3.84 1.68 10.36 16.6 56.9 54.9 16 29.2 508 328.1 1296.62 36.79 16.46 2.02 JAXW202-3347 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 17.71 NA NA NA NA NA 17.2 NA NA NA 2.96 11.31 15.1 59.3 52.4 13.4 25.5 624 459.69 2359.42 114.26 26.94 0 0.8 9.11 13.3 44.5 48.8 14.6 29.9 414 64.8 726.8 6.56 1.76 0 JAXW202-3348 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 20.91 NA NA NA NA NA 17.7 NA NA NA 3.16 10.38 19.1 55.3 53.3 18.4 34.5 303 769.14 2231.91 152.94 4.11 1.9 2.54 11.63 16.3 65 55.9 14 25.1 499 837.95 1633.98 68.33 0 0 JAXW202-3349 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 29.51 NA NA NA NA NA 26.46 NA NA NA 4.1 9.14 15.3 52.2 57.1 16.7 29.3 701 421.48 3480.9 166.05 29.93 1.64 1.12 9.45 15.9 55.2 58.4 16.8 28.8 554 118.27 981.79 11.2 8.74 0 JAXW202-3350 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 20.28 NA NA NA NA NA 19.13 NA NA NA 3.66 11.54 17.9 64 55.5 15.5 28 492 486.78 3040.36 131.39 1.83 0 2.1 11.15 17.4 62.3 55.9 15.6 27.9 427 412.23 1617.63 66.36 3.57 0 JAXW202-3351 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 19.31 NA NA NA NA NA 15.32 NA NA NA 2.14 10.97 15.1 47.2 43 13.8 32 581 263.01 1754.16 99.94 18.83 3.85 1.64 9.99 17.8 41.2 41.2 17.8 43.2 333 611.39 929.39 89.87 5.9 3.61 JAXW202-3352 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 21 NA NA NA NA NA 19.13 NA NA NA 6.62 11.62 19.1 66.2 57 16.4 28.9 481 1134.01 5230.46 248.91 3.97 1.99 3.18 10.35 17.4 59.5 57.5 16.8 29.2 682 672.89 2391.04 111.3 4.77 0 JAXW202-3353 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 22.63 NA NA NA NA NA 20.43 NA NA NA 2.84 12.1 19.6 63.5 52.5 16.2 30.9 382 676.77 2020.66 134.05 8.8 0 1.46 8.3 13.9 44.7 53.9 16.7 31.1 436 249.22 1098.5 96.07 11.1 5.11 JAXW202-3354 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 23.21 NA NA NA NA NA 19.15 NA NA NA 3.06 12.43 18.8 61.2 49.2 15.1 30.7 451 709.92 2140.16 159.43 44.98 5.51 1.74 9.69 14.9 48 49.5 15.4 31 463 194.01 1478.65 59.33 6.26 1.74 JAXW202-3355 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 18.88 NA NA NA NA NA 17.57 NA NA NA 5.26 12.46 19.8 58.3 46.8 15.9 34 335 783.74 4255.34 220.39 0 0 1.62 9.63 14.2 45.8 47.6 14.7 31 531 167.99 1395.79 52.49 3.73 0 JAXW202-3356 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 21.15 NA NA NA NA NA 19.13 NA NA NA 5.64 12.3 19.2 59.5 48.4 15.6 32.3 434 1095.85 4410.48 122.39 7.9 3.38 3.26 8.57 14.3 41.3 48.2 16.7 34.6 561 1150.45 1928.94 160.07 20.54 0 JAXW202-3357 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 25.5 NA NA NA NA NA 21.81 NA NA NA 6.26 11.99 19.6 67.1 56 16.3 29.2 555 896.43 5085 267.93 5.63 5.01 2.64 10.34 16.3 59.2 57.3 15.8 27.5 513 305.98 2283.34 33.26 11.09 6.07 JAXW202-3359 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 22.95 NA NA NA NA NA 20.15 NA NA NA 9.32 10.23 16.1 47.9 46.8 15.7 33.6 535 2139.87 6581.78 582.5 12.12 3.73 3.88 11.2 16.4 52.3 46.7 14.6 31.4 454 734.1 2955.01 177.32 13.19 0 JAXW202-3360 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 20.2 NA NA NA NA NA 20.73 NA NA NA 4.56 10.74 16.5 55.7 51.9 15.4 29.6 430 575.02 3869.16 108.98 6.84 0 1.62 9.31 12.6 47.1 50.6 13.5 26.8 262 35.8 1551.15 19.44 13.45 0 JAXW202-3361 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 21.01 NA NA NA NA NA 21.69 NA NA NA 3.28 12.63 18.3 62.9 49.8 14.5 29.1 494 831.48 2223.51 199.75 24.93 0 1.3 9.56 15.3 45 47.1 16 34 273 207.61 1064.05 26.65 1.69 0 JAXW202-3362 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 19.9 NA NA NA NA NA 19.23 NA NA NA 3.66 11.92 19.2 55.9 46.9 16.1 34.3 478 543.88 3020.23 92.96 2.93 0 2.46 8.38 13 38 45.3 15.5 34.2 424 258.3 2129.87 70.36 1.48 0 JAXW202-3363 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-25 NA 21.81 NA NA NA NA NA 20.6 NA NA NA 5.4 10.08 16.8 63.9 63.4 16.7 26.3 722 502.74 4705.56 182.52 7.56 1.62 4.8 9.42 15 59 62.6 15.9 25.4 358 2546.4 2048.64 176.16 25.44 3.36 JAXW202-3364 Diversity Outbred Female Group 21 - Set E - Adriamycin + Neupogen Doxorubicin+Neupogen 2010-11-26 2011-01-25 NA 21.63 NA NA NA NA NA 21 NA NA NA 3.68 9.77 16 56.2 57.5 16.4 28.5 575 761.02 2642.24 262.02 15.09 0 21.2 9.74 14.8 55 56.5 15.2 26.9 338 17235.6 2936.2 875.56 133.56 19.08 JAXW202-3365 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 27.28 NA NA NA NA NA 25.91 NA NA NA 2.22 12.06 17.4 63.2 52.4 14.4 27.5 472 547.9 1482.29 137.64 40.4 11.77 2.04 8.14 14.1 36.5 44.8 17.3 38.6 504 412.9 1479.2 127.3 13.46 7.34 JAXW202-3366 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 23.47 NA NA NA NA NA 21.61 NA NA NA 1.84 10.04 14.7 48.3 48.1 14.6 30.4 463 170.38 1547.26 111.32 11.04 0 2.1 7.62 11.7 35.2 46.2 15.4 33.2 504 401.52 1554.84 118.86 19.11 5.67 JAXW202-3367 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 17.77 NA NA NA NA NA 15.76 NA NA NA 4.86 10.79 19.3 51.9 48.1 17.9 37.2 382 639.58 4023.11 188.57 7.29 1.94 2.64 8.63 13.2 40.9 47.4 15.3 32.3 561 241.82 2309.21 88.97 0 0 JAXW202-3368 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 22.8 NA NA NA NA NA 20.63 NA NA NA 4.02 12.36 18.4 57.5 46.5 14.9 32 327 856.66 3090.98 57.49 9.25 5.23 1.46 9.55 14.1 48.3 50.6 14.8 29.2 301 197.25 1197.2 51.25 10.51 3.8 JAXW202-3369 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 21.86 NA NA NA NA NA 21.09 NA NA NA 3.7 11.29 17.6 61.8 54.7 15.6 28.5 298 772.93 2844.19 44.4 32.93 5.55 1.4 8.14 12 43.2 53.1 14.7 27.8 238 69.16 1281 49.7 0 0 JAXW202-3370 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 18.37 NA NA NA NA NA 18.4 NA NA NA 5.52 11.75 18 64.3 54.7 15.3 28 616 729.74 4594.85 167.26 26.5 1.66 3.86 9.11 13.9 48.3 53 15.3 28.8 720 356.28 3409.15 78.74 11.58 4.25 JAXW202-3371 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 20.18 NA NA NA NA NA 20.54 NA NA NA 5.86 11.35 17.7 59 52 15.6 30 374 663.94 4947.6 226.78 19.92 1.76 1.92 8.82 13.2 44.5 50.5 15 29.7 313 136.32 1736.26 47.42 0 0 JAXW202-3374 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 21.78 NA NA NA NA NA 20.39 NA NA NA 5.42 10.23 16 55 53.8 15.6 29.1 733 556.09 4728.95 108.4 21.14 5.42 3.32 11.77 19.7 61.4 52.2 16.7 32.1 517 508.29 2722.07 89.64 0 0 JAXW202-3375 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 25.88 NA NA NA NA NA 21.65 NA NA NA 3.7 11.26 16.9 61.9 55 15 27.3 465 488.4 3006.25 202.02 0 3.7 2.16 9.3 14.7 49.5 53.2 15.8 29.7 436 703.08 1392.34 35.86 20.09 8.64 JAXW202-3376 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 22.98 NA NA NA NA NA 21.92 NA NA NA 8.34 11.22 17.8 60.7 54.1 15.9 29.3 462 1110.05 6796.27 404.49 25.02 3.34 2.26 8.95 13.6 46.5 52 15.2 29.2 363 178.31 2042.59 39.1 0 0 JAXW202-3377 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 22.28 NA NA NA NA NA 18.83 NA NA NA 3.52 11.77 19.8 62 52.7 16.8 31.9 300 426.62 2961.38 121.44 8.8 1.76 1.38 9.63 13 38.5 40 13.5 33.8 407 114.82 1231.1 30.64 1.79 1.79 JAXW202-3378 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 25.69 NA NA NA NA NA 26.14 NA NA NA 3.86 10.23 15.4 51.5 50.3 15.1 29.9 691 672.41 3041.68 115.41 24.7 5.4 1.48 10.48 17.2 50 47.7 16.4 34.4 345 213.71 1170.83 91.76 1.78 1.78 JAXW202-3379 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 22.61 NA NA NA NA NA 22.11 NA NA NA 3.36 9.41 15.2 44.6 47.4 16.2 34.1 614 402.86 2868.77 72.24 12.43 3.7 0.92 8.28 11.9 37.9 45.8 14.4 31.4 479 23.37 891.94 4.69 0 0 JAXW202-3380 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 17.78 NA NA NA NA NA 17.95 NA NA NA 6.08 9.5 13.8 47.8 50.3 14.5 28.9 570 544.16 5294.46 214.62 20.67 6.08 1.2 7.19 11 34.6 48.1 15.3 31.8 257 97.08 1065 37.08 0.84 0 JAXW202-3381 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 27.23 NA NA NA NA NA 22.68 NA NA NA 9.06 11.52 18.5 57.3 49.7 16.1 32.3 299 1384.37 7392.05 269.08 13.59 1.81 2.48 9.49 14.6 46 48.5 15.4 31.7 277 74.9 2350.3 33.23 14.88 6.7 JAXW202-3382 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 24 NA NA NA NA NA 19.59 NA NA NA 8.6 9.03 16.3 45.7 50.6 18.1 35.7 401 1116.28 7317.74 152.22 9.46 2.58 0.9 8.71 13.6 43 49.4 15.6 31.6 266 81.9 793.17 21.42 0 3.51 JAXW202-3383 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 17.64 NA NA NA NA NA 16.02 NA NA NA 5.8 9.01 14.4 44.9 49.8 16 32.1 478 924.52 4628.4 235.48 4.64 6.96 1.7 8.13 11.5 39 48 14.1 29.5 307 46.24 1577.6 61.03 15.13 0 JAXW202-3384 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 27.02 NA NA NA NA NA 25.83 NA NA NA 4.74 11.77 17.2 63.7 54.1 14.6 27 514 626.15 3966.43 131.77 14.22 1.9 1.72 11.6 17.5 60.9 52.5 15.1 28.7 292 154.8 1498.29 66.91 0 0 JAXW202-3385 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 19.54 NA NA NA NA NA 20.48 NA NA NA 2.42 12.28 18.3 69.9 56.9 14.9 26.2 510 658.48 1647.54 102.85 9.2 1.69 2.48 8.07 12.6 44.5 55.1 15.6 28.3 688 247.75 2085.93 144.58 1.74 0 JAXW202-3386 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 28.56 NA NA NA NA NA 19.12 NA NA NA 4.4 10.54 17.2 62 58.8 16.3 27.7 578 647.24 3526.6 220.44 5.28 0 2.04 10.56 16.1 60.5 57.3 15.2 26.6 465 58.55 1907.4 63.04 9.38 1.84 JAXW202-3387 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 21.17 NA NA NA NA NA 19.76 NA NA NA 6.34 11.86 21.4 73.4 61.9 18 29.2 459 1127.89 4910.33 299.88 1.9 0 6.66 8.55 13.9 51 59.6 16.3 27.3 961 500.17 5856.8 297.7 5.33 0 JAXW202-3388 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 21.91 NA NA NA NA NA 18.91 NA NA NA 4.2 11.41 19.6 60.1 52.7 17.2 32.6 420 904.26 3050.04 239.82 5.88 0 2.68 7.87 14.4 39.7 50.4 18.3 36.3 614 473.02 2004.1 199.66 3.48 0 JAXW202-3389 Diversity Outbred Female Group 25 - set F - Adriamycin Doxorubicin 2010-11-26 2011-01-26 NA 24.63 NA NA NA NA NA 25.46 NA NA NA 7.72 11.89 17.2 61.9 52.1 14.5 27.8 680 941.07 6629.16 132.01 17.76 0 2.72 10.13 15.9 50.5 49.9 15.7 31.5 461 512.45 2088.14 113.15 6.26 0